
<html lang="en"     class="pb-page"  data-request-id="7db28ea0-3ca0-43c0-bf68-8f9c3f9cb11f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01107;issue:issue:10.1021/jmcmar.2018.61.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers" /></meta><meta name="dc.Creator" content="Prithiba  Mitra" /></meta><meta name="dc.Creator" content="Joseph M.  Eckenrode" /></meta><meta name="dc.Creator" content="Abhisek  Mandal" /></meta><meta name="dc.Creator" content="Amit K.  Jha" /></meta><meta name="dc.Creator" content="Shaimaa M.  Salem" /></meta><meta name="dc.Creator" content="Markos  Leggas" /></meta><meta name="dc.Creator" content="Jürgen  Rohr" /></meta><meta name="dc.Description" content="Mithramycin A (1) was identified as the top potential inhibitor of the aberrant ETS transcription factor EWS-FLI1, which causes Ewing sarcoma. Unfortunately, 1 has a narrow therapeutic window, comp..." /></meta><meta name="Description" content="Mithramycin A (1) was identified as the top potential inhibitor of the aberrant ETS transcription factor EWS-FLI1, which causes Ewing sarcoma. Unfortunately, 1 has a narrow therapeutic window, comp..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 16, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01107" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01107" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01107" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01107" /></link>
        
    
    

<title>Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01107" /></meta><meta property="og:title" content="Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0014.jpeg" /></meta><meta property="og:description" content="Mithramycin A (1) was identified as the top potential inhibitor of the aberrant ETS transcription factor EWS-FLI1, which causes Ewing sarcoma. Unfortunately, 1 has a narrow therapeutic window, compelling us to seek less toxic and more selective analogues. Here, we used MTMSA (2) to generate analogues via peptide coupling and fragment-based drug development strategies. Cytotoxicity assays in ETS and non-ETS dependent cell lines identified two dipeptide analogues, 60 and 61, with 19.1- and 15.6-fold selectivity, respectively, compared to 1.5-fold for 1. Importantly, the cytotoxicity of 60 and 61 is &lt;100 nM in ETS cells. Molecular assays demonstrated the inhibitory capacity of these analogues against EWS-FLI1 mediated transcription in Ewing sarcoma. Structural analysis shows that positioning the tryptophan residue in a distal position improves selectivity, presumably via interaction with the ETS transcription factor. Thus, these analogues may present new ways to target transcription factors for clinical use." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01107"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01107">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01107&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01107&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01107&amp;href=/doi/10.1021/acs.jmedchem.8b01107" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 8001-8016</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01079" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01112" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Prithiba Mitra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Prithiba Mitra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Prithiba++Mitra">Prithiba Mitra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph M. Eckenrode</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph M. Eckenrode</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+M.++Eckenrode">Joseph M. Eckenrode</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Abhisek Mandal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Abhisek Mandal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Abhisek++Mandal">Abhisek Mandal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amit K. Jha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amit K. Jha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amit+K.++Jha">Amit K. Jha</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shaimaa M. Salem</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shaimaa M. Salem</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shaimaa+M.++Salem">Shaimaa M. Salem</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9149-5365" title="Orcid link">http://orcid.org/0000-0002-9149-5365</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Markos Leggas</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Markos Leggas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</div></div><span class="conrtib-corresp"><strong>*</strong>M.L.: e-mail, <a href="/cdn-cgi/l/email-protection#a2cfc3d0c98ccec7c5c5c3d1e2d7c9db8cc7c6d7"><span class="__cf_email__" data-cfemail="dab7bba8b1f4b6bfbdbdbba99aafb1a3f4bfbeaf">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Markos++Leggas">Markos Leggas</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jürgen Rohr</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jürgen Rohr</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</div></div><span class="conrtib-corresp"><strong>*</strong>J.R.: e-mail, <a href="/cdn-cgi/l/email-protection#ec869e83849edeaccc998795c2898899"><span class="__cf_email__" data-cfemail="ddb7afb2b5afef9d">[email protected]</span> uky.edu</a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%BCrgen++Rohr">Jürgen Rohr</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6447-5951" title="Orcid link">http://orcid.org/0000-0001-6447-5951</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01107&amp;href=/doi/10.1021%2Facs.jmedchem.8b01107" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 8001–8016</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 16, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 July 2018</li><li><span class="item_label"><b>Published</b> online</span>16 August 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01107" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01107</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8001%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPrithiba%2BMitra%252C%2BJoseph%2BM.%2BEckenrode%252C%2BAbhisek%2BMandal%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D17%26contentID%3Dacs.jmedchem.8b01107%26title%3DDevelopment%2Bof%2BMithramycin%2BAnalogues%2Bwith%2BIncreased%2BSelectivity%2Btoward%2BETS%2BTranscription%2BFactor%2BExpressing%2BCancers%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8016%26publicationDate%3DSeptember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01107"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1175</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01107" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Prithiba&quot;,&quot;last_name&quot;:&quot;Mitra&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;M. Eckenrode&quot;},{&quot;first_name&quot;:&quot;Abhisek&quot;,&quot;last_name&quot;:&quot;Mandal&quot;},{&quot;first_name&quot;:&quot;Amit&quot;,&quot;last_name&quot;:&quot;K. Jha&quot;},{&quot;first_name&quot;:&quot;Shaimaa&quot;,&quot;last_name&quot;:&quot;M. Salem&quot;},{&quot;first_name&quot;:&quot;Markos&quot;,&quot;last_name&quot;:&quot;Leggas&quot;},{&quot;first_name&quot;:&quot;Jürgen&quot;,&quot;last_name&quot;:&quot;Rohr&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;8001-8016&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01107&quot;},&quot;abstract&quot;:&quot;Mithramycin A (1) was identified as the top potential inhibitor of the aberrant ETS transcription factor EWS-FLI1, which causes Ewing sarcoma. Unfortunately, 1 has a narrow therapeutic window, compelling us to seek less toxic and more selective analogues. Here, we used MTMSA (2) to generate analogues via peptide coupling and fragment-based drug development strategies. Cytotoxicity assays in ETS and non-ETS dependent cell lines identified two dipeptide analogues, 60 and 61, with 19.1- and 15.6-fold selectivity, respectively, compared to 1.5-fold for 1. Importantly, the cytotoxicity of 60 and 61 is &lt;100 nM in ETS cells. Molecular assays demonstrated the inhibitory capacity of these analogues against EWS-FLI1 mediated transcription in Ewing sarcoma. Structural analysis shows that positioning the tryptophan residue in a distal position improves selectivity, presumably via interaction with the ETS transcription factor. Thus, these analogues may present new ways to target transcription factors for clinical use.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01107&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01107" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01107&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01107" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01107&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01107" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01107&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01107&amp;href=/doi/10.1021/acs.jmedchem.8b01107" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01107" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01107" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01107%26sid%3Dliteratum%253Aachs%26pmid%3D30114371%26genre%3Darticle%26aulast%3DMitra%26date%3D2018%26atitle%3DDevelopment%2Bof%2BMithramycin%2BAnalogues%2Bwith%2BIncreased%2BSelectivity%2Btoward%2BETS%2BTranscription%2BFactor%2BExpressing%2BCancers%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D17%26spage%3D8001%26epage%3D8016%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/jmcmar.2018.61.issue-17/20180913/jmcmar.2018.61.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Mithramycin A (<b>1</b>) was identified as the top potential inhibitor of the aberrant ETS transcription factor EWS-FLI1, which causes Ewing sarcoma. Unfortunately, <b>1</b> has a narrow therapeutic window, compelling us to seek less toxic and more selective analogues. Here, we used MTMSA (<b>2</b>) to generate analogues via peptide coupling and fragment-based drug development strategies. Cytotoxicity assays in ETS and non-ETS dependent cell lines identified two dipeptide analogues, <b>60</b> and <b>61</b>, with 19.1- and 15.6-fold selectivity, respectively, compared to 1.5-fold for <b>1</b>. Importantly, the cytotoxicity of <b>60</b> and <b>61</b> is <100 nM in ETS cells. Molecular assays demonstrated the inhibitory capacity of these analogues against EWS-FLI1 mediated transcription in Ewing sarcoma. Structural analysis shows that positioning the tryptophan residue in a distal position improves selectivity, presumably via interaction with the ETS transcription factor. Thus, these analogues may present new ways to target transcription factors for clinical use.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mithramycin (MTM; <b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is an aureolic acid-type polyketide drug produced by various soil bacteria of the genus <i>Streptomyces</i> and was found to possess activity against a wide variety of human cancers.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> MTM (<b>1</b>) was clinically evaluated in the 1960s and 1970s as an agent for the chemotherapy of various cancers. Despite some remarkable success using MTM (<b>1</b>) as a single agent, the results were mixed due to its narrow therapeutic index and considerable variation in patients’ ability to tolerate the drug.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Another concern was the lack of understanding of MTM’s (<b>1</b>) mode of action. Taken together, these limitations limited clinical use of MTM (<b>1</b>) as a chemotherapeutic agent, and it has now been largely abandoned.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Interest in MTM (<b>1</b>) was renewed recently after the drug was identified as the top inhibitor of the ETS transcription factor fusion, EWS-FLI1, in a screen of more than 50 000 natural products and synthetic compounds. FLI1 and ERG are ETS transcription factors that are expressed as fusions with EWS and are the primary cause of Ewing sarcoma.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Aside from Ewing sarcoma, aberrant ETS transcription factors contribute significantly to the malignancy of prostate cancer, leukemia, and lymphoma. With respect to prostate cancer, approximately 50% of patients express a truncated form of ERG as a result of the TMPRSS2-ERG gene fusion.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Interestingly, the DNA binding domain of ERG and FLI1 is conserved, and thus molecules that interfere with the activity of one should also inhibit the other. Given the importance of these aberrant transcription factors in driving malignancy, the clinical use of MTM (<b>1</b>) gave investigators hope for a “targeted” therapy. This was tested in a recent national cancer institute (NCI) conducted clinical study where Ewing sarcoma patients were enrolled to assess the utility of MTM (<b>1</b>) in a population of patients, all of whom express ETS fusions. Unfortunately, the results were inconclusive because the trial was terminated early, due to toxicities. As such, the development of less toxic and more selective analogues of MTM (<b>1</b>) is highly desirable.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of mithramycin (MTM, <b>1</b>), mithramycin SA (MTMSA, <b>2</b>), mithramycin SA-tryptophan (MTMSA-Trp, <b>3</b>), and mithramycin SA phenylalanine (MTMSA-Phe, <b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our effort to develop such analogues is largely based on mechanistic studies that focused on understanding MTM’s (<b>1</b>) mechanism of action. At the molecular level, it is known that MTM (<b>1</b>) binds to GC-rich DNA as a Mg<sup>2+</sup> coordinated dimer and modulates the activity of the transcription factor Sp1 and presumably others.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> We previously found that mithramycin SA (MTMSA; <b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which is a combinatorial biosynthetic analogue of MTM (<b>1</b>) produced by <i>S. argillaceus</i>, upon inactivation of the <i>mtmW</i> gene,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> has no cytotoxicity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 19). Using the free carboxylic acid group in the 3-side chain of MTMSA, we coupled natural amino acids and small molecules to generate a series of analogues,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> out of which MTMSA-Trp (<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and MTMSA-Phe (<b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) were found to have cytotoxicity comparable to that of MTM (<b>1</b>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Most importantly, we demonstrated with crystallography studies that the 3-side chain of the MTMSA analogues can interact with FLI1.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In such complexes, aromatic 3-side chain MTMSA derivatives have sufficient length to directly interact with the FLI1 DNA binding domain of EWS-FLI1, reflecting the in vitro potency of MTMSA-Trp (<b>3</b>) and MTMSA-Phe (<b>4</b>) against Ewing sarcoma. Moreover, these studies pose a new mode-of-action hypothesis, which requires a ternary MTM (<b>1</b>)-DNA-FLI1 (or MTM (<b>1</b>)-DNA-ERG) complex. In this article, we describe our efforts to find more selective MTM (<b>1</b>) analogues for the treatment of cancers expressing aberrant ETS fusions or ETS factors. Our approach combined fragment-based drug development (FBDD) with structure–activity relationship (SAR) studies starting from of MTMSA-Trp (<b>3</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial Cytotoxicity (GI<sub>50</sub>) Screen in TC-32 (Ewing Sarcoma) and PC-3 (Non-Ewing Sarcoma) Cell Line of MTMSA-Trp (<b>3</b>) Analogues<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0012.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The asterisk (∗) indicates that regression is not estimable.</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63304" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63304" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Initial pharmacological studies showed that both MTMSA-Trp (<b>3</b>) and MTMSA-Phe (<b>4</b>) appeared to have the potential to overcome the limitation of MTM (<b>1</b>), with MTMSA-Trp (<b>3</b>) being the more cytotoxic of the two derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, entry 10).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> However, their selectivity toward Ewing sarcoma cell lines was only slightly improved compared to MTM (<b>1</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). We chose MTMSA-Trp (<b>3</b>) as a starting point to better understand and improve its potential binding properties to EWS-FLI1 by varying its electronic, steric, and hydrogen bonding properties of the tryptophan residue, with the major objective to increase the selectivity of it toward Ewing sarcoma cell lines while maintaining a cytotoxic activity comparable to MTM (<b>1</b>).</div><div class="NLM_p">To evaluate a potential hydrogen bonding of the indole-NH, it was protected by N-alkylation. After initial protection of the primary amine group of <span class="smallcaps smallerCapital">l</span>-tryptophan hydrochloride (<b>5</b>) with phthalimide using phthalic anhydride in the presence of excess triethylamine in refluxing toluene, which gave the protected tryptophan <b>6</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> in 80% yield, the indole N-methylation of <b>6</b> with MeI–NaH in DMF provided <b>7</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> in 60% yield, and benzylation with benzyl bromide under similar conditions furnished N-benzylated tryptophan <b>8</b> in 70% yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Likewise, treatment with allyl bromide and prenyl bromide gave <i>N</i>-allyltryptophan <b>9</b> and <i>N</i>-prenyltryptophan <b>10</b>,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> respectively. Treatment with hydrazine hydrate in MeOH–DCM at room temperature ensured the removal of the phthalimide protection group in all cases (<b>7</b>–<b>10</b>) to provide the corresponding amines (<b>11</b>–<b>14</b>) in 50–65% yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Selective Indole N-Alkylation of Tryptophan<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) phthalic anhydride, Et<sub>3</sub>N, toluene, reflux, 15 h, 80%; (b) NaH, alkyl bromide, DMF, 0 °C to rt, 10 h; (c) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, MeOH–DCM, rt.</p></p></figure><div class="NLM_p">To diversify the tryptophan residue, iridium-catalyzed borylation and palladium catalyzed cross-coupling reactions were applied. Borylation allowed the introduction of various functionalities into the indole core of tryptophan, since the carbon–boron bond can be easily modified. For the C7 diversification of tryptophan, the required borylated tryptophan <b>15</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> was prepared following the method developed by Movagasshi and co-workers starting from protected tryptophan <b>16</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). To incorporate an allyl residue into tryptophan, which could serve as a handle for further modifications through Grubbs chemistry, 7-allyltryptophan <b>17</b> was chosen.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. C7 Functionalization of Tryptophan Using Iridium Catalyzed Borylation Chemistry<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CuI, 1,10-Phen, KI, MeOH–H<sub>2</sub>O, 40%; (b) allyl(<i>n</i>-Bu)<sub>3</sub>Sn, Pd(PPh<sub>3</sub>)<sub>4</sub>, PhMe, 120 °C, 60%; (c) MeOH, Cu(OAc)<sub>2</sub>·H<sub>2</sub>O, Et<sub>3</sub>N, O<sub>2</sub>, rt 12 h; (d) CuTC, Togni reagent, 1,10-Phen, DCM, LiOH, H<sub>2</sub>O, rt; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, SPhos, K<sub>3</sub>PO<sub>4</sub>, PhI, PhMe, 80 °C, 70%.</p></p></figure><div class="NLM_p">Borylated tryptophan <b>15</b> was treated with potassium iodide in the presence of CuI as the catalyst and 1,10-phenanthroline as the ligand<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> to avail 7-iodotryptophan <b>18</b>, which upon Stille coupling reaction with allyltributylstannane furnished the allyltryptophan derivative <b>17</b> in 60% yield (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Chen–Lam coupling of <b>15</b> failed to provide an electron enriched methoxytryptophan <b>19</b>. Trifluoromethylation of <b>15</b> using the Togni reagent produced a complex mixture, possibly because of the interference of the free indole-NH. However, Suzuki coupling reaction of <b>15</b> with iodobenzene in the presence of Pd<sub>2</sub>(dba)<sub>3</sub> as the catalyst resulted in 7-phenyltryptophan <b>20</b> in 70% yield (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><div class="NLM_p">Functionalization of C6 of tryptophan was achieved by following a recently developed borylation of tryptophan <b>21</b> by Baran et al.,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> which provided an inseparable 4:1 mixture of C6 and C5 borylated Trp <b>22</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Treatment of the borylated tryptophan <b>22</b> with sodium azide in the presence of Cu(II) acetate as the catalyst produced 6-azidotryptophan <b>24</b> in good yield, which under Cu(I) catalyzed click chemistry conditions provided the triazolylphenyltryptophan <b>25</b> in 72% yield. After removal<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> of the <i>tert</i>-butyl carbamate and triisopropylsilyl protection, the triazolylphenyltryptophan free amine <b>23</b> was obtained in excellent yield. Trifluoromethylation of <b>22</b> using the Togni reagent successfully yielded an inseparable mixture of C5 and C6 trifluoromethlytated tryptophan <b>26</b> in 60% combined yield, complementing the requirement of the indole-NH protection. However, fluorination of <b>22</b> remained inaccessible under both nucleophilic and electrophilic conditions, owing to the labile nature of the triisopropyl silyl group (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. C6 Functionalization of Tryptophan Using Iridium Catalyzed Borylation Chemistry<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Ir[(cod)OMe]<sub>2</sub> (5 mol %), phenanthroline (10 mol %), HBPin (0.25 equiv), B<sub>2</sub>Pin<sub>2</sub> (4.0 equiv), hexane, 80 °C, 70%; (b) NaN<sub>3</sub>, Cu(OAc)<sub>2</sub>·H<sub>2</sub>O, MeOH, 70%; (c) phenylacetylene, CuI, DIPA, HOAc, DCM, 72%; (d) 4 N aq HCl, EtOAc, rt, 4 h; TBAF, THF, rt, 2 h, 85% (2 steps); (e) CuTC, Togni reagent, 1,10-Phen, DCM, LiOH, H<sub>2</sub>O, rt, 60%; (f) Cu(OTf)<sub>2</sub>, KF; (g) AgOTf, NaOH, Selectfluor.</p></p></figure><div class="NLM_p">The palladium catalyzed tryptophan synthesis<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> methodology was utilized to access electron rich and electron deficient tryptophan residues. The required aldehyde <b>28</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> was prepared from <i>S</i>-glutamic acid in four steps, subjected to the palladium catalyzed intramolecular cross-coupling reaction with three 2-iodoaniline derivatives (<b>30</b>–<b>32</b>) in the presence of palladium acetate as the catalyst and DABCO as the base. The reaction yielded 4-nitrotryptophan <b>33</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (50%), 4-methoxytryptophan <b>34</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (38%) and benzotryptophan <b>35</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (42%). NMR data of all the tryptophan derivatives (<b>33</b>–<b>35</b>) are in good agreement with previously reported data (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Palladium Catalyzed Tryptophan Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Five dipeptides (<b>36</b>–<b>40</b>)<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> were prepared following an FBDD approach to combine the two potent Phe and Trp structural elements. By use of DCC–HOBt coupling reaction of corresponding NBoc protected amino acids and methyl ester hydrochlorides in the presence of <i>N</i>-methylmorpholine (NMM) as the base, the desired dipeptides were obtained in good yields (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Select Dipeptides by HOBt–DCC Coupling</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Treatment of <b>41</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with (±)-epibromohydrin in the presence of cesium carbonate as base afforded the 1:1 diastereomeric mixture of epoxy-tethered tryptophan <b>42</b>. Deprotection of <b>42</b> by TFA–DCM afforded the trifluoroacetate salt <b>43</b> in 80% yield. Similarly, reaction with allyl bromide yielded 5-<i>O</i>-allyltryptophan derivative <b>44</b> in 82% yield. Both the <i>O</i>-allyl group and the epoxy residue could serve as reactive handles for further derivatization (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Alkylation of 5-Hydroxytryptophan<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, (±)-epibromohydrin, 80 °C, 12 h, 68%; (b) TFA, DCM, rt, 6 h, 80%; (c) Cs<sub>2</sub>CO<sub>3</sub>, DMF, allyl bromide, 80 °C, 12 h, 82%.</p></p></figure><div class="NLM_p">After deprotection of the <i>tert</i>-butyl carbamate of tryptophan derivatives by 4 N aq HCl in ethyl acetate, all of the free amines of the tryptophan derivatives were coupled with MTMSA (<b>2</b>) using PyBop as reagent and DIPEA as the base.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In each occasion, the corresponding MTMSA (<b>2</b>) analogues (<b>45</b>–<b>63</b>) were obtained in 10–26% yields (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>; see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_001.pdf" class="ext-link">Supporting Information</a> for HPLC profile, HRMS data, and individual yields of the reaction). The reaction of <b>43</b> with MTMSA (<b>2</b>) produced an inseparable mixture of diastereomeric MTMSA (<b>2</b>) coupled 1,2-diols, due to the opening of the epoxide ring under the reaction conditions.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of MTMSA (<b>2</b>) Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To evaluate the antiproliferative properties and selectivity of MTMSA (<b>2</b>) derivatives toward aberrant ETS transcription factors, such as EWS-FLI1, the following screening was performed: In the initial screen, MTM (<b>1</b>) analogues were tested for 72 h growth inhibition (GI<sub>50</sub>) in TC-32 cells, a commonly used Ewing sarcoma cell line expressing EWS-FLI1 sensitive to MTM (<b>1</b>). Analogues with a GI<sub>50</sub> < 250 nM in the TC-32 cell line were then further tested against PC-3 cells, a prostate cancer cell line lacking EWS-FLI1 expression, also for 72 h growth inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In this assay, MTM (<b>1</b>) displayed 2.6-fold lower GI<sub>50</sub> in TC-32 cells as compared to PC-3 cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Thus, analogues with >3-fold selectivity toward TC-32 cell line were considered selective and were further investigated in a broader panel of cell lines to confirm and validate the selectivity in the context of multiple ETS fusion or aberrant ETS expression and across multiple cancer types that do not depend on the ETS fusions. In this secondary screen, analogues were tested in panel of seven additional Ewing sarcoma cell lines that express the majority of the EWS-ETS fusions and on the only available prostate cancer cell line (VCaP) that expresses aberrant ERG. Results were compared to a panel of an additional eight cancer cell lines that lack aberrant expression of ETS fusions (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) to identify the most desired analogue. MTM (<b>1</b>), MTMSA-Trp (<b>3</b>), and MTMSA-Phe (<b>4</b>) were used as controls.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Initial Cytotoxicity (GI<sub>50</sub>) Screen against TC-32 (Ewing Sarcoma) and PC-3 (Non- Ewing Sarcoma) Cell Line of MTMSA (<b>2</b>)-Dipeptide Analogues<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The asterisk (∗) indicates that regression is not estimable.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Ewing Sarcoma Selectivity Index of Select MTMSA (<b>2</b>) Analogues Determined by Median Cytotoxicity (GI<sub>50</sub>) in Ewing Sarcoma Cell Lines Compared to Non-Ewing Sarcoma Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">entry</th><th class="colsep0 rowsep0" align="center">MTMSA (<b>2</b>) analogues</th><th class="colsep0 rowsep0" align="center" char=".">median GI<sub>50</sub> in Ewing sarcoma cell lines (nM)</th><th class="colsep0 rowsep0" align="center" char=".">median GI<sub>50</sub> in non-Ewing sarcoma cell lines (nM)</th><th class="colsep0 rowsep0" align="center" char=".">ratio of median GI<sub>50</sub> (non-Ewing sarcoma)/(Ewing sarcoma) (selectivity index)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity index ratio analogues/MTM (<b>1</b>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">991</td><td class="colsep0 rowsep0" align="char" char=".">19.1</td><td class="colsep0 rowsep0" align="char" char=".">12.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">856</td><td class="colsep0 rowsep0" align="char" char=".">15.6</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">152</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="char" char=".">684</td><td class="colsep0 rowsep0" align="char" char=".">1644</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char=".">485</td><td class="colsep0 rowsep0" align="char" char=".">532</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">466</td><td class="colsep0 rowsep0" align="char" char=".">419</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="char" char=".">561</td><td class="colsep0 rowsep0" align="char" char=".">1956</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">MTM (<b>1</b>)</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="left">MTMSA-Phe (<b>4</b>)</td><td class="colsep0 rowsep0" align="char" char=".">117</td><td class="colsep0 rowsep0" align="char" char=".">545</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">MTMSA-Trp (<b>3</b>)</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">109</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr></tbody></table></div></div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Median GI<sub>50</sub> of select MTMSA (<b>2</b>) analogues in a panel of eight Ewing sarcoma (in red, TC-32, 5838, RD-ES, TC-71, A-673, ES-2, ES-7, ES-8) as well as nine non-Ewing sarcoma (in blue, PC-3, DU 145, A549, LNCaP, U-118 MG, HeLa, HCT116, DMS 114, PANC-1) cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analogue <b>45</b> was designed to evaluate the potential role of the indole-NH. N-methylation will cut off the potential hydrogen-bonding donation and will increase the hydrophobicity of the indole ring. The <i>N</i>-methyl analogue <b>45</b> was found to be less active than MTMSA-Trp (<b>3</b>) against the TC-32 and PC-3 cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entry 1) but more selective toward TC-32. The increasing hydrophobicity of <b>45</b> probably makes it more target-specific than MTMSA-Trp (<b>3</b>). Inspired by these results, we synthesized N-benzylated analogue <b>46</b> to evaluate the effect of an additional aromatic ring. Surprisingly, N-benzylated analogue <b>46</b> completely lost its activity, against both the TC-32 and the PC-3 cell lines, probably due to steric hindrance at the binding site (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entry 2). Further modification by N-allylation (cf <b>47</b>) and N-prenylation (cf <b>48a</b>,<b>b</b>) to achieve a secondary interaction with the transcription factor also failed, resulting in complete loss of activity against both cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entries 3, 4, and 5).</div><div class="NLM_p">Analogues <b>52</b> and <b>53</b> were synthesized to understand the steric requirement of the C7 position of the tryptophan ring. Both the C7 phenyl analogue <b>52</b> and C7 allyl analogue <b>53</b> lost their activity, suggesting that the C7 position has to remain nonsubstituted to avoid steric hindrance (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entries 6, 7). To explore a click chemistry handle and to add a more distant (from the indole) phenyl ring, we designed the C6 functionalized analogue <b>54</b>, but it was found to be inactive (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entry 8), which discouraged us to further follow this approach for FBDD expansion.</div><div class="NLM_p">It is well documented that incorporation of CF<sub>3</sub> or F in a drug molecule can strongly affect the binding affinity, pharmacokinetic properties, and bioavailability, mostly by inserting strong H-bond acceptor sites. The presence of a CF<sub>3</sub> or F substituent in a drug also increases the hydrophilicity and the electronic environment of the molecule and significantly slows down the oxidative metabolism of the molecule without altering its size drastically. We found that analogue <b>55</b> with C-6-CF<sub>3</sub> lost its activity completely in both cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entry 9). However, the sterically less demanding C-6-F analogue <b>56</b> was found to be active in TC-32 cells with a selectivity of 6.9 and thus stood out as one of the potential candidates to be further studied and improved (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entry 10). The increase in hydrophilicity while maintaining similar size as the unsubstituted tryptophan (cf. <b>3</b>) could be the reason behind its activity with improved selectivity, in comparison to <b>55</b>. Electron rich or deficient tryptophans, <b>49</b> and <b>50</b>, respectively, were both found to be less active than the parent MTMSA-Trp (<b>3</b>), suggesting the importance of the steric factors over the electronic nature of the tryptophan ring (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entries 11 and 12). Incorporation of an allylic residue at indole-N (cf. <b>47</b>) and C7 of the tryptophan ring (cf. <b>53</b>) resulted in loss of activity in both the TC-32 and PC-3 cell lines; hence we synthesized analogue <b>51</b> with a 5-<i>O</i>-allyltryptophan residue to explore substitution at the 5-position. Analogue <b>51</b> was found to be active in the TC-32 cell line with a selectivity of 8.6 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entry 13). These results indicate the accessibility of the C5 over the C7 position to incorporate an additional residue and to further expand the Trp residue by FBDD, with the ultimate goal to avail a secondary interaction with EWS-FLI1. Analogue <b>57</b>, with an additional fused benzene ring added to tryptophan, documented a ∼34-fold decrease in activity in the TC-32 cell line, once more restricting the steric requirements for interaction with EWS-FLI1, and thus wiped out the possibility of adding π-donation directly to the tryptophan ring (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entry 14). Similarly, analogue <b>58</b>, where the indole ring was replaced by a naphthalene ring, lost activity in the TC-32 cell line, which again showed the importance of the indole ring for interactions with EWS-FLI1 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entry 15).</div><div class="NLM_p">Dipeptide analogues <b>59</b>–<b>63</b> were tested in TC-32 cell lines to validate the FBDD concept in the most straightforward way, combining Phe and Trp. The fact that the <i>N</i>-methyltryptophan analogue <b>45</b> showed a ∼4-fold increase in selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; entry 1) impelled us to include Trp-N-methylation into this series of analogues. Analogue MTMSA-Trp-Phe (<b>59</b>) was found to have similar activity as MTMSA-Trp (<b>3</b>) but was less selective, while MTMSA-Phe-Trp (<b>60</b>), with the opposite arrangement of the amino acid residues, showed significantly increased selectivity compared to <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>; entries 1 and 2). Likewise, analogue MTMSA-Trp-Trp (<b>61</b>), which contains two consecutive tryptophan moieties, was found to have much better selectivity than MTMSA-Trp (<b>3</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>; entry 3). Both <b>60</b> and <b>61</b> are about equally active in the TC-32 cell line (as <b>3</b>). This shows the importance of the Trp residue to be in a more distant position from the DNA-interacting MTM (<b>1</b>) core, to interact with the transcription factor and thus may account for the observed improved selectivity toward the EWS-FLI1 expressing TC-32 cell line over the PC-3 cell line. It is noteworthy that the di-<i>N</i>-methyl analogue of <b>61</b> (cf. <b>62</b>) lost its activity completely, which indicates the importance of the β indole-NH for the secondary interaction with EWS-FLI1 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>; entry 4). The loss of activity against TC-32 of analogue <b>63</b> indicates that a second phenylalanine residue is not advantageous (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>; entry 5). These studies concluded that a tryptophan moiety in the more distant, second position of the analogues is crucial and increases drastically the selectivity toward EWS-FLI1 while maintaining reasonable cytotoxic activity.</div><div class="NLM_p">Overall, the above-described initial screen identified five novel MTMSA (<b>2</b>) analogues with cytotoxicity (GI<sub>50</sub>) in TC-32 cells of less than 250 nM and selectivity against TC-32 cells greater than 3 times of that of PC-3, determined by PC-3/TC-32 GI<sub>50</sub> ratio (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, highlighted in red). To deepen these findings and to further investigate the most promising analogues, we expanded the array of cancer cell lines to include a panel of eight Ewing sarcoma cell lines (expressing aberrant ETS transcription factors) versus nine non-Ewing sarcoma cell lines (lacking aberrant ETS transcription factors) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>; see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">Despite an initial lack of selectivity and cytotoxicity, we included analogues <b>59</b> and <b>63</b>, respectively, to get a complete overview of dipeptide analogues. MTM (<b>1</b>), MTMSA-Trp (<b>3</b>), and MTMSA-Phe (<b>4</b>) were used as controls. The final selectivity ratio was calculated by taking the median GI<sub>50</sub> of the non-Ewing sarcoma panel over the Ewing sarcoma panel (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The median is presented as we were not able to estimate the GI<sub>50</sub> (exceeded 10 μM), which precludes the estimation of a mean value. Of the seven novel MTMSA (<b>2</b>) analogues that were tested on this secondary screen, only three were found to maintain selectivity greater than 3 against the panel of Ewing sarcoma cell lines versus non-Ewing sarcoma cell lines, namely, <b>60</b>, <b>61</b>, and <b>63</b>. The resulting Ewing sarcoma selectivity index ranked as follows: <b>60</b> (19.1) > <b>61</b> (15.6) ≫ MTMSA-Phe (<b>4</b>) (4.7) > <b>63</b> (3.5) > <b>59</b> (2.4) = <b>45</b> (2.4) > MTMSA-Trp (<b>3</b>) (2.3) > MTM (<b>1</b>) (1.5) > <b>51</b> (1.1) > <b>56</b> (0.9) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_p">Taking both Ewing sarcoma cytotoxicity (GI<sub>50</sub>) and selectivity index into account, a potency order of MTMSA (<b>2</b>) analogues was determined to be <b>60</b> > <b>61</b> ≫ MTMSA-Trp (<b>3</b>) = MTMSA-Phe (<b>4</b>) > MTM (<b>1</b>). Several initially promising MTMSA (<b>2</b>) analogues (cf. <b>45</b>, <b>51</b>, <b>56</b>, and <b>63</b>) were eliminated in the secondary screen when tested against the panel of Ewing sarcoma cell lines because of their poor cytotoxicity (GI<sub>50</sub> > 250 nM). In contrast, analogue <b>59</b> was cytotoxic (median GI<sub>50</sub> of 64) but eliminated due to poor selectivity (selectivity index of <3) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Interestingly and somewhat surprisingly, MTMSA-Phe (<b>4</b>) had a 3 times better ETS selectivity index of 4.7 than MTMSA-Trp (<b>3</b>, selectivity index 1.5), which initially was the lead molecule in this study (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). On the basis of these cytotoxicity screens, the overall best candidates for further development are analogues <b>60</b> and <b>61</b>, with a median ETS cytotoxicity of (GI<sub>50</sub>) 52 nM and 55 nM, respectively, and a drastically improved selectivity of >10-fold toward ETS depended cell lines, in comparison to MTM (<b>1</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_p">Previous modification of MTM (<b>1</b>) leading to the identification of EC-8105 with improved suppression of EWS-FLI1 by almost 10-fold focused on the introduction of an allyl carbonate residue in the 3B position of the disaccharide residue of MTM (<b>1</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, from our previous study of DNA-MTMSA-Trp (<b>3</b>) and DNA-MTMSA-Phe (<b>4</b>) crystal structures, it was anticipated that the 3-side chain can interact with FLI1 DNA binding domain.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Therefore, the identification of MTMSA-Phe-Trp (<b>60</b>) and MTMSA-Trp-Trp (<b>61</b>) with improved selectivity of 19.1 and 15.6, respectively, cemented our initial hypothesis that adding an additional tryptophan residue to MTMSA-Phe (<b>4</b>) and MTMSA-Trp (<b>3</b>) at the 3-side chain position would enhance their interaction with EWS-FLI1.</div><div class="NLM_p">Additionally, we tested all seven MTMSA (<b>2</b>) analogues in VCaP cells, which overexpress the TMPRSS2-ERG gene fusion, a common genomic alteration harbored by prostate cancer cells. We initially expected that they would follow a similar selectivity trend to 5838 cells, which overexpress the more rare EWS-ERG gene alteration in Ewing sarcoma. Our results indeed show that analogues <b>60</b> and <b>61</b> are the most selective for VCaP cells over other prostate cancer cell lines, with a selectivity ratio of 25.4 and 18.3, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), consistent with their Ewing sarcoma selectivity index (cf. <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Moreover, these analogues were more selective than MTM (<b>1</b>) for 5838 cells but not in the exact same rank order (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. GI<sub>50</sub> and Selectivity Index of Select MTMSA (<b>2</b>) Analogues in Cancer Cells Expressing Aberrant ERG Transcription Factors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">VCaP prostate cancer, TMPRSS2-ERG</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">5838 Ewing sarcoma, EWS-ERG</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">MTMSA (<b>2</b>) analogues</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">CI (95%)</th><th class="colsep0 rowsep0" align="center" char=".">median GI<sub>50</sub> in prostate cell lines lacking TMPRSS2-ERG</th><th class="colsep0 rowsep0" align="center" char=".">ratio of median GI<sub>50</sub> (prostate cells lacking TMPRSS2-ERG)/(VCaP)</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">CI (95%)</th><th class="colsep0 rowsep0" align="center" char=".">ratio of median GI<sub>50</sub> (non-Ewing sarcoma cell lines (cf <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>))/5838</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="left">34–45</td><td class="colsep0 rowsep0" align="char" char=".">991</td><td class="colsep0 rowsep0" align="char" char=".">25.4</td><td class="colsep0 rowsep0" align="char" char=".">149</td><td class="colsep0 rowsep0" align="left">121–186</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="left">25–37</td><td class="colsep0 rowsep0" align="char" char=".">568</td><td class="colsep0 rowsep0" align="char" char=".">18.3</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="left">40–70</td><td class="colsep0 rowsep0" align="char" char=".">16.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="left">12–34</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="left">25–60</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="char" char=".">307</td><td class="colsep0 rowsep0" align="left">87–1430</td><td class="colsep0 rowsep0" align="char" char=".">1557</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">121</td><td class="colsep0 rowsep0" align="left">98–151</td><td class="colsep0 rowsep0" align="char" char=".">13.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char=".">485</td><td class="colsep0 rowsep0" align="left">371–645</td><td class="colsep0 rowsep0" align="char" char=".">454</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="left">20–29</td><td class="colsep0 rowsep0" align="char" char=".">22.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">319</td><td class="colsep0 rowsep0" align="left">235–457</td><td class="colsep0 rowsep0" align="char" char=".">187</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">466</td><td class="colsep0 rowsep0" align="left">229–929</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="char" char=".">442</td><td class="colsep0 rowsep0" align="left">377–513</td><td class="colsep0 rowsep0" align="char" char=".">1132</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">579</td><td class="colsep0 rowsep0" align="left">350–966</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">MTM (<b>1</b>)</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="left">32–52</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="left">30–61</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">MTMSA-Phe (<b>4</b>)</td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="left">70–321</td><td class="colsep0 rowsep0" align="char" char=".">732</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="left">30–49</td><td class="colsep0 rowsep0" align="char" char=".">14.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">MTMSA-Trp (<b>3</b>)</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="left">45–80</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">4–10</td><td class="colsep0 rowsep0" align="char" char=".">18.2</td></tr></tbody></table></div></div><div class="NLM_p">Since it is recognized that MTM displaces Sp1 from DNA and likely affects the expression of Sp1 target genes (e.g., BCL-2), we performed qRT-PCR to determine the effect of MTM (<b>1</b>) and MTMSA analogue treatment on the expression of those genes as well as on EWS-FLI1 and its target gene NR0B1. The expression of EWS-FLI1 was reduced to approximately 70–75% after 6 h and then further reduced after 12 h treatment (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). The NR0B1 promoter contains a microsatellite region of GGAA repeats of DNA that binds to EWS-FLI1 for transcriptional regulation, through the conserved ETS binding domain of FLI1.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> NR0B1 mRNA expression was not affected by MTM (<b>1</b>) at the GI<sub>50</sub> at 6 and 12 h but was reduced to ∼75% after 6 h of treatment with MTMSA analogues, and it was further reduced after 12 h (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). In contrast both Sp1 and BCL-2 mRNA expression was reduced with MTM (<b>1</b>) and MTMSA analogues treatments after 6 and 12 h (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). Previously it was reported that 6 h treatment with 100 nM MTM (<b>1</b>) had no effect on mRNA expression of CCK.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Therefore, we used this gene as a negative control. Our results also showed no change in mRNA expression of CCK after 6 h treatment at the GI<sub>50</sub> (32 nM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) for MTM (<b>1</b>) and minimal effect with MTMSA analogues. However, after 12 h, CCK mRNA expression is reduced to ∼60% for both MTM (<b>1</b>) and MTMSA analogues (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E).</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. mRNA expression of (A) EWS-FLI1 and associated gene (B) NR0B1 is decreased after 6 and 12 h treatments with MTMSA analogues at respective GI<sub>50</sub>, analyzed by qRT-PCR. mRNA expression of (C) Sp1, a well-known downstream target of MTM (1), and associated gene (D) BCL-2 was also analyzed. mRNA expression of (E) CCK was analyzed as a negative control, previously reported as unaffected after 6 h of treatment with MTM at 100 nM.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Relative expressions were calculated using GAPDH expression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further investigate the interference of MTM (<b>1</b>) and MTMSA analogues with the binding of ETS transcription factors, we developed cell lines that express luciferase under the control of EWS-FLI1. TC-32 cells, which express EWS-FLI1, were stably transfected with a luciferase reporter vector and the control of the full length NR0B1 promoter. Cells were treated for 12 h with multiple concentrations between 0 and 10 μM. All MTMSA analogues decrease luciferase expression to 50% (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Additionally, a luciferase reporter vector under the control of a CMV promoter was tested as a nonspecific control. None of the analogues reduced CMV driven luciferase signal at the range of their GI<sub>50</sub> concentrations. MTM (<b>1</b>) and analogue <b>59</b> decrease CMV driven luciferase expression down to ∼50% and ∼75%, respectively, at concentrations between 1 and 10 μM, while analogues <b>60</b> and <b>61</b> had no effect at all, even when treated up to 10 μM (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) MTMSA analogues decrease the expression of luciferase controlled by NR0B1 promoter, a validated binding promoter of EWS-FLI1. TC-32 cells, expressing EWS-FLI1, were stably transfected with luciferase reporter vectors and treated for 12 h. (B) MTMSA analogues <b>60</b> and <b>61</b> did not decrease luciferase expression controlled by a nonspecific CMV promoter.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Lack of effect of analogues MTMSA-Phe-Trp (<b>60</b>) and MTMSA-Trp-Trp (<b>61</b>) on CMV promoter driven transcription while maintaining activities against EWS-FLI1 mediated transcription supports the observed selectivity in our cytotoxicity assays (cf. <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Furthermore, MTMSA-Trp-Phe (<b>59</b>), which reduces CMV promoter driven transcription, lacks selectivity in our cytotoxicity assays (cf. <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). This supports the conclusions made after the initial screening (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), namely, that a Trp residue in a second, more distant position from the MTM (<b>1</b>)-DNA binding core is crucial for an interaction with the EWS-FLI1 transcription factor. The importance of the Phe or the Trp moiety in the first position of the MTMSA-3-side chain and the impact of an additional Trp residue (cf. MTMSA (<b>2</b>) tripeptide analogues) remain to be investigated.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This study was aimed at refinement of two amino acid derivatives of MTMSA (<b>2</b>), namely, MTMSA-Trp (<b>3</b>) and MTMSA-Phe (<b>4</b>), both of which showed promising activity and increased selectivity in a preliminary cytotoxicity assay looking at effects on cell lines overexpressing aberrant ETS transcription factors. This was expected, since crystallographic studies investigating DNA-FLI1 interactions and the DNA binding modalities of the MTMSA-Phe (<b>4</b>) and MTMSA-Trp (<b>3</b>) analogues resulted in a new mode-of-action hypothesis of MTM (<b>1</b>) and these derivatives: a ternary complex of MTM (<b>1</b>)-DNA-FLI1 (similarly MTM (<b>1</b>)-DNA-ERG in the context of prostate cancer), in which the MTM (<b>1</b>) analogue binds to the minor groove of certain DNA microsatellites, with its core and trisaccharide side chain, and simultaneously to the FLI1 portion of EWS-FLI1 within the major groove of DNA. Aromatic residues of MTMSA (<b>2</b>) analogues are well poised to increase protein binding. Initially, the focus was on refining the Trp residue, since MTMSA-Trp (<b>3</b>) showed better cytotoxicity than MTMSA-Phe (<b>4</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The array of MTMSA-Trp (<b>3</b>) derivatives was achieved through iridium-catalyzed borylation and palladium-catalyzed tryptophan syntheses. The borylated tryptophans were further used to diversify the indol ring of tryptophan, before the PyBop coupling reaction with MTMSA (<b>2</b>) to generate sterically and electronically different MTMSA-Trp (<b>3</b>) analogues.</div><div class="NLM_p">Later, the studies were expanded to a fragment based drug development (FBDD) approach to combine the protein interactive aromatic rings of Trp and Phe, both of which appeared to be advantageous elements to increase selectivity toward ETS fusion expressing cell lines. These studies started with phenyl-expanded Trp derivatives, in which the indole of Trp was expanded by an aromatic ring or through phenyl-Trp derivatives, and ended with dipeptide analogues of MTMSA (<b>2</b>), with all combinations of dipeptide side chains, namely, MTMSA-Trp-Phe (<b>59</b>), MTMSA-Phe-Trp (<b>60</b>), MTMSA-Phe-Phe (<b>63</b>), and MTMSA-Trp-Trp (<b>61</b>).</div><div class="NLM_p">Initially all analogues were tested in the Ewing sarcoma TC-32 cell line that expresses EWS-FLI1 type I, the genotype in the majority of Ewing sarcoma patients. For target specificity analysis, these analogues were also tested in prostate PC-3 cell line that lacks dependence on aberrant ETS transcription factors. These comparative tests resulted in the identification of seven MTMSA analogues with increased specificity toward the Ewing sarcoma cell line (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). As a result, they were further evaluated against multiple Ewing sarcoma cell lines, as well as VCaP prostate cancer cell line, all of whom express various aberrant ETS transcription factors. This was compared to a panel of cell lines lacking expression of aberrant ETS transcription factors. Analogues <b>60</b> and <b>61</b> were found to have cytotoxic activities comparable to MTM (<b>1</b>) but showed >10-fold increased selectivity toward aberrant ETS dependent cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). To further investigate if this selectivity is a result of activity against aberrant ETS transcription factors, we looked at the effects on EWS-FLI1 and target gene NR0B1 mRNA expression with analogue treatment. Furthermore, we tested a luciferase reporter vector controlled by NR0B1 promoter, which binds to EWS-FLI1. We found that analogues <b>60</b> and <b>61</b> decreased EWS-FLI1 and NR0B1 mRNA expression, as well as NR0B1 promoter driven luciferase signal (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). However, analogues <b>60</b> and <b>61</b> did not decrease nonspecific CMV promoter driven luciferase signal (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), correlating well with the observed selectivity in cytotoxicity assays (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). This is in comparison to MTM (<b>1</b>) and analogue <b>59</b>, which decreased nonspecific CMV promoter driven luciferase signal (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) and therefore had no observed selectivity in cytotoxicity assays (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_p last">This expanded study confirmed that the tryptophan ring in second position of the 3-side chains of analogues <b>60</b> and <b>61</b> may play a significant role to afford better selectivity against ETS dependent cell lines.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry. General</h3><div class="NLM_p last">All commercial reagents were used without further purification. The required amine for the synthesis of <b>56</b> and <b>58</b> was prepared by protecting the commercially available corresponding tryptophan in the presence of thionyl chloride in methanol. Solvents were dried and distilled following the standard procedures. TLC was carried out on precoated plates (Merck silica gel 60, GF254), and the spots were visualized with UV, fluorescent light or by charring with phosphomolybdic acid hydrate (PMA). Column chromatography was performed on silica gel (230–400 mesh). <sup>1</sup>H and <sup>13</sup>C NMR spectra for the compounds were recorded with Varian 400 or 600 MHz spectrometers. <sup>1</sup>H and <sup>13</sup>C chemical shifts are reported in ppm downfield of tetramethylsilane and referenced to residual solvent peaks (CHCl<sub>3</sub>; δ<sub>H</sub> = 7.26 and δ<sub>C</sub> = 77.23, MeOH-<i>d</i><sub>4</sub>; δ<sub>H</sub>= 3.31 and δ<sub>C</sub> = 49.1). Multiplicities are reported using the following abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad resonance, ap = apparent. The phrase “usual workup” or “worked up in usual manner” refers to washing of the organic phase with water (2 × 1/4 the volume of organic phase) and brine (1 × <sup>1</sup>/<sub>4</sub> the volume of organic phase), drying (anhydrous Na<sub>2</sub>SO<sub>4</sub>), filtration, and concentration under reduced pressure. Yields referred to isolated yields after purification. Analytical LC/MS was performed on a Waters 2965 (Kinetex 5U EVO C18 100A, 250 mm × 4.6 mm, a linear gradient from A/B 75:25 to 30:70 (20 min), 30:70 to 0:100 (2 min), 0:100 (2 min,); 0:100 to 75:25 (2 min), 75:25 (4 min) (A = H<sub>2</sub>O + 0.1% formic acid, B = MeCN + 0.1% formic acid), flow rate 0.5 mL/min) equipped with an Waters ZQ 2000 mass spectrometer and Waters 2996 photodiode array detector. The purity of all analogues used in the bioassays was determined by this method to be >95%. Mass spectra were taken on ABSciex QTOF mass spectrometer.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure A. N-Alkylation of <b>6</b></h3><div class="NLM_p last">To a stirred solution of <b>6</b> (1 equiv) in dry DMF was added 60% NaH (1.5 equiv) in portions at 0 °C, and the mixture was stirred for 30 min after which respective halide (1.5 equiv) was added. The reaction mixture was stirred at rt for 12 h, cooled to 0 °C, and quenched with methanol. It was diluted with ethyl acetate, worked up in the usual manner, and subjected to column chromatography with silica gel using 20% ethyl acetate in hexane as eluent.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure for the Deprotection of Phthalimide</h3><div class="NLM_p last">To a stirred solution of phtalimide (cf. <b>7</b> to <b>10</b>) (1 equiv) in MeOH–DCM (1:1; 10 mL) was added hydrazine hydrate (1.5 equiv), and the reaction mixture was stirred at rt for 24 h. It was then filtered through Celite, washed with ethyl acetate, and concentrated under reduced vacuum. It was purified in reverse phase silica using 20% acetonitrile in water as mobile phase to obtain the free amine (cf. <b>11</b> to <b>14</b>) in 45–60% yield. The free amine was only characterized by LCMS and directly used without further purification in the PyBop coupling reaction with MTMSA (<b>2</b>).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure B: Procedure of Synthesis of Tryptophan from Aldehyde <b>28</b></h3><div class="NLM_p last">A mixture of <i>o</i>-iodoaniline (1.1 equiv), aldehyde <b>28</b> (1.0 equiv), and DABCO (3 equiv) in dry DMF was degassed for 30 min using argon. Pd(OAc)<sub>2</sub> (5 mol %) was added to the reaction, and the resulting reaction mixture was heated at 85 °C in a pressure tube for 24 h. The reaction mixture was cooled to room temperature, diluted with water, extracted with ethyl acetate, and worked up in the usual manner. The crude product was purified by flash column chromatography to obtain the corresponding tryptophan derivative.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure C: Procedure for HOBt–DCC Coupling Reaction<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></h3><div class="NLM_p last">To a solution of NBocAA-OH (1 equiv) in dry THF were added HOBt (1.2 equiv) and DCC (1.2 equiv), and the mixture was stirred at 0 °C for 1 h. Then HCl·AA-OMe (1.1 equiv) was added to the reaction mixture and pH was adjusted to be between 8–9 by adding excess NMM. The reaction mixture was stirred for 12 h at room temperature, filtered, and concentrated under reduced pressure. The residue was dissolved in ethyl acetate, washed with saturated aq NaHCO<sub>3</sub>, and worked up in the usual manner. The crude product was purified by flash column chromatography to obtain the corresponding protected dipeptide.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure D: Procedure for PyBop Coupling Reaction</h3><div class="NLM_p last">To a stirred solution of MTMSA (<b>2</b>) (1 equiv) in dry DMF were added PyBop (1.5 equiv), free amine (3.0 equiv), and excess triethylamine (adjusted to pH 8). The reaction mixture was stirred at room temperature under argon atmosphere until disappearance of MTMSA (<b>2</b>). It was quenched by adding saturated NaCl solution and extracted with <i>n</i>-BuOH. The organic fraction was collected and concentrated under reduced pressure and purified by HPLC to obtain pure MTMSA (<b>2</b>) analogues.</div></div><div id="sec4_1_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Methyl (<i>S</i>)-3-(1-Benzyl-1<i>H</i>-indol-3-yl)-2-(1,3-dioxoisoindolin-2-yl)propanoate (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> (512 mg, 70%) was prepared as a yellow semisolid by N-benzylation of <b>6</b> (581 mg, 1.67 mmol) with benzyl bromide (0.3 mL, 2.5 mmol) using 60% NaH (100 mg, 2.5 mmol) as base, following general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.75–7.73 (m, 2H), 7.67–7.62 (m, 3H), 7.17–7.05 (m, 6H), 6.93 (s, 1H), 6.89–6.86 (m, 2H), 5.30 (dd, <i>J</i> = 9.9, 6.4 Hz, 1H), 5.16 (ABq, <i>J</i> = 14.8 Hz, 2H), 3.81 (s, 3H), 3.79–3.75 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.8, 167.6, 137.6, 136.6, 134.1, 131.8, 128.7, 128.0, 127.5, 127.0, 126.6, 123.5, 122.1, 119.5, 118.9, 110.3, 109.8, 53.0, 52.8, 49.9, 24.9; HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 439.1659, found 439.1638.</div></div><div id="sec4_1_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Methyl (<i>S</i>)-3-(1-Allyl-1<i>H</i>-indol-3-yl)-2-(1,3-dioxoisoindolin-2-yl)propanoate (<b>9</b>)</h3><div class="NLM_p last">Compound <b>9</b> (400 mg, 85%) was prepared as a yellow semisolid by N-allylation of <b>6</b> (425 mg, 1.22 mmol) with allyl bromide (0.16 mL, 1.83 mmol) using 60% NaH (75 mg, 1.83 mmol) as base, following general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.76–7.73 (m, 2H), 7.66–7.60 (m, 2H), 7.61 (d, <i>J</i> = 7.9 Hz, 1H), 7.19 (d, <i>J</i> = 8.4 Hz, 1H), 7.13 (t, <i>J</i> = 8.0, 1H), 7.05 (t, <i>J</i> = 8.4, 1H), 6.88 (s, 1H), 5.83–5.74 (m, 1H), 5.27 (t, <i>J</i> = 7.6 Hz, 1H), 4.97–4.93 (m, 1H), 4.78–4.73 (m, 1H), 4.62–4.50 (m, 2H), 3.80 (s, 3H), 3.75 (d, <i>J</i> = 8.1 Hz, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.8, 167.6, 136.4, 134.1, 133.5, 131.9, 127.9, 126.6, 123.5, 121.9, 119.3, 118.8, 116.7, 110.1, 109.7, 53.0, 52.8, 48.5, 24.9; HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 389.1501, found 389.1488.</div></div><div id="sec4_1_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Methyl (<i>R</i>)-2-(<i>tert</i>-Butoxycarbonyl)-3-(7-iodo-1<i>H</i>-indol-3-yl)propanoate (<b>18</b>)</h3><div class="NLM_p last">To a solution of <b>15</b> (740 mg, 1.67 mmol) in methanol (15 mL) in a pressure tube were added CuI (35 mg, 0.183 mmol, 10.0 mol %), 1,10-phen (60.0 mg, 0.34 mmol, 20.0 mol %), and KI (420 mg, 2.53 mmol, 1.50 equiv). The mixture was stirred at room temperature, water (3.5 mL) was added, and it was sealed under air. The mixture was heated at 80 °C for 2 h, cooled to room temperature, and diluted with water (40 mL). It was extracted with Et<sub>2</sub>O (3 × 35 mL) and worked up in the usual manner. The crude compound was subjected to column chromatography with silica gel using 30% ethyl acetate in hexane as eluent to obtain <b>18</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.19 (s, 1H), 7.54 (apt, <i>J</i> = 8.4 Hz, 2H), 7.06 (s, 1H), 6.88 (t, <i>J</i> = 7.7 Hz, 1H), 5.08 (d, <i>J</i> = 8.2 Hz, 1H), 4.64 (dd, <i>J</i> = 12.8, 6.0 Hz, 1H), 3.67 (s, 3H), 3.30–3.20 (m, 2H), 1.42 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.7, 155.3, 138.1, 131.0, 128.0, 123.3, 121.5, 119.1, 112.1, 80.1, 76.1, 54.3, 52.5, 28.52, 28.49; HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>22</sub>IN<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 445.0625, found 445.0620.</div></div><div id="sec4_1_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Methyl (<i>R</i>)-3-(7-Allyl-1<i>H</i>-indol-3-yl)-2-(<i>tert</i>-butoxycarbonyl)propanoate (<b>17</b>)</h3><div class="NLM_p last">To a stirred solution of <b>18</b> (115 mg, 0.29 mmol) in dry toluene (5 mL) were added allyl tributyltin (0.13 mL, 0.4 mmol) and tetrakis(triphenylphosphine)palladium(0) (70 mg, 0.06 mmol, 20 mol %). The reaction mixture was refluxed under argon atmosphere for 24 h, cooled to room temperature, and diluted with ethyl acetate (50 mL). After usual workup followed by column chromatography with silica gel using 25% ethyl acetate in hexane as eluent, <b>17</b> (56 mg, 60%) was obtained as a yellow liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1H), 7.44 (d, <i>J</i> = 7.8 Hz, 1H), 7.07 (t, <i>J</i> = 7.5 Hz, 1H), 7.03–6.97 (m, 2H), 6.11–6.01 (m, 1H), 5.28–5.13 (m, 2H), 5.07 (d, <i>J</i> = 8.2 Hz, 1H), 4.64 (q, <i>J</i> = 6.3 Hz, 1H), 3.68 (s, 3H), 3.62 (d, <i>J</i> = 6.5 Hz, 2H), 3.28 (dd, <i>J</i> = 5.6, 2.6 Hz, 2H), 1.42 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.0, 155.4, 136.9, 135.7, 122.7, 122.5, 122.3, 120.1, 117.4, 116.6, 110.7, 80.0, 54.4, 52.4, 37.0, 28.5, 28.2; HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 359.1971, found 359.1965.</div></div><div id="sec4_1_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl (<i>R</i>)-2-(<i>tert</i>-Butoxycarbonyl)-3-(7-phenyl-1<i>H</i>-indol-3-yl)propanoate (<b>20</b>)</h3><div class="NLM_p last">To a stirred solution of <b>18</b> (160 mg, 0.36 mmol) in dry toluene (5 mL) were added iodobenzene (70 μL, 0.6 mmol), K<sub>3</sub>PO<sub>4</sub> (180 mg, 0.84 mmol), Sphos (18 mg, 0.044 mmol, 12 mol %), and tris(dibenzylideneacetone)dipalladium(0) (20 mg, 0.02 mmol, 5 mol %). The reaction mixture was heated under argon atmosphere at 80 °C for 16 h, cooled to room temperature, and diluted with ethyl acetate (50 mL). Workup in the usual manner followed by column chromatography with silica gel using 20% ethyl acetate in hexane as eluent gave <b>17</b> (100 mg, 70%) as a yellow liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.34 (s, 1H), 7.62 (d, <i>J</i> = 7.2 Hz, 2H), 7.56–7.48 (m, 3H), 7.39 (t, <i>J</i> = 7.2 Hz, 1H), 7.22–7.19 (m, 2H), 7.02 (s, 1H), 5.11 (d, <i>J</i> = 8.2 Hz, 1H), 4.66 (q, <i>J</i> = 6.0 Hz, 1H), 3.70 (s, 3H), 3.37–3.27 (m, 2H), 1.44 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.9, 155.4, 139.2, 134.2, 129.3, 128.4, 128.3 127.7, 125.9, 123.2, 122.3, 120.4, 118.3, 110.9, 80.0, 54.4, 52.5, 28.5, 28.3; HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 395.1971, found 395.1965.</div></div><div id="sec4_1_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl (<i>R</i>)-3-(6-Azido-1-(triisopropylsilyl)-1<i>H</i>-indol-3-yl)-2-(<i>tert</i>-butoxycarbonyl)propanoate (<b>24</b>, Mixture of C6 and C5 Isomers, Major C6 Isomer)</h3><div class="NLM_p last">To a solution of <b>22</b> (244 mg, 0.41 mmol) in methanol (5 mL), were added sodium azide (40 mg, 0.61 mmol) and copper(II) acetate monohydrate (8.2 mg, 0.041 mmol, 10 mol %). The reaction mixture was heated at 55 °C under air for 12 h, diluted with ethyl acetate, and worked up in the usual manner. Purification by column chromatography with silica gel using 25% ethyl acetate in hexane as eluent gave <b>24</b> (147 mg, 70%) as a yellow liquid as an inseparable mixture of two isomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, major C6-azido isomer) δ 7.49 (d, <i>J</i> = 8.5 Hz, 1H), 7.08 (d, <i>J</i> = 1.9 Hz, 1H), 7.00 (s, 1H), 6.86 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 5.09 (d, <i>J</i> = 8.2 Hz, 1H), 4.64 (q, <i>J</i> = 5.6 Hz, 1H), 3.63 (s, 3H), 3.26- 3.22 (m, 2H), 1.68–161 (m, 3H), 1.43 (s, 9H), 1.13 (d, <i>J</i> = 6.0 Hz, 18H); HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>42</sub>N<sub>5</sub>O<sub>4</sub>Si [M + H]<sup>+</sup> 516.3006, found 516.3001.</div></div><div id="sec4_1_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Methyl (2<i>R</i>)-2-(<i>tert</i>-Butoxycarbonyl)-3-(6-(4-phenyl-1<i>H</i>-1,2,3-triazol-1-yl)-(triisopropylsilyl)-1<i>H</i>-indol-3-yl)propanoate (<b>25</b>, Mixture of C6 and C5 Isomers, Major C6 Isomer)</h3><div class="NLM_p last">To a solution of <b>24</b> (150 mg, 0.3 mmol) in dry DCM (2 mL) were added phenylacetylene (32 μL, 0.28 mmol), copper(I) iodide (1.2 mg, 0.02 equiv), DIPEA (0.04 equiv), and acetic acid (1 μL, 0.06 equiv). The reaction mixture was stirred at room temperature for 2 h, diluted with DCM (3 mL), and purified by column chromatography with silica gel using 30% ethyl acetate in hexane as eluent, giving <b>25</b> (130 mg, 72%) as a yellow liquid as an inseparable mixture of two isomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, major C6 isomer) δ 8.20 (s, 1H), 8.01 (d, <i>J</i> = 1.8 Hz, 1H), 7.95–7.91 (m, 2H), 7.63 (d, <i>J</i> = 8.5 Hz, 1H), 7.47–7.39 (m, 3H), 7.37–7.30 (m, 1H), 7.14 (s, 1H), 5.13 (d, <i>J</i> = 8.4 Hz, 1H), 4.67 (q, <i>J</i> = 6.3 Hz, 1H), 3.63 (s, 3H), 3.29 (apt, <i>J</i> = 6.2 Hz, 2H), 1.73–166 (m, 3H), 1.43 (s, 9H), 1.14 (d, <i>J</i> = 7.5 Hz, 18H); HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>48</sub>N<sub>5</sub>O<sub>4</sub>Si [M + H]<sup>+</sup> 618.3476, found 618.3447.</div></div><div id="sec4_1_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Methyl 2-<i>tert</i>-Butoxycarbonylamino-3-(6-trifluoromethyl-1-triisopropylsilanyl-1<i>H</i>-indol-3-yl)propanoate (<b>26</b>)</h3><div class="NLM_p last">A mixture of <b>22</b> (150 mg, 0.25 mmol), 1,10-Phen (9 mg, 0.05 mmol), LiOH·H<sub>2</sub>O (21 mg, 0.5 mmol), CuTC (5 mg, 0.025 mmol), and 3,3-dimethyl-1-(trifluoromethyl)-1,2-benziodoxol (Togni’s reagent) (91 mg, 0.28 mmol) in DCM (2 mL) was stirred under argon atmosphere at rt for 12 h. The reaction mixture was diluted with DCM (10 mL), filtered through a Celite pad, and concentrated under reduced pressure. The crude compound was purified by column chromatography with silica gel using 30% ethyl acetate in hexane as eluent, giving <b>26</b> (58 mg, 60%) as a yellow liquid as an inseparable mixture of two isomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, mixture of C5 and C6 isomers) δ 7.77 (d, <i>J</i> = 1.3 Hz), 7.70 (s), 7.59 (d, <i>J</i> = 8.4 Hz), 7.35 (dd, <i>J</i> = 14.3, 8.4 Hz), 7.27 (d, <i>J</i> = 10.8 Hz), 7.15 (s), 6.93 (s), 5.05 (t, <i>J</i> = 8.6 Hz), 4.63 (dq, <i>J</i> = 13.5, 5.9 Hz), 3.61 (s), 3.27–3.05 (m), 1.71–1.56 (m), 1.42 (s), 1.21–1.06 (m). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>, mixture of C5 and C6 isomers) δ −54.2, −60.5. HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>22</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 386.1453, found 386.1462.</div></div><div id="sec4_1_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Methyl 2-[2-<i>tert</i>-Butoxycarbonylamino-3-(1-methyl-1<i>H</i>-indol-3-yl)propionylamino]-3-(1-methyl-1<i>H</i>-indol-3-yl)propanoate (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> (58 g, 70%) was prepared following the general procedure A by HOBt–DCC coupling of BocNH-NMeTrp-OH (50 mg, 0.15 mmol) with NH<sub>2</sub>-NMeTrp-OMe (40 mg, 0.17 mmol) in the presence of HOBt (20 mg, 0.15 mmol) and DCC (35 mg, 0.17 mmol) in THF (5 mL) as a white solid. Mp 128 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.66 (d, <i>J</i> = 7.9 Hz, 1H), 7.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.27–7.23 (m, 1H), 7.23–7.18 (m, 1H), 7.14 (t, <i>J</i> = 7.0 Hz, 3H), 6.94 (s, 1H), 6.85 (t, <i>J</i> = 7.3 Hz, 1H), 6.38–6.26 (m, 2H), 5.09 (d, <i>J</i> = 8.1 Hz, 1H), 4.79 (q, <i>J</i> = 6.0 Hz, 1H), 4.45 (d, <i>J</i> = 7.5 Hz, 1H), 3.67 (s, 3H), 3.59 (s, 3H), 3.55 (s, 3H), 3.36 (q, <i>J</i> = 4.7 Hz, 1H), 3.15 (td, <i>J</i> = 13.8, 12.8, 6.3 Hz, 2H), 3.06 (dd, <i>J</i> = 14.7, 5.4 Hz, 1H), 1.38 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.6, 171.1,155.3, 136.9, 136.7, 128.2, 128.0, 127.7, 127.5, 121.8, 121.7, 119.3, 119.1, 119.0, 118.3, 109.3, 108.9, 107.8, 52.8, 52.2, 32.6, 32.5, 28.2, 28.1, 27.5. HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>37</sub>N<sub>4</sub>O<sub>5</sub> [M + H]<sup>+</sup> 533.2764, found 533.2835.</div></div><div id="sec4_1_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl 2-(2-<i>tert</i>-Butoxycarbonylamino-3-phenylpropionylamino)-3-phenylpropanoate (<b>40</b>)</h3><div class="NLM_p last">Compound <b>40</b> (1.8 g, 75%)) was prepared following general procedure A by HOBt–DCC coupling of BocNH-Phe-OH (2.0 g, 5.65 mmol) with HCl·NH<sub>2</sub>-Phe-OMe (1.12, 6.21 mmol) in the presence of HOBt (900 mg, 6.67 mmol) and DCC (1.38 g, 6.67 mmol) in THF (60 mL) as a white solid. Mp 117 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.29–7.26 (m, 1H), 7.24 (td, <i>J</i> = 3.8, 1.4 Hz, 2H), 7.21 (dt, <i>J</i> = 5.8, 1.6 Hz, 3H), 7.17 (d, <i>J</i> = 7.4 Hz, 2H), 6.95 (dd, <i>J</i> = 6.4, 2.3 Hz, 2H), 6.24 (br s, 1H), 4.91 (br s, 1H), 4.76 (d, <i>J</i> = 6.7 Hz, 1H), 4.31 (br s, 1H), 3.65 (s, 3H), 3.06–2.95 (m, 4H), 1.38 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.3, 170.7, 155.2 136.5, 135.6, 129.3(3C), 129.2(2C), 128.6, 128.5 (2C), 127.1, 126.9, 53.2, 52.3 (2C), 37.9 (2C), 28.2(3C); HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>30</sub>N<sub>2</sub>NaO<sub>5</sub> [M + Na]<sup>+</sup> 449.2052, found 449.2027.</div></div><div id="sec4_1_6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Methyl 2-<i>tert</i>-Butoxycarbonylamino-3-(5-oxiranylmethoxy-1<i>H</i>-indol-3-yl)propanoate (<b>42</b>)</h3><div class="NLM_p last">To a stirred solution of <b>41</b> (200 mg, 0.60 mmol) in dry DMF (6 mL) were added cesium carbonate (390 mg, 1.2 mmol) and (±)-epibromohydrin (77 μL, 0.90 mmol). The reaction mixture was stirred at 60 °C for 12 h, cooled to rt, and concentrated under reduced pressure. It was diluted with ethyl acetate and worked up in the usual manner and subjected to column chromatography with silica gel using 30% ethyl acetate in hexane as eluent to afford <b>42</b> (150 mg, 68%, dr = 1:1) as a yellow semi soild. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (s, 1H), 7.20 (d, <i>J</i> = 8.7 Hz, 1H), 7.02 (d, <i>J</i> = 2.4 Hz, 1H), 6.94 (s, 1H), 6.86 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.13 (dt, <i>J</i> = 6.7, 3.4 Hz, 1H), 4.61 (dt, <i>J</i> = 14.7, 5.9 Hz, 1H), 4.25 (dt, <i>J</i> = 11.0, 3.3 Hz, 1H), 3.99 (dt, <i>J</i> = 10.7, 5.2 Hz, 1H), 3.65 (s, 3H), 3.38 (dq, <i>J</i> = 7.1, 3.1 Hz, 1H), 3.21 (d, <i>J</i> = 5.7 Hz, 2H), 2.90 (t, <i>J</i> = 4.6 Hz, 1H), 2.77 (dd, <i>J</i> = 5.0, 2.7 Hz, 1H), 1.41 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 170.0, 155.5, 153.1, 131.8, 128.1, 124.0, 113.0, 112.96, 112.2, 109.9, 102.3, 80.1, 70.0, 69.9, 54.4, 52.4, 50.6, 44.9, 28.5, 28.3. HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>27</sub>N<sub>2</sub>O<sub>6</sub> [M + H]<sup>+</sup> 391.1869, found 391.1874.</div></div><div id="sec4_1_6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl 3-(5-Allyloxy-1<i>H</i>-indol-3-yl)-2-<i>tert</i>-butoxycarbonylaminopropanoate (<b>44</b>)</h3><div class="NLM_p last">To a stirred solution of <b>41</b> (200 mg, 0.60 mmol) in dry DMF (6 mL) were added cesium carbonate (390 mg, 1.2 mmol) and allyl bromide (0.12 mL, 1.40 mmol). The reaction mixture was stirred at 60 °C for 12 h, cooled to rt, and concentrated under reduced pressure. It was diluted with ethyl acetate and worked up in the usual manner and subjected to column chromatography with silica gel using 30% ethyl acetate in hexane as eluent to afford <b>44</b> (182 mg, 82%) as a yellow semisolid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 7.22 (d, <i>J</i> = 8.8 Hz, 1H), 7.03 (s, 1H), 6.96 (d, <i>J</i> = 2.5 Hz, 1H), 6.88 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 6.11 (ddt, <i>J</i> = 16.3, 10.6, 5.3 Hz, 1H), 5.45 (dd, <i>J</i> = 17.3, 1.9 Hz, 1H), 5.36–5.23 (m, 1H), 5.10 (d, <i>J</i> = 8.3 Hz, 1H), 4.64 (d, <i>J</i> = 7.2 Hz, 1H), 4.58 (d, <i>J</i> = 5.4 Hz, 2H), 3.68 (s, 3H), 3.23 (d, <i>J</i> = 5.5 Hz, 2H), 1.42 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.0, 155.5, 153.3, 134.1, 131.6, 128.2, 123.8, 117.6, 113.3, 112.1, 110.1, 102.3, 80.1, 70.0, 54.4, 52.5, 28.5, 28.3; HRMS (TOF MS ES+) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup> 375.1920, found 375.1916.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Analogue <b>60</b></h3><div class="NLM_p last">Analogue <b>60</b> (12 mg, 10%) was prepared as a yellow solid from MTMSA (<b>2</b>) (90 mg, 0.09 mmol) using PyBop (72 mg, 0.14 mmol), NH<sub>2</sub>-Phe-Trp-OMe (100 mg, 0.27 mmol) and DMF (5 mL), following general procedure D. Mp 154 °C; <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.51 (d, <i>J</i> = 7.8 Hz, 1H), 7.37–7.25 (m, 5H), 7.14–7.10 (m, 2H), 7.07–7.04 (m, 1H), 6.69 (t, <i>J</i> = 7.8 Hz, 1H), 6.41 (s, 1H), 6.26 (s, 1H), 5.07–5.00 (m, 2H), 4.84–4.79 (m, 2H), 4.77–4.67 (m, 2H), 4.40 (brs, 1H), 4.08 (dd, <i>J</i> = 8.7, 5.3 Hz, 1H), 3.99 (brs, 1H), 3.91–3.86 (m, 2H), 3.82–3.78 (m, 2H), 3.76–3.70 (m, 4H), 3.69 (s, 3H), 3.67–3.59 (m, 3H), 3.55–3.51 (m, 1H), 3.45–3.40 (m, 2H), 3.38 (s, 3H), 3.29–3.21 (m, 6H), 3.17–3.10 (m, 3H), 3.03–2.97 (m, 3H), 2.65–2.60 (m, 1H), 2.47–2.45 (m, 1H), 2.39–2.34 (m, 2H), 2.28–2.10 (5H), 2.02–1.80 (m, 6H), 1.66–1.62 (m, 4H), 1.44 (d, <i>J</i> = 6.1 Hz, 3H), 1.40 (d, <i>J</i> = 5.6 Hz, 3H), 1.37 (d, <i>J</i> = 6.1 Hz, 3H), 1.33 (d, <i>J</i> = 7.3 Hz, 3H), 1.30 (d, <i>J</i> = 6.2 Hz, 3H), 1.28 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 204.3, 174.3, 173.7, 173.5, 169.6, 164.7, 160.3, 156.7, 139.4, 139.0, 138.1, 137.9, 136.3, 135.5, 130.6, 130.5, 130.2, 129.7, 128.9, 128.7, 128.6, 127.8, 124.8, 124.5, 122.6, 122.5, 119.9, 119.9, 119.2, 119.1, 118.3, 112.4, 112.4, 111.8, 110.4, 109.0, 108.6, 102.0, 100.1, 99.9, 98.9, 98.1, 80.9, 80.8, 78.1, 77.9, 77.4, 76.6, 76.4, 73.7, 73.4, 72.1, 72.0, 71.9, 71.8, 70.5, 60.4, 55.5, 55.0, 54.9, 52.9, 49.9, 47.9, 45.2, 44.8, 40.8, 38.6, 38.2, 33.2, 28.6, 28.5, 27.3, 18.8, 18.8, 18.2, 17.1. HRMS (TOF MS ES−) <i>m</i>/<i>z</i> calcd for C<sub>70</sub>H<sub>90</sub>N<sub>3</sub>O<sub>25</sub> [M – H]<sup>−</sup> 1372.5863, found 1372.5890.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Analogue <b>61</b></h3><div class="NLM_p last">Analogue <b>61</b> (17 mg, 14%) was prepared as a yellow solid from MTMSA (<b>2</b>) (90 mg, 0.09 mmol) using PyBop (72 mg, 0.14 mmol), NH<sub>2</sub>-Trp-Trp-OMe (110 mg, 0.27 mmol), and DMF (5 mL), following general procedure D. Mp 165 °C; <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 7.72 (d, <i>J</i> = 7.9 Hz, 1H), 7.50 (d, <i>J</i> = 7.8 Hz, 1H), 7.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.28 (d, <i>J</i> = 8.1 Hz, 1H), 7.23 (d, <i>J</i> = 7.1 Hz, 2H), 7.09 (d, <i>J</i> = 8.9 Hz, 3H), 7.01 (t, <i>J</i> = 7.7 Hz, 1H), 6.55 (s, 1H), 5.91 (s, 1H), 5.29 (brs, 1H), 5.06 (brs, 1H), 5.01–5.00 (m, 2H), 4.83 (t, <i>J</i> = 6.6 Hz, 1H), 4.79 (d, <i>J</i> = 9.8 Hz, 1H), 4.71–4.62 (m, 1H), 4.41 (d, <i>J</i> = 11.1 Hz, 1H), 4.00 (s, 1H), 3.90–3.80 (m, 2H), 3.76–3.69 (m, 2H), 3.68 (s, 3H), 3.63–3.57 (m, 2H), 3.42–3.35 (m, 4H), 3.29–3.26 (m, 3H), 3.19–3.14 (m, 2H), 3.07 (t, <i>J</i> = 8.7 Hz, 1H), 3.02–2.93 (m, 2H), 2.57–2.47 (m, 1H), 2.34–2.13 (m, 5H), 1.97–1.93 (m, 2H), 1.90–1.85 (m, 1H), 1.80 (q, <i>J</i> = 11.3 Hz, 1H), 1.72 (d, <i>J</i> = 15.1 Hz, 1H), 1.64–1.53 (m, 3H), 1.46 (d, <i>J</i> = 6.1 Hz, 3H), 1.37–1.27 (m, 15H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 204.0, 174.2, 173.9, 173.7, 160.2, 139.6, 138.2, 137.9, 136.4, 128.9, 128.8, 125.0, 124.8, 122.7, 122.5, 120.1, 119.9, 119.8, 119.2, 112.6, 112.4, 111.5, 111.1, 110.4, 109.1, 101.8, 100.0, 100.0, 99.0, 97.9, 80.9, 78.2, 77.9, 77.6, 77.4, 76.6, 76.3, 73.7, 73.3, 72.1, 72.0, 71.9, 71.8, 70.4, 64.4, 60.4, 54.9, 54.5, 52.9, 49.9, 47.4, 47.4, 45.3, 40.7, 38.2, 38.1, 33.2, 28.5, 27.4, 27.3, 27.3, 18.8, 18.7, 18.2, 18.2, 17.1. HRMS (TOF MS ES−) <i>m</i>/<i>z</i> calcd for C<sub>72</sub>H<sub>91</sub>N<sub>4</sub>O<sub>25</sub> [M-H]<sup>−</sup> 1411.5972, found 1411.5985.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Isolation of MTMSA (<b>2</b>) from <i>S. argillaceus</i> M7W1<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></h3><div class="NLM_p last"><i>S. argillaceus</i> M7W1 colonies were selected by multiple spore to spore passages over R5A agar plates supplied with 50 μg/mL apramycin. The visually darkest colony was cultured for 48 h (30 °C, 220 rpm) in TSB medium supplemented with 50 μg/mL apramycin and subsequently used to inoculate a modified R5A medium (100 g/L sucrose, 5 g/L glucose, 5 g/L soybean powder, 1 g/L yeast extract, 15 g/L MOPS, 5 g/L glycerol, 5 g/L MgCl<sub>2</sub>·6H<sub>2</sub>O, 1 g/L CaCO<sub>3</sub>, pH 7.5) for 8 days (30 °C, 240 rpm). The culture broth was centrifuged (3500 rpm, 30 min), and the supernatant liquid was adjusted to pH 5.5 and extracted with <i>n</i>-BuOH (2 × equal volume). The butanol fraction was concentrated under reduced pressure and purified with silica gel chromatography (gradient of chloroform/methanol/acetic acid = 15:1:0.1 to 10:1:0.1) to obtain 90% pure MTMSA (<b>2</b>), which was further purified by HPLC<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> to obtain pure MTMSA (<b>2</b>, yellow solid, 20 mg/L).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Cell Culture Media and Materials</h3><div class="NLM_p last">RPMI-1640 (Sigma, St. Louis, MO), DMEM (Sigma, St. Louis, MO), and F12K (Sigma, St. Louis, MO) media were prepared with 10% v/v heat-inactivated fetal bovine serum (FBS) (Atlanta Biologicals, Flowery Branch, GA) and 1% v/v 10,000 units/mL penicillin and 10 000 μg/mL streptomycin (PS) (Life Technologies, Carlsbad, CA). McCoy’s 5A (Sigma, St. Louis, MO) medium was prepared with 15% v/v FBS and 1% v/v PS. All media were prepared with 1.5–2 g/L sodium bicarbonate (Sigma, St. Louis, MO), pH was adjusted to 7.2, and filtered with 0.2 μm filters (Corning, Corning, NY) prior to use. TC-32 (RPMI-1640), RD-ES (RPMI-1640), TC-71 (RPMI-1640), A-673 (DMEM), and 5838 (McCoy’s 5A) cell lines (culture medium) were gifts from Dr. Timothy Cripe (Hospital Research Foundation, Columbus, OH). ES-8 (RPMI-1640), ES-2 (RPMI-1640), and ES-7 (RPMI-1640) were gifts from Dr. Peter Houghton (Greehey Children’s Cancer Research Institute, San Antonio, TX). VCaP (DMEM), PC-3 (RPMI-1640), DU 145 (RPMI-1640), PANC-1 (DMEM), U-118 MG (DMEM), HeLa (DMEM), A549 (F12K), and DMS 114 (RPMI-1640) cell lines were from ATCC (Manassas, VA). LNCaP (RPMI-1640) cell line was a gift from Dr. Vivek Rangnekar (University of Kentucky College of Medicine, Lexington, KY). HCT 116 (McCoy’s 5A) cell line was a gift from the Genetic Resource Core Facility (Dr. Bert Vogelstein, John Hopkins School of Medicine, Baltimore, MD). All cell lines were grown at 37 °C under 5% CO<sub>2</sub> in a humid incubator and were tested regularly for mycoplasma using the MycoAlert mycoplasma detection kit (Lonza, Basel, Switzerland).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 72 h Growth Inhibition (GI<sub>50</sub>) Assay</h3><div class="NLM_p">Cells were seeded in clear 96-well plates (VWR, Radnor, PA) at a cell density appropriate for exponential growth over 5 days. Following a 24 h attachment period, cells in duplicate wells were treated with half-log increments of respective compounds (0 nM and 0.3 nM to 10 μM). Working stocks were prepared from an initial 10 mM drug stock diluted in either 100% EtOH or DMSO. All wells contained a final concentration of 0.1% v/v respective organic solvent. Immediately following treatment, cell viability was measured for (day 0) no-treatment control wells. Cell viability was measured in the remaining wells after 72 h of incubation with compound or vehicle control. For viability measurements, 0.1 mM resazurin (Sigma, St. Louis, MO) was added to wells, and following 3 h of incubation at 37 °C, fluorescence readings (EM 560 nm, EX 590 nm) were recorded using a SpectraMax M5 plate reader (Molecular Devices, Sunnyvale, CA). Percent cell viability, relative to the initial seeding concentration, was calculated using the following formula:<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_m001.gif" alt="" id="_i40" /></img></span></div><div class="NLM_p last">Percent cell viability was plotted against concentration (log [M]), and regression software GraphPad Prism 7.0 (GraphPad Software, La Jolla, CA) was used to curve-fit data and calculate a respective 72 h growth inhibition (GI<sub>50</sub>).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> In Vitro Selectivity Screen Using Ewing Sarcoma GI<sub>50</sub> Model</h3><div class="NLM_p last">The GI<sub>50</sub> of MTMSA (<b>2</b>) analogues was estimated first in TC-32 cells. Analogues with GI<sub>50</sub> values less than 250 nM in TC-32 cells were further tested in PC-3 cells. The ratio of GI<sub>50</sub> values (PC-3/TC-32) was then estimated, and MTMSA (<b>2</b>) analogues with a ratio greater than 3 were selected for additional testing. A selectivity index for the compounds was then determined by taking the ratio of the median GI<sub>50</sub> found in the non-Ewing sarcoma cell lines compared to the median GI<sub>50</sub> found in ETS dependent cell lines.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Statistical Analysis of GI<sub>50</sub> Results</h3><div class="NLM_p last">The GI<sub>50</sub> value was determined by pooling all available experiments and reported with 95% confidence interval. All compounds were tested at least once in multiwall replicates, and each experiment included one or two control compounds (i.e., MTM (<b>1</b>) or MTMSA-Trp (<b>3</b>)) to ensure the stable response of the cell lines. The selectivity index was estimated by measuring the ratio of GI<sub>50</sub> estimates in non-Ewing sarcoma/ETS dependent cell lines. Median values are reported since the GI<sub>50</sub> was not estimable in some cases.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Cloning of NR0B1 and CMV Promoter-Driven Luciferase Reporter Vectors</h3><div class="NLM_p last">Full-length NR0B1 promoter sequence was PCR amplified using Q5 high-fidelity DNA polymerase (New England Biolabs, Ipswich, MA) from genomic DNA of TC-32 cells and cloned into the pGLUC-Basic 2 vector (New England Biolabs, Ipswich, MA). XhoI and KpnI restriction sites were incorporated into the primers. After restriction enzyme (New England Biolabs, Ipswich, MA) digest and purification by gel electrophoresis, the target amplicon was ligated into the pGLUC-Basic 2 vector using T4 DNA ligase (Thermo Fisher Scientific, Waltham, MA). Chemically competent TOP10 <i>E. coli</i> cells were used to propagate vectors under ampicillin selection (100 μg/mL) (Thermo Fisher Scientific, Waltham, MA). The resulting vectors were extracted and purified using GeneJET plasmid prep kit (Thermo Fisher Scientific, Waltham, MA). The purified vector was transfected into TC-32 cells using Lipofectamine 3000 (Thermo Fisher Scientific, Waltham, MA) with subsequent G418 selection (1 mg/mL) (VWR, Radnor, PA). Separately, TC-32 cells were transfected with pCMV-Red Firefly vector (Thermo Fisher Scientific, Waltham, MA) with subsequent puromycin selection (0.1 mg/mL) (Sigma, St. Louis, MO) as a control.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Luciferase Reporter Assay in Stably Transfected TC-32 Cells</h3><div class="NLM_p last">Selected TC-32 cells, expressing either NR0B1 or CMV luciferase reporter vectors, were seeded in clear 96-well plates at a density of 10 000 cells/well. Following a 24 h attachment period, cells were treated in duplicate with half-log increments of respective compounds (0 nM and 0.3 nM to 10 μM). After a 12 h treatment, the medium was removed and cells were washed 3 times with DPBS (Thermo Fisher Scientific, Waltham, MA). Cells were directly lysed on a plate shaker for 30 min at room temperature using 100 μL of passive membrane lysis solution. Lysates (80 μL) were transferred to a white luminescence plate. Luciferase substrate, either coelenterazine or D-luciferin (50 μL of 1X solution) for NR0B1 or CMV vectors, respectively, was added in a Glomax 96 microplate luminometer (Promega, Madison, WI), and luminescence was immediately measured. Delay before and after injections was set to the default of 0.4 s, and a 10 s integration time was used. All reagents used in this assay were from the dual luciferase reporter assay system (Promega, Madison, WI). Concurrently, an additional 96-well plate was seeded and treated under the exact same conditions to determine cell viability using resazurin assay. Luminescence results were normalized to cell viability.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Relative mRNA Expression (qRT-PCR)</h3><div class="NLM_p last">TC-32 cells were seeded in 6-well plates at a density of 300 000 cells/well. When 80% confluent, ∼72 h later, cells were washed with DPBS and treated with respective compounds (0 nM and GI<sub>50</sub> nM). After 6 and 12 h treatments the medium was removed. Cells were washed with DPBS and 500 μL of 0.05% trypsin with 0.53 mM EDTA (Corning, Corning, NY) was added. After a 2–3 min incubation, cells detached from the plate and 1 mL of fresh RPMI medium was immediately added. Cells were collected in 1.5 mL tubes on ice and centrifuged to a pellet at 1200<i>g</i> for 5 min. Supernatant was removed, and cell pellets were lysed with 600 μL of RLT lysis buffer (Qiagen, Hilden, Germany). Lysates were centrifuged through QIAshredder inserts for complete cell disruption (Qiagen, Hilden, Germany). RNeasy mini spin columns were used to isolate pure RNA (Qiagen, Hilden, Germany). RNA concentrations were measured using NanoDrop 2000 spectrometer (Thermo Fisher Scientific, Waltham, MA), and a 100 ng/μL stock solution was prepared. RNA (1 μg) was used to prepare cDNA with a MultiScribe reverse transcriptase (Thermo Fisher Scientific, Waltham, MA). qRT-PCR reactions were conducted using Maxima SYBR green Taq DNA polymerase (Thermo Fisher Scientific, Waltham, MA). EpMotion5070 (Eppendorf, Hamburg, Germany) robot was used to mix reactions in 384-well plates, and thermocycling was completed on a QuantStudio 7 Flex (Thermo Fisher Scientific, Waltham, MA). GAPDH served as the housekeeping gene for comparing relative expression of target genes. All primers (IDT, Coralville, IA) were verified to amplify a single amplicon of appropriate size by gel electrophoresis and melting curve analysis.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01107" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01107" class="ext-link">10.1021/acs.jmedchem.8b01107</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC profiles and HRMS data of all the MTMSA analogues, LCMS data of all the free amines, detailed cytotoxicity data of select MTMSA analogues, and primers used for qRT-PCR (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings with associated biochemical and biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_001.pdf">jm8b01107_si_001.pdf (980.78 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_002.csv">jm8b01107_si_002.csv (13.82 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01107" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markos Leggas</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University
of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0c616d7e672260696b6b6d7f4c79677522696879"><span class="__cf_email__" data-cfemail="4a272b382164262f2d2d2b390a3f2133642f2e3f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jürgen Rohr</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University
of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6447-5951" title="Orcid link">http://orcid.org/0000-0001-6447-5951</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dab0a8b5b2a8e89afaafb1a3f4bfbeaf"><span class="__cf_email__" data-cfemail="6208100d0a105022">[email protected]</span> uky.edu</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prithiba Mitra</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University
of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph M. Eckenrode</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University
of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abhisek Mandal</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University
of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amit K. Jha</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University
of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaimaa M. Salem</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy, University
of Kentucky, Lee T. Todd, Jr. Building, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9149-5365" title="Orcid link">http://orcid.org/0000-0002-9149-5365</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>P.M. and J.M.E. contributed equally. P.M. and J.R. designed all the molecules. P.M. and A.M. synthesized all the analogues. S.M.S. and A.K.J. optimized the media for the production of MTMSA (2). P.M., A.K.J., and A.M. contributed to the isolation of MTMSA (2). J.M.E. and M.L. designed the cytotoxicity and molecular assays. J.M.E. performed all the assays. The manuscript was written through contributions of all authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3737-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73772" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73772" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Institutes of Health Grants CA 091901 and GM 105977 to J.R. as well as the U.S. Department of Defense Grant PC150300 to J.R. and M.L. We acknowledge Markey Cancer Center and Dance Blue Foundation for their financial support. We also acknowledge Dr. Oleg V. Tsodikov for his valuable thoughts in designing analogues. We thank Dr. Madan Kharel and Dr. Khaled Shabaan of the UK Center for Pharmaceutical Research Innovation (CPRI) for their help to prepare larger amounts of mithramycin SA, and we thank UK College of Pharmacy for the NMR facility.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">FLI1</td><td class="NLM_def"><p class="first last">friend leukemia integration 1 transcription factor</p></td></tr><tr><td class="NLM_term">ETS</td><td class="NLM_def"><p class="first last">E26 transformation-specific</p></td></tr><tr><td class="NLM_term">ERG</td><td class="NLM_def"><p class="first last">E26-transformation-specific-related gene</p></td></tr><tr><td class="NLM_term">TMPRSS2</td><td class="NLM_def"><p class="first last">transmembrane protease, serine 2</p></td></tr><tr><td class="NLM_term">Sp1</td><td class="NLM_def"><p class="first last">specificity protein 1</p></td></tr><tr><td class="NLM_term">BCL-2</td><td class="NLM_def"><p class="first last">B-cell lymphoma 2</p></td></tr><tr><td class="NLM_term">NR0B1</td><td class="NLM_def"><p class="first last">nuclear receptor subfamily 0, group B, member 1</p></td></tr><tr><td class="NLM_term">CCK</td><td class="NLM_def"><p class="first last">cholecystokinin</p></td></tr><tr><td class="NLM_term">CMV</td><td class="NLM_def"><p class="first last">cytomegalovirus</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">qRT-PCR</td><td class="NLM_def"><p class="first last">quantitative reverse transcription polymerase chain reaction</p></td></tr><tr><td class="NLM_term">GADPH</td><td class="NLM_def"><p class="first last">glyceraldehyde 3-phosphate dehydrogenase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohlert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Künzel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machinek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span> <span> </span><span class="NLM_article-title">The structure of mithramycin reinvestigated</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1021/np980355k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np980355k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=119-121&author=S.+Wohlertauthor=E.+K%C3%BCnzelauthor=R.+Machinekauthor=C.+Mendezauthor=J.+Salasauthor=J.+Rohr&title=The+structure+of+mithramycin+reinvestigated&doi=10.1021%2Fnp980355k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fnp980355k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp980355k%26sid%3Dliteratum%253Aachs%26aulast%3DWohlert%26aufirst%3DS.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DMachinek%26aufirst%3DR.%26aulast%3DMendez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DThe%2520structure%2520of%2520mithramycin%2520reinvestigated%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1999%26volume%3D62%26spage%3D119%26epage%3D121%26doi%3D10.1021%2Fnp980355k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Méndez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J. A.</span></span> <span> </span><span class="NLM_article-title">The biosynthesis of aureolic acid group antibiotics</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1006/bioo.1998.1110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1006%2Fbioo.1998.1110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1Smt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=41-54&author=J.+Rohrauthor=C.+M%C3%A9ndezauthor=J.+A.+Salas&title=The+biosynthesis+of+aureolic+acid+group+antibiotics&doi=10.1006%2Fbioo.1998.1110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Biosynthesis of Aureolic Acid Group Antibiotics</span></div><div class="casAuthors">Rohr, Jurgen; Mendez, Carmen; Salas, Jose A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-54</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 54 refs.  Biosynthetic studies on mithramycin (aureolic acid) using to a great extent modern genetic methods revealed several novel aspects of the biosynthesis of this class of antitumor agent.  It could be proven that the aglycon moiety of the aureolic acids is constructed by a type II polyketide synthase via a single decaketide chain which undergoes a folding, as seen in the tetracyclines, followed by an initial 7,12-cyclization.  Finally, after three more cyclizations, a linear tetracyclic intermediate (premithramycinone) arises, which is a tetracycline-like mol.  Premithramycinone is consecutively methylated and glycosylated (via premithramycins A1, A1, A2 and A3 ) to form premithramycin B , the ultimate tetracyclic intermediate, whose fourth ring finally gets oxidatively opened through a Baeyer-Villiger type oxidn. to yield mithramycin .  Most of the gene cluster coding for the mithramycin biosynthesis has been identified and sequenced and several gene functions were identified through insertional inactivation of specific genes and structure elucidation of accumulated products.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprXvppb1x-37Vg90H21EOLACvtfcHk0lgHq9lb8RRMDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1Smt7g%253D&md5=47daafdc58177c77724c0a7f3c7784d7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1006%2Fbioo.1998.1110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbioo.1998.1110%26sid%3Dliteratum%253Aachs%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520biosynthesis%2520of%2520aureolic%2520acid%2520group%2520antibiotics%26jtitle%3DBioorg.%2520Chem.%26date%3D1999%26volume%3D27%26spage%3D41%26epage%3D54%26doi%3D10.1006%2Fbioo.1998.1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kofman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlia, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Economou, S. G.</span></span> <span> </span><span class="NLM_article-title">Mithramycin in the treatment of metastatic ewing’s sarcoma</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">889</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1002/1097-0142(197304)31:4<889::AID-CNCR2820310419>3.0.CO;2-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1002%2F1097-0142%28197304%2931%3A4%3C889%3A%3AAID-CNCR2820310419%3E3.0.CO%3B2-H" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1973&pages=889-893&author=S.+Kofmanauthor=C.+P.+Perliaauthor=S.+G.+Economou&title=Mithramycin+in+the+treatment+of+metastatic+ewing%E2%80%99s+sarcoma&doi=10.1002%2F1097-0142%28197304%2931%3A4%3C889%3A%3AAID-CNCR2820310419%3E3.0.CO%3B2-H"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%28197304%2931%3A4%3C889%3A%3AAID-CNCR2820310419%3E3.0.CO%3B2-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%2528197304%252931%253A4%253C889%253A%253AAID-CNCR2820310419%253E3.0.CO%253B2-H%26sid%3Dliteratum%253Aachs%26aulast%3DKofman%26aufirst%3DS.%26aulast%3DPerlia%26aufirst%3DC.%2BP.%26aulast%3DEconomou%26aufirst%3DS.%2BG.%26atitle%3DMithramycin%2520in%2520the%2520treatment%2520of%2520metastatic%2520ewing%25E2%2580%2599s%2520sarcoma%26jtitle%3DCancer%26date%3D1973%26volume%3D31%26spage%3D889%26epage%3D893%26doi%3D10.1002%2F1097-0142%28197304%2931%3A4%3C889%3A%3AAID-CNCR2820310419%3E3.0.CO%3B2-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Balamuth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womer, R. B.</span></span> <span> </span><span class="NLM_article-title">Ewing’s sarcoma</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(09)70286-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1016%2FS1470-2045%2809%2970286-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=20152770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=184-192&author=N.+Balamuthauthor=R.+B.+Womer&title=Ewing%E2%80%99s+sarcoma&doi=10.1016%2FS1470-2045%2809%2970286-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Ewing's sarcoma</span></div><div class="casAuthors">Balamuth, Naomi J.; Womer, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Progress in the treatment of Ewing's sarcoma, the second most common bone tumor in children and adolescents, has improved survival from about 10% in the period before chemotherapy was introduced to about 75% today for patients with localized tumors.  However, patients with metastases still fare badly, and the therapy carries short-term and long-term toxicities.  Multidisciplinary care is indispensable for these patients.  Mol. techniques and new imaging modalities are affecting the diagnosis and classification of patients with Ewing's sarcoma.  Cooperative group studies have led to chemotherapy regimens using the same drugs (vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide), although the exact regimens differ in Europe and North America.  The EWS-ETS family of gene fusions and their downstream effects in Ewing's sarcomas provide opportunities for new approaches to treatment.  These include the inhibition of the fusion gene or its protein product, and pathways related to IGF1 and mTOR.  Inhibition of tyrosine kinases, exploitation of non-apoptotic cell death, and interference with angiogenesis are promising new approaches.  With many new approaches and relatively few patients, it will be challenging to integrate new and established treatments through clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIMK60c3BVxLVg90H21EOLACvtfcHk0lg3gU1wsd4lNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGgur4%253D&md5=f16ac27df030a6d367e18aebc838eafe</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2809%2970286-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252809%252970286-4%26sid%3Dliteratum%253Aachs%26aulast%3DBalamuth%26aufirst%3DN.%26aulast%3DWomer%26aufirst%3DR.%2BB.%26atitle%3DEwing%25E2%2580%2599s%2520sarcoma%26jtitle%3DLancet%2520Oncol.%26date%3D2010%26volume%3D11%26spage%3D184%26epage%3D192%26doi%3D10.1016%2FS1470-2045%2809%2970286-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kofman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenstein, R.</span></span> <span> </span><span class="NLM_article-title">Mithramycin in the treatment of disseminated cancer</span>. <i>Cancer Chemother. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=14088839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A280%3ADyaF2c%252Fks1GjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1963&pages=77-96&author=S.+Kofmanauthor=R.+Eisenstein&title=Mithramycin+in+the+treatment+of+disseminated+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED CANCER</span></div><div class="casAuthors">KOFMAN S; EISENSTEIN R</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy reports</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-96</span>
        ISSN:<span class="NLM_cas:issn">0069-0112</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5y_72QMlRq5SWdIdmEou5fW6udTcc2eatfcecmcDWfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2c%252Fks1GjtQ%253D%253D&md5=5b5e5a59401ba63a808e028d58016113</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKofman%26aufirst%3DS.%26aulast%3DEisenstein%26aufirst%3DR.%26atitle%3DMithramycin%2520in%2520the%2520treatment%2520of%2520disseminated%2520cancer%26jtitle%3DCancer%2520Chemother.%2520Rep.%26date%3D1963%26volume%3D32%26spage%3D77%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kofman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medrek, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. W.</span></span> <span> </span><span class="NLM_article-title">Mithramycin in the treatment of embryonal cancer</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">938</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1002/1097-0142(196407)17:7<938::AID-CNCR2820170714>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1002%2F1097-0142%28196407%2917%3A7%3C938%3A%3AAID-CNCR2820170714%3E3.0.CO%3B2-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1964&pages=938-948&author=S.+Kofmanauthor=T.+J.+Medrekauthor=R.+W.+Alexander&title=Mithramycin+in+the+treatment+of+embryonal+cancer&doi=10.1002%2F1097-0142%28196407%2917%3A7%3C938%3A%3AAID-CNCR2820170714%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%28196407%2917%3A7%3C938%3A%3AAID-CNCR2820170714%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%2528196407%252917%253A7%253C938%253A%253AAID-CNCR2820170714%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DKofman%26aufirst%3DS.%26aulast%3DMedrek%26aufirst%3DT.%2BJ.%26aulast%3DAlexander%26aufirst%3DR.%2BW.%26atitle%3DMithramycin%2520in%2520the%2520treatment%2520of%2520embryonal%2520cancer%26jtitle%3DCancer%26date%3D1964%26volume%3D17%26spage%3D938%26epage%3D948%26doi%3D10.1002%2F1097-0142%28196407%2917%3A7%3C938%3A%3AAID-CNCR2820170714%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delattre, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plougastel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmaze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joubert, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouleau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span> <span> </span><span class="NLM_article-title">Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">162</span>, <span class="refDoi"> DOI: 10.1038/359162a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1038%2F359162a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1992&pages=162&author=O.+Delattreauthor=J.+Zucmanauthor=B.+Plougastelauthor=C.+Desmazeauthor=T.+Melotauthor=M.+Peterauthor=H.+Kovarauthor=I.+Joubertauthor=P.+de+Jongauthor=G.+Rouleauauthor=A.+Auriasauthor=G.+Thomas&title=Gene+fusion+with+an+ETS+DNA-binding+domain+caused+by+chromosome+translocation+in+human+tumours&doi=10.1038%2F359162a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F359162a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F359162a0%26sid%3Dliteratum%253Aachs%26aulast%3DDelattre%26aufirst%3DO.%26aulast%3DZucman%26aufirst%3DJ.%26aulast%3DPlougastel%26aufirst%3DB.%26aulast%3DDesmaze%26aufirst%3DC.%26aulast%3DMelot%26aufirst%3DT.%26aulast%3DPeter%26aufirst%3DM.%26aulast%3DKovar%26aufirst%3DH.%26aulast%3DJoubert%26aufirst%3DI.%26aulast%3Dde%2BJong%26aufirst%3DP.%26aulast%3DRouleau%26aufirst%3DG.%26aulast%3DAurias%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DG.%26atitle%3DGene%2520fusion%2520with%2520an%2520ETS%2520DNA-binding%2520domain%2520caused%2520by%2520chromosome%2520translocation%2520in%2520human%2520tumours%26jtitle%3DNature%26date%3D1992%26volume%3D359%26spage%3D162%26doi%3D10.1038%2F359162a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, C. T.</span></span> <span> </span><span class="NLM_article-title">EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1038/ng1297-495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1038%2Fng1297-495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=9398859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADyaK2sXnvFWrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=495-497&author=W.+A.+Mayauthor=A.+Arvandauthor=A.+D.+Thompsonauthor=B.+S.+Braunauthor=M.+Wrightauthor=C.+T.+Denny&title=EWS%2FFLI1-induced+manic+fringe+renders+NIH+3T3+cells+tumorigenic&doi=10.1038%2Fng1297-495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic</span></div><div class="casAuthors">May, William A.; Arvand, Afsane; Thompson, Andrew D.; Braun, Benjamin S.; Wright, Marcienne; Denny, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">495-497</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">EWS/FLI1, a fusion gene found in Ewing's sarcoma, encodes a transcriptional regulator and promotes cellular transformation by modulating the transcription of specific target genes.  The authors have found that EWS/FLI1 and structurally related fusion proteins upregulate manic fringe (MFNG), a recently described member of the Fringe gene family instrumental in somatic development.  MFNG is also expressed in human tumor-derived cell lines expressing EWS/FLI1.  Overexpression of MFNG in NIH 3T3 cells renders them tumorigenic in mice with severe combined immunodeficiency disease (SCID).  These data demonstrate that part of the oncogenic effect of EWS/FLI1 is to transcriptionally deregulate a member of a family of morphogenic genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo21egGdVAYbrVg90H21EOLACvtfcHk0lhewKA1_2m9dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvFWrs7g%253D&md5=cf3fc24878a314b34c63f36511c246a3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng1297-495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1297-495%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DW.%2BA.%26aulast%3DArvand%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DA.%2BD.%26aulast%3DBraun%26aufirst%3DB.%2BS.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DDenny%26aufirst%3DC.%2BT.%26atitle%3DEWS%252FFLI1-induced%2520manic%2520fringe%2520renders%2520NIH%25203T3%2520cells%2520tumorigenic%26jtitle%3DNat.%2520Genet.%26date%3D1997%26volume%3D17%26spage%3D495%26epage%3D497%26doi%3D10.1038%2Fng1297-495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomlins, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanasekaran, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varambally, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tchinda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuefer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span> <span> </span><span class="NLM_article-title">Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1126/science.1117679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1126%2Fscience.1117679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=16254181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFChsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=644-648&author=S.+A.+Tomlinsauthor=D.+R.+Rhodesauthor=S.+Pernerauthor=S.+M.+Dhanasekaranauthor=R.+Mehraauthor=X.+W.+Sunauthor=S.+Varamballyauthor=X.+Caoauthor=J.+Tchindaauthor=R.+Kueferauthor=C.+Lee&title=Recurrent+fusion+of+TMPRSS2+and+ETS+transcription+factor+genes+in+prostate+cancer&doi=10.1126%2Fscience.1117679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer</span></div><div class="casAuthors">Tomlins, Scott A.; Rhodes, Daniel R.; Perner, Sven; Dhanasekaran, Saravana M.; Mehra, Rohit; Sun, Xiao-Wei; Varambally, Sooryanarayana; Cao, Xuhong; Tchinda, Joelle; Kuefer, Rainer; Lee, Charles; Montie, James E.; Shah, Rajal B.; Pienta, Kenneth J.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">5748</span>),
    <span class="NLM_cas:pages">644-648</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Recurrent chromosomal rearrangements have not been well characterized in common carcinomas.  We used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression.  Two ETS transcription factors, ERG and ETV1, were identified as outliers in prostate cancer.  We identified recurrent gene fusions of the 5' untranslated region of TMPRSS2 to ERG or ETV1 in prostate cancer tissues with outlier expression.  By using fluorescence in situ hybridization, we demonstrated that 23 of 29 prostate cancer samples harbor rearrangements in ERG or ETV1.  Cell line expts. suggest that the androgen-responsive promoter elements of TMPRSS2 mediate the overexpression of ETS family members in prostate cancer.  These results have implications in the development of carcinomas and the mol. diagnosis and treatment of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTX7VlR2WkVbVg90H21EOLACvtfcHk0lhBYQp29Znhpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFChsLjJ&md5=99162c7c1f22c60b16b254550fafa7ca</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1117679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1117679%26sid%3Dliteratum%253Aachs%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DRhodes%26aufirst%3DD.%2BR.%26aulast%3DPerner%26aufirst%3DS.%26aulast%3DDhanasekaran%26aufirst%3DS.%2BM.%26aulast%3DMehra%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DX.%2BW.%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DTchinda%26aufirst%3DJ.%26aulast%3DKuefer%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26atitle%3DRecurrent%2520fusion%2520of%2520TMPRSS2%2520and%2520ETS%2520transcription%2520factor%2520genes%2520in%2520prostate%2520cancer%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D644%26epage%3D648%26doi%3D10.1126%2Fscience.1117679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. J.</span></span> <span> </span><span class="NLM_article-title">Solution structure of the mithramycin dimer-DNA complex</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">6588</span>– <span class="NLM_lpage">6604</span>, <span class="refDoi"> DOI: 10.1021/bi00077a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00077a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADyaK3sXltlWjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=6588-6604&author=M.+Sastryauthor=D.+J.+Patel&title=Solution+structure+of+the+mithramycin+dimer-DNA+complex&doi=10.1021%2Fbi00077a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Solution structure of the mithramycin dimer-DNA complex</span></div><div class="casAuthors">Sastry, Mallika; Patel, Dinshaw J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6588-604</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The authors have characterized the NMR parameters for the complexes formed by the Mg2+-coordinated mithramycin dimer with self-complementary d(T-G-G-C-C-A) and d(T-C-G-C-G-A) duplexes.  The soln. structure of the latter complex has been detd. using a combined NMR-mol. dynamics study including relaxation matrix refinement.  The Mg2+-coordinated mithramycin dimer-d(T-C-G-C-G-A) complex exhibits a 2-fold center of symmetry with the divalent cation coordinated aglycons positioned opposite the central (G3-C4)·(G3-C4) segment such that the aglycon C8 hydroxyl oxygens form sym. sequence-specific hydrogen bonds to guanine amino protons in the complex.  The C-D-E trisaccharide segments of each monomer in the mithramycin dimer adopt extended conformations, are positioned inside the minor groove, and are directed toward the either end of the duplex.  The C-D saccharide component of one monomer and the aglycol of the other monomer in the mithramycin dimer share a widened minor groove with the hydrophobic edges of the C and D sugars interacting with individual strands of the duplex.  The E-sugar ring is positioned in the floor of the minor groove, and its hydroxyl-bearing face interacts with both strands of the duplex through hydrogen-bonding and hydroprobic intermol. interactions.  The A-B disaccharide and the hydrophilic side chain form intermol. contacts with the sugar-phosphate backbone in the complex.  The antiparallel alignment of divalent cation coordinated monomers in the mithramycin dimer results in the two outwardly directed C-D-E trisaccharide segments generating a right-handed continuous hexasaccharide domain that spans six base pairs in the minor groove of the duplex.  The soln. structure of the mithramycin dimer-DNA complex reported in this study and the soln. structure of the chromomycin dimer-DNA complex reported previously [Gao, X., Mirau, P., & Patel, D. J. (1992) J. Mol. Biol. 223, 259-279] show global similarities, as well as local differences that are of interest.  All four nucleotides in the tetranucleotide segment of the duplex centered about the sequence-specific (G-C)·(G-C) step adopt A-DNA sugar puckers and glycosidic torsion angles in the chromomycin dimer-DNA complex, while only the central cytidine adopts an A-DNA sugar pucker and glycosidic torsion angle in the mithramycin dimer-DNA complex.  Further, differences in both the hydrogen bonding and the hydrophobic nature of the substituents on the E-sugar face positioned in the floor of the minor groove result in reduced sequence selectivity for mithramycin dimer-DNA complexes relative to chromomycin dimer-DNA complexes.  These high-resoln. soln. structural studies provide plausible explanations for modulations in the sequence selectivity within the aureolic acid family of antitumor drug dimers for their DNA target sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPb4MWRqe2x7Vg90H21EOLACvtfcHk0lhBYQp29Znhpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlWjsbc%253D&md5=fff7ce3dd76317afad43c7a807eee634</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi00077a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00077a012%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26atitle%3DSolution%2520structure%2520of%2520the%2520mithramycin%2520dimer-DNA%2520complex%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D6588%26epage%3D6604%26doi%3D10.1021%2Fbi00077a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remsing, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nur-e-Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Lozano, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braña, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rix, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Méndez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span> <span> </span><span class="NLM_article-title">Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer streptomyces argillaceus through combinatorial biosynthesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">5745</span>– <span class="NLM_lpage">5753</span>, <span class="refDoi"> DOI: 10.1021/ja034162h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja034162h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=5745-5753&author=L.+L.+Remsingauthor=A.+M.+Gonz%C3%A1lezauthor=M.+Nur-e-Alamauthor=M.+J.+Fern%C3%A1ndez-Lozanoauthor=A.+F.+Bra%C3%B1aauthor=U.+Rixauthor=M.+A.+Oliveiraauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=Mithramycin+SK%2C+a+novel+antitumor+drug+with+improved+therapeutic+index%2C+mithramycin+SA%2C+and+demycarosyl-mithramycin+SK%3A+three+new+products+generated+in+the+mithramycin+producer+streptomyces+argillaceus+through+combinatorial+biosynthesis&doi=10.1021%2Fja034162h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin SK, A Novel Antitumor Drug with Improved Therapeutic Index, Mithramycin SA, and Demycarosyl-mithramycin SK: Three New Products Generated in the Mithramycin Producer Streptomyces argillaceus through Combinatorial Biosynthesis</span></div><div class="casAuthors">Remsing, Lily L.; Gonzalez, Ana M.; Nur-e-Alam, Mohammad; Fernandez-Lozano, M. Jose; Brana, Alfredo F.; Rix, Uwe; Oliveira, Marcos A.; Mendez, Carmen; Salas, Jose A.; Rohr, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5745-5753</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To gain initial structure-activity relationships regarding the highly functionalized pentyl side chain attached at C-3 of mithramycin (MTM), we focused on a post-polyketide synthase (post-PKS) tailoring step of the MTM biosynthesis by Streptomyces argillaceus ATCC 12956, which was proposed to be catalyzed by ketoreductase (KR) MtmW.  In this last step of the MTM biosynthesis, a keto group of the pentyl side chain is reduced to a secondary alc., and we anticipated the generation of an MTM deriv. with an addnl. keto group in the 3-side chain.  Insertional inactivation of mtmW, a gene located ∼8 kb downstream of the mithramycin-PKS genes, yielded an S. argillaceus mutant, which accumulated three new mithramycin analogs, namely mithramycin SA, demycarosyl-mithramycin SK, and mithramycin SK (MTM-SK).  The structures of these three compds. confirmed indirectly the proposed role of MtmW in MTM biosynthesis.  However, the new mithramycin derivs. bear unexpectedly shorter 3-side chains (Et or butyl) than MTM, presumably caused by nonenzymic rearrangement or cleavage reactions of the initially formed pentyl side chain with a reactive β-dicarbonyl functional group.  The major product, MTM-SK, was tested in vitro against a variety of human cancer cell lines, as well as in an in vitro toxicity assay, and showed an improved therapeutic index, in comparison to the parent drug, MTM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNPA1wWdO_uLVg90H21EOLACvtfcHk0ljFNY1niiKGtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFGnsr0%253D&md5=030ab7acf1d1e6315ae6273120193bc0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fja034162h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja034162h%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DA.%2BM.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez-Lozano%26aufirst%3DM.%2BJ.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DOliveira%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DMithramycin%2520SK%252C%2520a%2520novel%2520antitumor%2520drug%2520with%2520improved%2520therapeutic%2520index%252C%2520mithramycin%2520SA%252C%2520and%2520demycarosyl-mithramycin%2520SK%253A%2520three%2520new%2520products%2520generated%2520in%2520the%2520mithramycin%2520producer%2520streptomyces%2520argillaceus%2520through%2520combinatorial%2520biosynthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D5745%26epage%3D5753%26doi%3D10.1021%2Fja034162h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span> <span> </span><span class="NLM_article-title">Semi-synthetic mithramycin SA derivatives with improved anti-cancer activity</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1111%2Fcbdd.12107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=23331575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFSnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=615-624&author=D.+Scottauthor=J.+M.+Chenauthor=Y.+Baeauthor=J.+Rohr&title=Semi-synthetic+mithramycin+SA+derivatives+with+improved+anti-cancer+activity&doi=10.1111%2Fcbdd.12107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Semi-synthetic mithramycin SA derivatives with improved anticancer activity</span></div><div class="casAuthors">Scott, Daniel; Chen, Jhong-Min; Bae, Younsoo; Rohr, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">615-624</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mithramycin (MTM) is a potent anti-cancer agent that has recently garnered renewed attention.  This manuscript describes the design and development of mithramycin derivs. through a combinational approach of biosynthetic analog generation followed by synthetic manipulation for further derivatization.  Mithramycin SA is a previously discovered analog produced by the M7W1 mutant strain alongside the improved mithramycin analogs mithramycin SK and mithramycin SDK.  Mithramycin SA shows decreased anti-cancer activity compared to mithramycin and has a shorter, two carbon aglycon side chain that is terminated in a carboxylic acid.  The aglycon side chain is responsible for an interaction with the DNA-phosphate backbone as mithramycin interacts with its target DNA.  It was therefore decided to further functionalize this side chain through reactions with the terminal carboxylic acid in an effort to enhance the interaction with the DNA phosphate backbone and improve the anti-cancer activity.  This side chain was modified with a variety of mols. increasing the anti-cancer activity to a comparable level to mithramycin SK.  This work shows the ability to transform the previously useless mithramycin SA into a valuable mol. and opens the door to further functionalization and semi-synthetic modification for the development of mols. with increased specificity and/or drug formulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTa3ey2wYReLVg90H21EOLACvtfcHk0ljFNY1niiKGtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFSnsrY%253D&md5=244713ab138576371da084c6dc44bb88</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12107%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DBae%26aufirst%3DY.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DSemi-synthetic%2520mithramycin%2520SA%2520derivatives%2520with%2520improved%2520anti-cancer%2520activity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D615%26epage%3D624%26doi%3D10.1111%2Fcbdd.12107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leggas, M.</span>; <span class="NLM_string-name">Eckenrode, J.</span>; <span class="NLM_string-name">Mitra, P.</span>; <span class="NLM_string-name">Jha, J.</span>; <span class="NLM_string-name">Salem, S.</span>; <span class="NLM_string-name">Mandal, A.</span>; <span class="NLM_string-name">Thorson, J.</span>; <span class="NLM_string-name">Rohr, J.</span></span> <i>Molecular Targets and Cancer Therapeutics</i>, Proceedings of the AACR-NCI-EORTC International Conference, Philadelphia, PA, Oct 26–30, 2017; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2017</span>; Abstract B043.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+Leggas&author=J.+Eckenrode&author=P.+Mitra&author=J.+Jha&author=S.+Salem&author=A.+Mandal&author=J.+Thorson&author=J.+Rohr&title=Molecular+Targets+and+Cancer+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLeggas%26aufirst%3DM.%26btitle%3DMolecular%2520Targets%2520and%2520Cancer%2520Therapeutics%26pub%3DAACR%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span> </span><span class="NLM_article-title">Mithramycin-SA analogues with reduced toxicity
for the treatment of ETS transcription factor-driven tumors</span>.  <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume">17</span> (<span class="NLM_issue">1 Suppl.</span>), <span class="refDoi"> DOI: 10.1158/1535-7163.TARG-17-B043</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1158%2F1535-7163.TARG-17-B043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mithramycin-SA+analogues+with+reduced+toxicity%0Afor+the+treatment+of+ETS+transcription+factor-driven+tumors.+Mol.+Cancer+Ther.+2018%2C+17+%281+Suppl.%29%2C+10.1158%2F1535-7163.TARG-17-B043."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.TARG-17-B043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.TARG-17-B043%26sid%3Dliteratum%253Aachs%26atitle%3DMithramycin-SA%2520analogues%2520with%2520reduced%2520toxicity%250Afor%2520the%2520treatment%2520of%2520ETS%2520transcription%2520factor-driven%2520tumors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26issue%3D1%2520Suppl%26doi%3D10.1158%2F1535-7163.TARG-17-B043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidenbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsodikov, O. V.</span></span> <span> </span><span class="NLM_article-title">Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">8990</span>– <span class="NLM_lpage">9004</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1093%2Fnar%2Fgkw761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=27587584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFaku7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=8990-9004&author=C.+Houauthor=S.+Weidenbachauthor=K.+E.+Canoauthor=Z.+Wangauthor=P.+Mitraauthor=D.+N.+Ivanovauthor=J.+Rohrauthor=O.+V.+Tsodikov&title=Structures+of+mithramycin+analogues+bound+to+DNA+and+implications+for+targeting+transcription+factor+FLI1&doi=10.1093%2Fnar%2Fgkw761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1</span></div><div class="casAuthors">Hou, Caixia; Weidenbach, Stevi; Cano, Kristin E.; Wang, Zhonghua; Mitra, Prithiba; Ivanov, Dmitri N.; Rohr, Jurgen; Tsodikov, Oleg V.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8990-9004</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Transcription factors have been considered undruggable, but this paradigm has been recently challenged.  DNA binding natural product mithramycin (MTM) is a potent antagonist of oncogenic transcription factor EWS-FLI1.  Structural details of MTM recognition of DNA, including the FLI1 binding sequence GGA(A/T), are needed to understand how MTM interferes with EWS-FLI1.  We report a crystal structure of an MTM analog MTM SA-Trp bound to a DNA oligomer contg. a site GGCC, and two structures of a novel analog MTM SA-Phe in complex with DNA.  MTM SA-Phe is bound to sites AGGG and GGGT on one DNA, and to AGGG and GGGA(T) (a FLI1 binding site) on the other, revealing how MTM recognizes different DNA sequences.  Unexpectedly, at sub-micromolar concns. MTMs stabilize FLI1-DNA complex on GGAA repeats, which are crit. for the oncogenic function of EWS-FLI1.  We also directly demonstrate by NMR formation of a ternary FLI1-DNA-MTM complex on a single GGAA FLI1/MTM binding site.  These biochem. and structural data and a new FLI1-DNA structure suggest that MTM binds the minor groove and perturbs FLI1 bound nearby in the major groove.  This ternary complex model may lead to development of novel MTM analogs that selectively target EWS-FLI1 or other oncogenic transcription factors, as anti-cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPVKMe-9H0mrVg90H21EOLACvtfcHk0libFHOQgMkcFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFaku7zP&md5=3fa616913d7ad05b0834fa41635f051b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw761%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DC.%26aulast%3DWeidenbach%26aufirst%3DS.%26aulast%3DCano%26aufirst%3DK.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMitra%26aufirst%3DP.%26aulast%3DIvanov%26aufirst%3DD.%2BN.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DTsodikov%26aufirst%3DO.%2BV.%26atitle%3DStructures%2520of%2520mithramycin%2520analogues%2520bound%2520to%2520DNA%2520and%2520implications%2520for%2520targeting%2520transcription%2520factor%2520FLI1%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2016%26volume%3D44%26spage%3D8990%26epage%3D9004%26doi%3D10.1093%2Fnar%2Fgkw761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alqahtani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porwal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bis, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karty, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanathan, R.</span></span> <span> </span><span class="NLM_article-title">Synergism between genome sequencing, tandem mass spectrometry and bio-inspired synthesis reveals insights into nocardioazine B biogenesis</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">7177</span>– <span class="NLM_lpage">7192</span>, <span class="refDoi"> DOI: 10.1039/C5OB00537J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1039%2FC5OB00537J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=7177-7192&author=N.+Alqahtaniauthor=S.+K.+Porwalauthor=E.+D.+Jamesauthor=D.+M.+Bisauthor=J.+A.+Kartyauthor=A.+L.+Laneauthor=R.+Viswanathan&title=Synergism+between+genome+sequencing%2C+tandem+mass+spectrometry+and+bio-inspired+synthesis+reveals+insights+into+nocardioazine+B+biogenesis&doi=10.1039%2FC5OB00537J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC5OB00537J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00537J%26sid%3Dliteratum%253Aachs%26aulast%3DAlqahtani%26aufirst%3DN.%26aulast%3DPorwal%26aufirst%3DS.%2BK.%26aulast%3DJames%26aufirst%3DE.%2BD.%26aulast%3DBis%26aufirst%3DD.%2BM.%26aulast%3DKarty%26aufirst%3DJ.%2BA.%26aulast%3DLane%26aufirst%3DA.%2BL.%26aulast%3DViswanathan%26aufirst%3DR.%26atitle%3DSynergism%2520between%2520genome%2520sequencing%252C%2520tandem%2520mass%2520spectrometry%2520and%2520bio-inspired%2520synthesis%2520reveals%2520insights%2520into%2520nocardioazine%2520B%2520biogenesis%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D7177%26epage%3D7192%26doi%3D10.1039%2FC5OB00537J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, A.
S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, M. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzepa, H. S.</span></span> <span> </span><span class="NLM_article-title">Studies in sigmatropic rearrangements of <i>N</i>-prenylindole derivatives–a formal enantiomerically pure synthesis of tryprostatin B</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3966</span>– <span class="NLM_lpage">3972</span>, <span class="refDoi"> DOI: 10.1039/b606457d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1039%2Fb606457d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=3966-3972&author=A.%0AS.+P.+Cardosoauthor=M.+M.+B.+Marquesauthor=N.+Srinivasanauthor=S.+Prabhakarauthor=A.+M.+Loboauthor=H.+S.+Rzepa&title=Studies+in+sigmatropic+rearrangements+of+N-prenylindole+derivatives%E2%80%93a+formal+enantiomerically+pure+synthesis+of+tryprostatin+B&doi=10.1039%2Fb606457d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fb606457d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb606457d%26sid%3Dliteratum%253Aachs%26aulast%3DCardoso%26aufirst%3DA.%2BS.%2BP.%26aulast%3DMarques%26aufirst%3DM.%2BM.%2BB.%26aulast%3DSrinivasan%26aufirst%3DN.%26aulast%3DPrabhakar%26aufirst%3DS.%26aulast%3DLobo%26aufirst%3DA.%2BM.%26aulast%3DRzepa%26aufirst%3DH.%2BS.%26atitle%3DStudies%2520in%2520sigmatropic%2520rearrangements%2520of%2520N-prenylindole%2520derivatives%25E2%2580%2593a%2520formal%2520enantiomerically%2520pure%2520synthesis%2520of%2520tryprostatin%2520B%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D3966%26epage%3D3972%26doi%3D10.1039%2Fb606457d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loach, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozkal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Movassaghi, M.</span></span> <span> </span><span class="NLM_article-title">Derivatization of C3-alkylindoles including tryptophans and tryptamines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">11254</span>– <span class="NLM_lpage">11263</span>, <span class="refDoi"> DOI: 10.1021/jo502062z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo502062z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=11254-11263&author=R.+P.+Loachauthor=O.+S.+Fentonauthor=K.+Amaikeauthor=D.+S.+Siegelauthor=E.+Ozkalauthor=M.+Movassaghi&title=Derivatization+of+C3-alkylindoles+including+tryptophans+and+tryptamines&doi=10.1021%2Fjo502062z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo502062z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo502062z%26sid%3Dliteratum%253Aachs%26aulast%3DLoach%26aufirst%3DR.%2BP.%26aulast%3DFenton%26aufirst%3DO.%2BS.%26aulast%3DAmaike%26aufirst%3DK.%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26aulast%3DOzkal%26aufirst%3DE.%26aulast%3DMovassaghi%26aufirst%3DM.%26atitle%3DDerivatization%2520of%2520C3-alkylindoles%2520including%2520tryptophans%2520and%2520tryptamines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D11254%26epage%3D11263%26doi%3D10.1021%2Fjo502062z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Sterically controlled iodination of arenes via iridium-catalyzed C–H borylation</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1021/ol303164h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol303164h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyiur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=140-143&author=B.+M.+Partridgeauthor=J.+F.+Hartwig&title=Sterically+controlled+iodination+of+arenes+via+iridium-catalyzed+C%E2%80%93H+borylation&doi=10.1021%2Fol303164h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sterically controlled iodination of arenes via iridium-catalyzed C-H borylation</span></div><div class="casAuthors">Partridge, Benjamin M.; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-143</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mild method to prep. aryl and heteroaryl iodides by sequential C-H borylation and iodination is reported.  The regioselectivity of this process is controlled by steric effects on the C-H borylation step and is complementary to existing methods to form aryl iodides.  The iodination of boronic esters has potential for the synthesis of radiolabeled aryl iodides, as demonstrated by the concise synthesis of a potential tracer for SPECT imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo3JtHd06qSLVg90H21EOLACvtfcHk0libFHOQgMkcFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyiur7J&md5=e946fdf8ad48a36227499d7aa6599c68</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fol303164h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol303164h%26sid%3Dliteratum%253Aachs%26aulast%3DPartridge%26aufirst%3DB.%2BM.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DSterically%2520controlled%2520iodination%2520of%2520arenes%2520via%2520iridium-catalyzed%2520C%25E2%2580%2593H%2520borylation%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D140%26epage%3D143%26doi%3D10.1021%2Fol303164h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simke, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Total synthesis of erruculogen and fumitremorgin a enabled by ligand-controlled CH borylation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">10160</span>– <span class="NLM_lpage">10163</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b07154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b07154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=10160-10163&author=Y.+Fengauthor=D.+Holteauthor=J.+Zollerauthor=S.+Umemiyaauthor=L.+R.+Simkeauthor=P.+S.+Baran&title=Total+synthesis+of+erruculogen+and+fumitremorgin+a+enabled+by+ligand-controlled+CH+borylation&doi=10.1021%2Fjacs.5b07154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b07154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b07154%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DHolte%26aufirst%3DD.%26aulast%3DZoller%26aufirst%3DJ.%26aulast%3DUmemiya%26aufirst%3DS.%26aulast%3DSimke%26aufirst%3DL.%2BR.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DTotal%2520synthesis%2520of%2520erruculogen%2520and%2520fumitremorgin%2520a%2520enabled%2520by%2520ligand-controlled%2520CH%2520borylation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D10160%26epage%3D10163%26doi%3D10.1021%2Fjacs.5b07154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed, modular synthesis of highly functionalized indoles and tryptophans by direct annulation of substituted <i>o</i>-haloanilines and aldehydes</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">7826</span>– <span class="NLM_lpage">7834</span>, <span class="refDoi"> DOI: 10.1021/jo061471s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo061471s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVyks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=7826-7834&author=Y.+Jiaauthor=J.+Zhu&title=Palladium-catalyzed%2C+modular+synthesis+of+highly+functionalized+indoles+and+tryptophans+by+direct+annulation+of+substituted+o-haloanilines+and+aldehydes&doi=10.1021%2Fjo061471s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed, Modular Synthesis of Highly Functionalized Indoles and Tryptophans by Direct Annulation of Substituted o-Haloanilines and Aldehydes</span></div><div class="casAuthors">Jia, Yanxing; Zhu, Jieping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7826-7834</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One-pot synthesis of indoles by a palladium-catalyzed annulation of o-haloanilines and aldehydes has been developed.  Coupling of o-iodoaniline with aldehyde is realized under mild ligandless conditions [Pd(OAc)2, DABCO, DMF, 85 °C], whereas X-Phos is found to be the ligand of choice for coupling reactions involving o-chloroanilines/o-bromoanilines and aldehydes.  A variety of o-haloanilines with different electronic properties are suitable substrates, and aldehydes including chiral ones participated in this reaction without racemization.  Coupling of (S)-2-N,N-di-tert-butoxycarbonyl-5-oxopentanoate, derived from L-glutamic acid, with o-haloanilines provides a rapid access to the ring-A-substituted tryptophans in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1GhE5W5DDrVg90H21EOLACvtfcHk0lgFLa0E2FdF3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVyks70%253D&md5=c141d2c793edc66ee1ffbf9ed5f4b290</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjo061471s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061471s%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DPalladium-catalyzed%252C%2520modular%2520synthesis%2520of%2520highly%2520functionalized%2520indoles%2520and%2520tryptophans%2520by%2520direct%2520annulation%2520of%2520substituted%2520o-haloanilines%2520and%2520aldehydes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D7826%26epage%3D7834%26doi%3D10.1021%2Fjo061471s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokotos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padrón, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín, V. S.</span></span> <span> </span><span class="NLM_article-title">A general approach to the asymmetric synthesis of unsaturated lipidic α-amino acids. The first synthesis of α-aminoarachidonic acid</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3741</span>– <span class="NLM_lpage">3744</span>, <span class="refDoi"> DOI: 10.1021/jo9715128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9715128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=3741-3744&author=G.+Kokotosauthor=J.+M.+Padr%C3%B3nauthor=T.+Mart%C3%ADnauthor=W.+A.+Gibbonsauthor=V.+S.+Mart%C3%ADn&title=A+general+approach+to+the+asymmetric+synthesis+of+unsaturated+lipidic+%CE%B1-amino+acids.+The+first+synthesis+of+%CE%B1-aminoarachidonic+acid&doi=10.1021%2Fjo9715128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo9715128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9715128%26sid%3Dliteratum%253Aachs%26aulast%3DKokotos%26aufirst%3DG.%26aulast%3DPadr%25C3%25B3n%26aufirst%3DJ.%2BM.%26aulast%3DMart%25C3%25ADn%26aufirst%3DT.%26aulast%3DGibbons%26aufirst%3DW.%2BA.%26aulast%3DMart%25C3%25ADn%26aufirst%3DV.%2BS.%26atitle%3DA%2520general%2520approach%2520to%2520the%2520asymmetric%2520synthesis%2520of%2520unsaturated%2520lipidic%2520%25CE%25B1-amino%2520acids.%2520The%2520first%2520synthesis%2520of%2520%25CE%25B1-aminoarachidonic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D3741%26epage%3D3744%26doi%3D10.1021%2Fjo9715128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudy-Floc’h, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngerebara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, L.</span></span> <span> </span><span class="NLM_article-title">Novel β-carboline-tripeptide conjugates attenuate mesenteric ischemia/reperfusion injury in the rat</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2441</span>– <span class="NLM_lpage">2452</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.03.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1016%2Fj.ejmech.2011.03.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2441-2452&author=W.+Biauthor=Y.+Biauthor=P.+Xueauthor=Y.+Zhangauthor=X.+Gaoauthor=Z.+Wangauthor=M.+Liauthor=M.+Baudy-Floc%E2%80%99hauthor=N.+Ngerebaraauthor=X.+Liauthor=M.+Gibsonauthor=L.+Bi&title=Novel+%CE%B2-carboline-tripeptide+conjugates+attenuate+mesenteric+ischemia%2Freperfusion+injury+in+the+rat&doi=10.1016%2Fj.ejmech.2011.03.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.03.029%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DW.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DBaudy-Floc%25E2%2580%2599h%26aufirst%3DM.%26aulast%3DNgerebara%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGibson%26aufirst%3DM.%26aulast%3DBi%26aufirst%3DL.%26atitle%3DNovel%2520%25CE%25B2-carboline-tripeptide%2520conjugates%2520attenuate%2520mesenteric%2520ischemia%252Freperfusion%2520injury%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2441%26epage%3D2452%26doi%3D10.1016%2Fj.ejmech.2011.03.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coste, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toumi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razafimahaléo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couty, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evano, G.</span></span> <span> </span><span class="NLM_article-title">Copper-catalyzed cyclization of iodo-tryptophans: A straightforward synthesis of pyrroloindoles</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3841</span>– <span class="NLM_lpage">3844</span>, <span class="refDoi"> DOI: 10.1021/ol8015513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol8015513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=3841-3844&author=A.+Costeauthor=M.+Toumiauthor=K.+Wrightauthor=V.+Razafimahal%C3%A9oauthor=F.+Coutyauthor=J.+Marrotauthor=G.+Evano&title=Copper-catalyzed+cyclization+of+iodo-tryptophans%3A+A+straightforward+synthesis+of+pyrroloindoles&doi=10.1021%2Fol8015513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fol8015513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol8015513%26sid%3Dliteratum%253Aachs%26aulast%3DCoste%26aufirst%3DA.%26aulast%3DToumi%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DRazafimahal%25C3%25A9o%26aufirst%3DV.%26aulast%3DCouty%26aufirst%3DF.%26aulast%3DMarrot%26aufirst%3DJ.%26aulast%3DEvano%26aufirst%3DG.%26atitle%3DCopper-catalyzed%2520cyclization%2520of%2520iodo-tryptophans%253A%2520A%2520straightforward%2520synthesis%2520of%2520pyrroloindoles%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D3841%26epage%3D3844%26doi%3D10.1021%2Fol8015513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozett, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venter, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokada, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R.</span></span> <span> </span><span class="NLM_article-title">Catalytic enantioselective acyl transfer: the case for 4-PPY with a C-3 carboxamide peptide auxiliary based on synthesis and modelling studies</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">10914</span>– <span class="NLM_lpage">10925</span>, <span class="refDoi"> DOI: 10.1039/C6OB01991A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1039%2FC6OB01991A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=27814425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2itbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=10914-10925&author=R.+E.+Cozettauthor=G.+A.+Venterauthor=M.+R.+Gokadaauthor=R.+Hunter&title=Catalytic+enantioselective+acyl+transfer%3A+the+case+for+4-PPY+with+a+C-3+carboxamide+peptide+auxiliary+based+on+synthesis+and+modelling+studies&doi=10.1039%2FC6OB01991A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic enantioselective acyl transfer: the case for 4-PPY with a C-3 carboxamide peptide auxiliary based on synthesis and modelling studies</span></div><div class="casAuthors">Cozett, Rudy E.; Venter, Gerhard A.; Gokada, Maheswara Rao; Hunter, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">10914-10925</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of 4-pyrrolidinopyridine (4-PPY) C-3 carboxamides contg. peptide-based side chains have been synthesized and evaluated in the kinetic resoln. of a small library of chiral benzylic secondary alcs.  A key design element was the incorporation of a tryptophan residue in the peptide side chain for promoting π-stacking between peptide side chain and the pyridinium ring of the N-acyl intermediate, in which modeling was used as a structure-based guiding tool.  Together, a catalyst contg. a LeuTrp-N-Boc side chain (catalyst 8) was identified that achieved s-values up to and in slight excess of 10.  A transition-state model based on the modeling is proposed to explain the origin of enantioselectivity.  This study establishes the usefulness of modeling as a structure-based guiding tool for enantioselectivity optimization as well as the potential for developing scalable peptide-based DMAP-type catalysts for large-scale resoln. work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0gd3nkVAMrVg90H21EOLACvtfcHk0lhPT-Zk_OS3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2itbfF&md5=eceaeb772caf945d87daaa4622c3c467</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC6OB01991A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB01991A%26sid%3Dliteratum%253Aachs%26aulast%3DCozett%26aufirst%3DR.%2BE.%26aulast%3DVenter%26aufirst%3DG.%2BA.%26aulast%3DGokada%26aufirst%3DM.%2BR.%26aulast%3DHunter%26aufirst%3DR.%26atitle%3DCatalytic%2520enantioselective%2520acyl%2520transfer%253A%2520the%2520case%2520for%25204-PPY%2520with%2520a%2520C-3%2520carboxamide%2520peptide%2520auxiliary%2520based%2520on%2520synthesis%2520and%2520modelling%2520studies%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D10914%26epage%3D10925%26doi%3D10.1039%2FC6OB01991A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvet, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunatilleke, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podust, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Rational development of 4-aminopyridyl-based inhibitors targeting trypanosoma cruzi CYP51 as anti-chagas agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7651</span>– <span class="NLM_lpage">7668</span>, <span class="refDoi"> DOI: 10.1021/jm401067s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401067s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7651-7668&author=J.+Y.+Choiauthor=C.+M.+Calvetauthor=S.+S.+Gunatillekeauthor=C.+Ruizauthor=M.+D.+Cameronauthor=J.+H.+McKerrowauthor=L.+M.+Podustauthor=W.+R.+Roush&title=Rational+development+of+4-aminopyridyl-based+inhibitors+targeting+trypanosoma+cruzi+CYP51+as+anti-chagas+agents&doi=10.1021%2Fjm401067s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401067s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401067s%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DCalvet%26aufirst%3DC.%2BM.%26aulast%3DGunatilleke%26aufirst%3DS.%2BS.%26aulast%3DRuiz%26aufirst%3DC.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DRational%2520development%2520of%25204-aminopyridyl-based%2520inhibitors%2520targeting%2520trypanosoma%2520cruzi%2520CYP51%2520as%2520anti-chagas%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7651%26epage%3D7668%26doi%3D10.1021%2Fjm401067s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kidd, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitchen-Goosen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segars, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebregiorgis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woldemichael, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessnick, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madaj, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, L.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Sabín, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morís, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grohar, P. J.</span></span> <span> </span><span class="NLM_article-title">Identification of mithramycin analogues with improved targeting of the EWS-FLI1 transcription factor</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4105</span>– <span class="NLM_lpage">4118</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-15-2624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1158%2F1078-0432.CCR-15-2624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=26979396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKrsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=4105-4118&author=C.+L.+Osgoodauthor=N.+Maloneyauthor=C.+G.+Kiddauthor=S.+Kitchen-Goosenauthor=L.+Segarsauthor=M.+Gebregiorgisauthor=G.+M.+Woldemichaelauthor=M.+Heauthor=S.+Sankarauthor=S.+L.+Lessnickauthor=M.+Kangauthor=M.+Smithauthor=L.+Turnerauthor=Z.+B.+Madajauthor=M.+E.+Winnauthor=L.%0AE.+N%C3%BA%C3%B1ezauthor=Z.+Gonz%C3%A1lez-Sab%C3%ADnauthor=L.+J.+Helmanauthor=F.+Mor%C3%ADsauthor=P.+J.+Grohar&title=Identification+of+mithramycin+analogues+with+improved+targeting+of+the+EWS-FLI1+transcription+factor&doi=10.1158%2F1078-0432.CCR-15-2624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor</span></div><div class="casAuthors">Osgood, Christy L.; Maloney, Nichole; Kidd, Christopher G.; Kitchen-Goosen, Susan; Segars, Laura; Gebregiorgis, Meti; Woldemichael, Girma M.; He, Min; Sankar, Savita; Lessnick, Stephen L.; Kang, Min; Smith, Malcolm; Turner, Lisa; Madaj, Zachary B.; Winn, Mary E.; Nuunez, Luz-Elena; Gonzunalez-Sabunain, Javier; Helman, Lee J.; Morunaiis, Francisco; Grohar, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4105-4118</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The goal of this study was to identify second-generation mithramycin analogs that better target the EWS-FLI1 transcription factor for Ewing sarcoma.  We previously established mithramycin as an EWS-FLI1 inhibitor, but the compd.'s toxicity prevented its use at effective concns. in patients.  Exptl. Design: We screened a panel of mithralogs to establish their ability to inhibit EWS-FLI1 in Ewing sarcoma.  We compared the IC50 with the MTD established in mice to det. the relationship between efficacy and toxicity.  We confirmed the suppression of EWS-FLI1 at the promoter, mRNA, gene signature, and protein levels.  We established an improved therapeutic window by using time-lapse microscopy to model the effects on cellular proliferation in Ewing sarcoma cells relative to HepG2 control cells.  Finally, we established an improved therapeutic window using a xenograft model of Ewing sarcoma.  Results: EC-8105 was found to be the most potent analog and was able to suppress EWS-FLI1 activity at concns. nontoxic to other cell types.  EC-8042 was substantially less toxic than mithramycin in multiple species but maintained suppression of EWS-FLI1 at similar concns.  Both compds. markedly suppressed Ewing sarcoma xenograft growth and inhibited EWS-FLI1 in vivo.  Conclusions: These results provide a basis for the continued development of EC-8042 and EC-8105 as EWS-FLI1 inhibitors for the clinic.  Clin Cancer Res; 22(16); 4105-18. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS5IC764aGtLVg90H21EOLACvtfcHk0lh9LD_6iVO8-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKrsbnO&md5=a6acb4a7a1cc70459829e9b4537bf25f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-2624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-2624%26sid%3Dliteratum%253Aachs%26aulast%3DOsgood%26aufirst%3DC.%2BL.%26aulast%3DMaloney%26aufirst%3DN.%26aulast%3DKidd%26aufirst%3DC.%2BG.%26aulast%3DKitchen-Goosen%26aufirst%3DS.%26aulast%3DSegars%26aufirst%3DL.%26aulast%3DGebregiorgis%26aufirst%3DM.%26aulast%3DWoldemichael%26aufirst%3DG.%2BM.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DSankar%26aufirst%3DS.%26aulast%3DLessnick%26aufirst%3DS.%2BL.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DTurner%26aufirst%3DL.%26aulast%3DMadaj%26aufirst%3DZ.%2BB.%26aulast%3DWinn%26aufirst%3DM.%2BE.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DL.%2BE.%26aulast%3DGonz%25C3%25A1lez-Sab%25C3%25ADn%26aufirst%3DZ.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26aulast%3DMor%25C3%25ADs%26aufirst%3DF.%26aulast%3DGrohar%26aufirst%3DP.%2BJ.%26atitle%3DIdentification%2520of%2520mithramycin%2520analogues%2520with%2520improved%2520targeting%2520of%2520the%2520EWS-FLI1%2520transcription%2520factor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D4105%26epage%3D4118%26doi%3D10.1158%2F1078-0432.CCR-15-2624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Aragoncillo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Lopez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pestana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J.</span></span> <span> </span><span class="NLM_article-title">DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing’s tumor cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">6034</span>– <span class="NLM_lpage">6043</span>, <span class="refDoi"> DOI: 10.1038/onc.2008.203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1038%2Fonc.2008.203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=6034-6043&author=E.+Garcia-Aragoncilloauthor=J.+Carrilloauthor=E.+Lalliauthor=N.+Agraauthor=G.+Gomez-Lopezauthor=A.+Pestanaauthor=J.+Alonso&title=DAX1%2C+a+direct+target+of+EWS%2FFLI1+oncoprotein%2C+is+a+principal+regulator+of+cell-cycle+progression+in+Ewing%E2%80%99s+tumor+cells&doi=10.1038%2Fonc.2008.203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fonc.2008.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2008.203%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Aragoncillo%26aufirst%3DE.%26aulast%3DCarrillo%26aufirst%3DJ.%26aulast%3DLalli%26aufirst%3DE.%26aulast%3DAgra%26aufirst%3DN.%26aulast%3DGomez-Lopez%26aufirst%3DG.%26aulast%3DPestana%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DJ.%26atitle%3DDAX1%252C%2520a%2520direct%2520target%2520of%2520EWS%252FFLI1%2520oncoprotein%252C%2520is%2520a%2520principal%2520regulator%2520of%2520cell-cycle%2520progression%2520in%2520Ewing%25E2%2580%2599s%2520tumor%2520cells%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D6034%26epage%3D6043%26doi%3D10.1038%2Fonc.2008.203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grohar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woldemichael, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currier, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helman, L. J.</span></span> <span> </span><span class="NLM_article-title">Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">978</span>, <span class="refDoi"> DOI: 10.1093/jnci/djr156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1093%2Fjnci%2Fdjr156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=21653923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2011&pages=962-978&author=P.+J.+Groharauthor=G.+M.+Woldemichaelauthor=L.+B.+Griffinauthor=A.+Mendozaauthor=Q.-R.+Chenauthor=C.+Yeungauthor=D.+G.+Currierauthor=S.+Davisauthor=C.+Khannaauthor=J.+Khanauthor=J.+B.+McMahonauthor=L.+J.+Helman&title=Identification+of+an+inhibitor+of+the+EWS-FLI1+oncogenic+transcription+factor+by+high-throughput+screening&doi=10.1093%2Fjnci%2Fdjr156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening</span></div><div class="casAuthors">Grohar, Patrick J.; Woldemichael, Girma M.; Griffin, Laurie B.; Mendoza, Arnulfo; Chen, Qing-Rong; Yeung, Choh; Currier, Duane G.; Davis, Sean; Khanna, Chand; Khan, Javed; McMahon, James B.; Helman, Lee J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">962-978</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Chromosomal translocations generating oncogenic transcription factors are the hallmark of a variety of tumors, including many sarcomas.  Ewing sarcoma family of tumors (ESFTs) are characterized by the t(11;22)(q24;q12) translocation that generates the Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1 (EWS-FLI1) fusion transcription factor responsible for the highly malignant phenotype of this tumor.  Although continued expression of EWS-FLI1 is believed to be crit. for ESFT cell survival, a clin. effective small-mol. inhibitor remains elusive likely because EWS-FLI1 is a transcription factor and therefore widely felt to be "undruggable.  " Methods We developed a high-throughput screen to evaluate more than 50 000 compds. for inhibition of EWS-FLI1 activity in TC32 ESFT cells.  We used a TC32 cell-based luciferase reporter screen using the EWS-FLI1 downstream target NR0B1 promoter and a gene signature secondary screen to sort and prioritize the compds.  We characterized the lead compd., mithramycin, based on its ability to inhibit EWS-FLI1 activity in vitro using microarray expression profiling, quant. reverse transcription-polymerase chain reaction, and immunoblot anal., and in vivo using immunohistochem.  We studied the impact of this inhibition on cell viability in vitro and on tumor growth in ESFT xenograft models in vivo (n = 15-20 mice per group).  All statistical tests were two-sided.  Results Mithramycin inhibited expression of EWS-FLI1 downstream targets at the mRNA and protein levels and decreased the growth of ESFT cells at half maximal inhibitory concns. between 10 (95% confidence interval [CI] = 8 to 13 nM) and 15 nM (95% CI = 13 to 19 nM).  Mithramycin suppressed the growth of two different ESFT xenograft tumors and prolonged the survival of ESFT xenograft-bearing mice by causing a decrease in mean tumor vol.  For example, in the TC32 xenograft model, on day 15 of treatment, the mean tumor vol. for the mithramycin-treated mice was approx. 3% of the tumor vol. obsd. in the control mice (mithramycin vs control: 69 vs 2388 mm3, difference = 2319 mm3, 95% CI = 1766 to 2872 mm3, P < .001).  Conclusion Mithramycin inhibits EWS-FLI1 activity and demonstrates ESFT antitumor activity both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-zpZMmMy4bLVg90H21EOLACvtfcHk0lh9LD_6iVO8-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cltro%253D&md5=814cc95d2b54de9b275cc1df8a1b19ee</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjr156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjr156%26sid%3Dliteratum%253Aachs%26aulast%3DGrohar%26aufirst%3DP.%2BJ.%26aulast%3DWoldemichael%26aufirst%3DG.%2BM.%26aulast%3DGriffin%26aufirst%3DL.%2BB.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DQ.-R.%26aulast%3DYeung%26aufirst%3DC.%26aulast%3DCurrier%26aufirst%3DD.%2BG.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DKhanna%26aufirst%3DC.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26atitle%3DIdentification%2520of%2520an%2520inhibitor%2520of%2520the%2520EWS-FLI1%2520oncogenic%2520transcription%2520factor%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2011%26volume%3D103%26spage%3D962%26epage%3D978%26doi%3D10.1093%2Fjnci%2Fdjr156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yang Liu, Joseph M. Eckenrode, Yinan Zhang, Jianjun Zhang, Reiya C. Hayden, Annet Kyomuhangi, Larissa V. Ponomareva, Zheng Cui, Jürgen Rohr, Oleg V. Tsodikov, Steven G. Van Lanen, Khaled A. Shaaban, Markos Leggas, <span class="NLM_string-name hlFld-ContribAuthor">Jon S. Thorson</span>. </span><span class="cited-content_cbyCitation_article-title">Mithramycin 2′-Oximes with Improved Selectivity, Pharmacokinetics, and Ewing Sarcoma Antitumor Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 14067-14086. <a href="https://doi.org/10.1021/acs.jmedchem.0c01526" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01526%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMithramycin%252B2%2525E2%252580%2525B2-Oximes%252Bwith%252BImproved%252BSelectivity%25252C%252BPharmacokinetics%25252C%252Band%252BEwing%252BSarcoma%252BAntitumor%252BEfficacy%26aulast%3DLiu%26aufirst%3DYang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18092020%26date%3D16112020%26volume%3D63%26issue%3D22%26spage%3D14067%26epage%3D14086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Irene Herrera-González, Elena M. Sánchez-Fernández, Abhijit Sau, Cristina Nativi, José M. García Fernández, M. Carmen Galán, <span class="NLM_string-name hlFld-ContribAuthor">Carmen Ortiz Mellet</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of Iminosugar 2-Deoxy(thio)glycosides from Bicyclic Iminoglycal Carbamates Promoted by Cerium(IV) Ammonium Nitrate and Cooperative Brønsted Acid-Type Organocatalysis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (7)
                                     , 5038-5047. <a href="https://doi.org/10.1021/acs.joc.0c00324" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00324%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoselective%252BSynthesis%252Bof%252BIminosugar%252B2-Deoxy%252528thio%252529glycosides%252Bfrom%252BBicyclic%252BIminoglycal%252BCarbamates%252BPromoted%252Bby%252BCerium%252528IV%252529%252BAmmonium%252BNitrate%252Band%252BCooperative%252BBr%2525C3%2525B8nsted%252BAcid-Type%252BOrganocatalysis%26aulast%3DHerrera-Gonz%25C3%25A1lez%26aufirst%3DIrene%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08022020%26date%3D23032020%26date%3D11032020%26volume%3D85%26issue%3D7%26spage%3D5038%26epage%3D5047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caixia  Hou</span>, <span class="hlFld-ContribAuthor ">Abhisek  Mandal</span>, <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Tsodikov</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2021,</strong> <em>29 </em>
                                    (5)
                                     , 404-412.e4. <a href="https://doi.org/10.1016/j.str.2020.11.012" title="DOI URL">https://doi.org/10.1016/j.str.2020.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2020.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2020.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DAllosteric%252Binterference%252Bin%252Boncogenic%252BFLI1%252Band%252BERG%252Btransactions%252Bby%252Bmithramycins%26aulast%3DHou%26aufirst%3DCaixia%26date%3D2021%26volume%3D29%26issue%3D5%26spage%3D404%26epage%3D412.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei Yun  Lin</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Damron</span>, <span class="hlFld-ContribAuthor ">Megan E.  Oest</span>, <span class="hlFld-ContribAuthor ">Jason A.  Horton</span>. </span><span class="cited-content_cbyCitation_article-title">Mithramycin A Radiosensitizes EWS:Fli1+ Ewing Sarcoma Cells by Inhibiting Double Strand Break Repair. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Radiation Oncology*Biology*Physics</span><span> <strong>2021,</strong> <em>109 </em>
                                    (5)
                                     , 1454-1471. <a href="https://doi.org/10.1016/j.ijrobp.2020.12.010" title="DOI URL">https://doi.org/10.1016/j.ijrobp.2020.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijrobp.2020.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijrobp.2020.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Radiation%2520Oncology%252ABiology%252APhysics%26atitle%3DMithramycin%252BA%252BRadiosensitizes%252BEWS%25253AFli1%25252B%252BEwing%252BSarcoma%252BCells%252Bby%252BInhibiting%252BDouble%252BStrand%252BBreak%252BRepair%26aulast%3DLin%26aufirst%3DMei%2BYun%26date%3D2021%26volume%3D109%26issue%3D5%26spage%3D1454%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. R.  Rivas</span>, <span class="hlFld-ContribAuthor ">Y.  Liu</span>, <span class="hlFld-ContribAuthor ">S. S.  Alhakeem</span>, <span class="hlFld-ContribAuthor ">J. M.  Eckenrode</span>, <span class="hlFld-ContribAuthor ">F.  Marti</span>, <span class="hlFld-ContribAuthor ">J. P.  Collard</span>, <span class="hlFld-ContribAuthor ">Y.  Zhang</span>, <span class="hlFld-ContribAuthor ">K. A.  Shaaban</span>, <span class="hlFld-ContribAuthor ">N.  Muthusamy</span>, <span class="hlFld-ContribAuthor ">G. C.  Hildebrandt</span>, <span class="hlFld-ContribAuthor ">R. A.  Fleischman</span>, <span class="hlFld-ContribAuthor ">L.  Chen</span>, <span class="hlFld-ContribAuthor ">J. S.  Thorson</span>, <span class="hlFld-ContribAuthor ">M.  Leggas</span>, <span class="hlFld-ContribAuthor ">S.  Bondada</span>. </span><span class="cited-content_cbyCitation_article-title">Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2021,</strong> <em>98 </em><a href="https://doi.org/10.1038/s41375-021-01217-1" title="DOI URL">https://doi.org/10.1038/s41375-021-01217-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-021-01217-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-021-01217-1%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DInterleukin-10%252Bsuppression%252Benhances%252BT-cell%252Bantitumor%252Bimmunity%252Band%252Bresponses%252Bto%252Bcheckpoint%252Bblockade%252Bin%252Bchronic%252Blymphocytic%252Bleukemia%26aulast%3DRivas%26aufirst%3DJ.%2BR.%26date%3D2021%26date%3D2021%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Schweer</span>, <span class="hlFld-ContribAuthor ">J. Robert  McCorkle</span>, <span class="hlFld-ContribAuthor ">Jurgen  Rohr</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Tsodikov</span>, <span class="hlFld-ContribAuthor ">Frederick  Ueland</span>, <span class="hlFld-ContribAuthor ">Jill  Kolesar</span>. </span><span class="cited-content_cbyCitation_article-title">Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (1)
                                     , 70. <a href="https://doi.org/10.3390/biomedicines9010070" title="DOI URL">https://doi.org/10.3390/biomedicines9010070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9010070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9010070%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DMithramycin%252Band%252BAnalogs%252Bfor%252BOvercoming%252BCisplatin%252BResistance%252Bin%252BOvarian%252BCancer%26aulast%3DSchweer%26aufirst%3DDavid%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D1%26spage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Kormanec</span>, <span class="hlFld-ContribAuthor ">Renata  Novakova</span>, <span class="hlFld-ContribAuthor ">Dominika  Csolleiova</span>, <span class="hlFld-ContribAuthor ">Lubomira  Feckova</span>, <span class="hlFld-ContribAuthor ">Bronislava  Rezuchova</span>, <span class="hlFld-ContribAuthor ">Beatrica  Sevcikova</span>, <span class="hlFld-ContribAuthor ">Dagmar  Homerova</span>. </span><span class="cited-content_cbyCitation_article-title">The antitumor antibiotic mithramycin: new advanced approaches in modification and production. </span><span class="cited-content_cbyCitation_journal-name">Applied Microbiology and Biotechnology</span><span> <strong>2020,</strong> <em>104 </em>
                                    (18)
                                     , 7701-7721. <a href="https://doi.org/10.1007/s00253-020-10782-x" title="DOI URL">https://doi.org/10.1007/s00253-020-10782-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00253-020-10782-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00253-020-10782-x%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Microbiology%2520and%2520Biotechnology%26atitle%3DThe%252Bantitumor%252Bantibiotic%252Bmithramycin%25253A%252Bnew%252Badvanced%252Bapproaches%252Bin%252Bmodification%252Band%252Bproduction%26aulast%3DKormanec%26aufirst%3DJan%26date%3D2020%26date%3D2020%26volume%3D104%26issue%3D18%26spage%3D7701%26epage%3D7721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Artemy D.  Beniaminov</span>, <span class="hlFld-ContribAuthor ">Galina V.  Chashchina</span>, <span class="hlFld-ContribAuthor ">Mikhail A.  Livshits</span>, <span class="hlFld-ContribAuthor ">Olga I.  Kechko</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Mitkevich</span>, <span class="hlFld-ContribAuthor ">Olga K.  Mamaeva</span>, <span class="hlFld-ContribAuthor ">Anna N.  Tevyashova</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Shtil</span>, <span class="hlFld-ContribAuthor ">Anna K.  Shchyolkina</span>, <span class="hlFld-ContribAuthor ">Dmitry N.  Kaluzhny</span>. </span><span class="cited-content_cbyCitation_article-title">Discrimination between G/C Binding Sites by Olivomycin A Is Determined by Kinetics of the Drug-DNA Interaction. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (15)
                                     , 5299. <a href="https://doi.org/10.3390/ijms21155299" title="DOI URL">https://doi.org/10.3390/ijms21155299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21155299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21155299%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscrimination%252Bbetween%252BG%25252FC%252BBinding%252BSites%252Bby%252BOlivomycin%252BA%252BIs%252BDetermined%252Bby%252BKinetics%252Bof%252Bthe%252BDrug-DNA%252BInteraction%26aulast%3DBeniaminov%26aufirst%3DArtemy%2BD.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D15%26spage%3D5299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan  Wheeler</span>, <span class="hlFld-ContribAuthor ">Xia  Yu</span>, <span class="hlFld-ContribAuthor ">Caixia  Hou</span>, <span class="hlFld-ContribAuthor ">Prithiba  Mitra</span>, <span class="hlFld-ContribAuthor ">Jhong‐Min  Chen</span>, <span class="hlFld-ContribAuthor ">Frank  Herkules</span>, <span class="hlFld-ContribAuthor ">Dmitri N.  Ivanov</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Tsodikov</span>, <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Cryptic Intermediate in Late Steps of Mithramycin Biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (2)
                                     , 836-842. <a href="https://doi.org/10.1002/ange.201910241" title="DOI URL">https://doi.org/10.1002/ange.201910241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201910241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201910241%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDiscovery%252Bof%252Ba%252BCryptic%252BIntermediate%252Bin%252BLate%252BSteps%252Bof%252BMithramycin%252BBiosynthesis%26aulast%3DWheeler%26aufirst%3DRyan%26date%3D2020%26date%3D2019%26volume%3D132%26issue%3D2%26spage%3D836%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan  Wheeler</span>, <span class="hlFld-ContribAuthor ">Xia  Yu</span>, <span class="hlFld-ContribAuthor ">Caixia  Hou</span>, <span class="hlFld-ContribAuthor ">Prithiba  Mitra</span>, <span class="hlFld-ContribAuthor ">Jhong‐Min  Chen</span>, <span class="hlFld-ContribAuthor ">Frank  Herkules</span>, <span class="hlFld-ContribAuthor ">Dmitri N.  Ivanov</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Tsodikov</span>, <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Cryptic Intermediate in Late Steps of Mithramycin Biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (2)
                                     , 826-832. <a href="https://doi.org/10.1002/anie.201910241" title="DOI URL">https://doi.org/10.1002/anie.201910241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201910241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201910241%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDiscovery%252Bof%252Ba%252BCryptic%252BIntermediate%252Bin%252BLate%252BSteps%252Bof%252BMithramycin%252BBiosynthesis%26aulast%3DWheeler%26aufirst%3DRyan%26date%3D2020%26volume%3D59%26issue%3D2%26spage%3D826%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph M.  Eckenrode</span>, <span class="hlFld-ContribAuthor ">Prithiba  Mitra</span>, <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>, <span class="hlFld-ContribAuthor ">Markos  Leggas</span>. </span><span class="cited-content_cbyCitation_article-title">Bioanalytical method for quantitative determination of mithramycin analogs in mouse plasma by HPLC–QTOF. </span><span class="cited-content_cbyCitation_journal-name">Biomedical Chromatography</span><span> <strong>2019,</strong> <em>33 </em>
                                    (8)
                                     <a href="https://doi.org/10.1002/bmc.4544" title="DOI URL">https://doi.org/10.1002/bmc.4544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bmc.4544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbmc.4544%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Chromatography%26atitle%3DBioanalytical%252Bmethod%252Bfor%252Bquantitative%252Bdetermination%252Bof%252Bmithramycin%252Banalogs%252Bin%252Bmouse%252Bplasma%252Bby%252BHPLC%2525E2%252580%252593QTOF%26aulast%3DEckenrode%26aufirst%3DJoseph%2BM.%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caixia  Hou</span>, <span class="hlFld-ContribAuthor ">Jürgen  Rohr</span>, <span class="hlFld-ContribAuthor ">Sean  Parkin</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Tsodikov</span>. </span><span class="cited-content_cbyCitation_article-title">How mithramycin stereochemistry dictates its structure and DNA binding function. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (5)
                                     , 735-741. <a href="https://doi.org/10.1039/C9MD00100J" title="DOI URL">https://doi.org/10.1039/C9MD00100J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00100J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00100J%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DHow%252Bmithramycin%252Bstereochemistry%252Bdictates%252Bits%252Bstructure%252Band%252BDNA%252Bbinding%252Bfunction%26aulast%3DHou%26aufirst%3DCaixia%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D5%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of mithramycin (MTM, <b>1</b>), mithramycin SA (MTMSA, <b>2</b>), mithramycin SA-tryptophan (MTMSA-Trp, <b>3</b>), and mithramycin SA phenylalanine (MTMSA-Phe, <b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Selective Indole N-Alkylation of Tryptophan<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) phthalic anhydride, Et<sub>3</sub>N, toluene, reflux, 15 h, 80%; (b) NaH, alkyl bromide, DMF, 0 °C to rt, 10 h; (c) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, MeOH–DCM, rt.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. C7 Functionalization of Tryptophan Using Iridium Catalyzed Borylation Chemistry<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CuI, 1,10-Phen, KI, MeOH–H<sub>2</sub>O, 40%; (b) allyl(<i>n</i>-Bu)<sub>3</sub>Sn, Pd(PPh<sub>3</sub>)<sub>4</sub>, PhMe, 120 °C, 60%; (c) MeOH, Cu(OAc)<sub>2</sub>·H<sub>2</sub>O, Et<sub>3</sub>N, O<sub>2</sub>, rt 12 h; (d) CuTC, Togni reagent, 1,10-Phen, DCM, LiOH, H<sub>2</sub>O, rt; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, SPhos, K<sub>3</sub>PO<sub>4</sub>, PhI, PhMe, 80 °C, 70%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. C6 Functionalization of Tryptophan Using Iridium Catalyzed Borylation Chemistry<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Ir[(cod)OMe]<sub>2</sub> (5 mol %), phenanthroline (10 mol %), HBPin (0.25 equiv), B<sub>2</sub>Pin<sub>2</sub> (4.0 equiv), hexane, 80 °C, 70%; (b) NaN<sub>3</sub>, Cu(OAc)<sub>2</sub>·H<sub>2</sub>O, MeOH, 70%; (c) phenylacetylene, CuI, DIPA, HOAc, DCM, 72%; (d) 4 N aq HCl, EtOAc, rt, 4 h; TBAF, THF, rt, 2 h, 85% (2 steps); (e) CuTC, Togni reagent, 1,10-Phen, DCM, LiOH, H<sub>2</sub>O, rt, 60%; (f) Cu(OTf)<sub>2</sub>, KF; (g) AgOTf, NaOH, Selectfluor.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Palladium Catalyzed Tryptophan Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Select Dipeptides by HOBt–DCC Coupling</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Alkylation of 5-Hydroxytryptophan<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, (±)-epibromohydrin, 80 °C, 12 h, 68%; (b) TFA, DCM, rt, 6 h, 80%; (c) Cs<sub>2</sub>CO<sub>3</sub>, DMF, allyl bromide, 80 °C, 12 h, 82%.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of MTMSA (<b>2</b>) Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Median GI<sub>50</sub> of select MTMSA (<b>2</b>) analogues in a panel of eight Ewing sarcoma (in red, TC-32, 5838, RD-ES, TC-71, A-673, ES-2, ES-7, ES-8) as well as nine non-Ewing sarcoma (in blue, PC-3, DU 145, A549, LNCaP, U-118 MG, HeLa, HCT116, DMS 114, PANC-1) cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. mRNA expression of (A) EWS-FLI1 and associated gene (B) NR0B1 is decreased after 6 and 12 h treatments with MTMSA analogues at respective GI<sub>50</sub>, analyzed by qRT-PCR. mRNA expression of (C) Sp1, a well-known downstream target of MTM (1), and associated gene (D) BCL-2 was also analyzed. mRNA expression of (E) CCK was analyzed as a negative control, previously reported as unaffected after 6 h of treatment with MTM at 100 nM.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Relative expressions were calculated using GAPDH expression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/medium/jm-2018-011072_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) MTMSA analogues decrease the expression of luciferase controlled by NR0B1 promoter, a validated binding promoter of EWS-FLI1. TC-32 cells, expressing EWS-FLI1, were stably transfected with luciferase reporter vectors and treated for 12 h. (B) MTMSA analogues <b>60</b> and <b>61</b> did not decrease luciferase expression controlled by a nonspecific CMV promoter.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b01107/20180907/images/large/jm-2018-011072_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01107&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72647" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72647" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohlert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Künzel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machinek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span> <span> </span><span class="NLM_article-title">The structure of mithramycin reinvestigated</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1021/np980355k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np980355k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=119-121&author=S.+Wohlertauthor=E.+K%C3%BCnzelauthor=R.+Machinekauthor=C.+Mendezauthor=J.+Salasauthor=J.+Rohr&title=The+structure+of+mithramycin+reinvestigated&doi=10.1021%2Fnp980355k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fnp980355k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp980355k%26sid%3Dliteratum%253Aachs%26aulast%3DWohlert%26aufirst%3DS.%26aulast%3DK%25C3%25BCnzel%26aufirst%3DE.%26aulast%3DMachinek%26aufirst%3DR.%26aulast%3DMendez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DThe%2520structure%2520of%2520mithramycin%2520reinvestigated%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1999%26volume%3D62%26spage%3D119%26epage%3D121%26doi%3D10.1021%2Fnp980355k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Méndez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J. A.</span></span> <span> </span><span class="NLM_article-title">The biosynthesis of aureolic acid group antibiotics</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1006/bioo.1998.1110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1006%2Fbioo.1998.1110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1Smt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=41-54&author=J.+Rohrauthor=C.+M%C3%A9ndezauthor=J.+A.+Salas&title=The+biosynthesis+of+aureolic+acid+group+antibiotics&doi=10.1006%2Fbioo.1998.1110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Biosynthesis of Aureolic Acid Group Antibiotics</span></div><div class="casAuthors">Rohr, Jurgen; Mendez, Carmen; Salas, Jose A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-54</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 54 refs.  Biosynthetic studies on mithramycin (aureolic acid) using to a great extent modern genetic methods revealed several novel aspects of the biosynthesis of this class of antitumor agent.  It could be proven that the aglycon moiety of the aureolic acids is constructed by a type II polyketide synthase via a single decaketide chain which undergoes a folding, as seen in the tetracyclines, followed by an initial 7,12-cyclization.  Finally, after three more cyclizations, a linear tetracyclic intermediate (premithramycinone) arises, which is a tetracycline-like mol.  Premithramycinone is consecutively methylated and glycosylated (via premithramycins A1, A1, A2 and A3 ) to form premithramycin B , the ultimate tetracyclic intermediate, whose fourth ring finally gets oxidatively opened through a Baeyer-Villiger type oxidn. to yield mithramycin .  Most of the gene cluster coding for the mithramycin biosynthesis has been identified and sequenced and several gene functions were identified through insertional inactivation of specific genes and structure elucidation of accumulated products.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprXvppb1x-37Vg90H21EOLACvtfcHk0ljqbviaoy2g5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1Smt7g%253D&md5=47daafdc58177c77724c0a7f3c7784d7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1006%2Fbioo.1998.1110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbioo.1998.1110%26sid%3Dliteratum%253Aachs%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520biosynthesis%2520of%2520aureolic%2520acid%2520group%2520antibiotics%26jtitle%3DBioorg.%2520Chem.%26date%3D1999%26volume%3D27%26spage%3D41%26epage%3D54%26doi%3D10.1006%2Fbioo.1998.1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kofman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlia, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Economou, S. G.</span></span> <span> </span><span class="NLM_article-title">Mithramycin in the treatment of metastatic ewing’s sarcoma</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">889</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1002/1097-0142(197304)31:4<889::AID-CNCR2820310419>3.0.CO;2-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1002%2F1097-0142%28197304%2931%3A4%3C889%3A%3AAID-CNCR2820310419%3E3.0.CO%3B2-H" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1973&pages=889-893&author=S.+Kofmanauthor=C.+P.+Perliaauthor=S.+G.+Economou&title=Mithramycin+in+the+treatment+of+metastatic+ewing%E2%80%99s+sarcoma&doi=10.1002%2F1097-0142%28197304%2931%3A4%3C889%3A%3AAID-CNCR2820310419%3E3.0.CO%3B2-H"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%28197304%2931%3A4%3C889%3A%3AAID-CNCR2820310419%3E3.0.CO%3B2-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%2528197304%252931%253A4%253C889%253A%253AAID-CNCR2820310419%253E3.0.CO%253B2-H%26sid%3Dliteratum%253Aachs%26aulast%3DKofman%26aufirst%3DS.%26aulast%3DPerlia%26aufirst%3DC.%2BP.%26aulast%3DEconomou%26aufirst%3DS.%2BG.%26atitle%3DMithramycin%2520in%2520the%2520treatment%2520of%2520metastatic%2520ewing%25E2%2580%2599s%2520sarcoma%26jtitle%3DCancer%26date%3D1973%26volume%3D31%26spage%3D889%26epage%3D893%26doi%3D10.1002%2F1097-0142%28197304%2931%3A4%3C889%3A%3AAID-CNCR2820310419%3E3.0.CO%3B2-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Balamuth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womer, R. B.</span></span> <span> </span><span class="NLM_article-title">Ewing’s sarcoma</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(09)70286-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1016%2FS1470-2045%2809%2970286-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=20152770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=184-192&author=N.+Balamuthauthor=R.+B.+Womer&title=Ewing%E2%80%99s+sarcoma&doi=10.1016%2FS1470-2045%2809%2970286-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Ewing's sarcoma</span></div><div class="casAuthors">Balamuth, Naomi J.; Womer, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Progress in the treatment of Ewing's sarcoma, the second most common bone tumor in children and adolescents, has improved survival from about 10% in the period before chemotherapy was introduced to about 75% today for patients with localized tumors.  However, patients with metastases still fare badly, and the therapy carries short-term and long-term toxicities.  Multidisciplinary care is indispensable for these patients.  Mol. techniques and new imaging modalities are affecting the diagnosis and classification of patients with Ewing's sarcoma.  Cooperative group studies have led to chemotherapy regimens using the same drugs (vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide), although the exact regimens differ in Europe and North America.  The EWS-ETS family of gene fusions and their downstream effects in Ewing's sarcomas provide opportunities for new approaches to treatment.  These include the inhibition of the fusion gene or its protein product, and pathways related to IGF1 and mTOR.  Inhibition of tyrosine kinases, exploitation of non-apoptotic cell death, and interference with angiogenesis are promising new approaches.  With many new approaches and relatively few patients, it will be challenging to integrate new and established treatments through clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIMK60c3BVxLVg90H21EOLACvtfcHk0lhdVGL7Jq4NUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGgur4%253D&md5=f16ac27df030a6d367e18aebc838eafe</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2809%2970286-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252809%252970286-4%26sid%3Dliteratum%253Aachs%26aulast%3DBalamuth%26aufirst%3DN.%26aulast%3DWomer%26aufirst%3DR.%2BB.%26atitle%3DEwing%25E2%2580%2599s%2520sarcoma%26jtitle%3DLancet%2520Oncol.%26date%3D2010%26volume%3D11%26spage%3D184%26epage%3D192%26doi%3D10.1016%2FS1470-2045%2809%2970286-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kofman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenstein, R.</span></span> <span> </span><span class="NLM_article-title">Mithramycin in the treatment of disseminated cancer</span>. <i>Cancer Chemother. Rep.</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=14088839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A280%3ADyaF2c%252Fks1GjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1963&pages=77-96&author=S.+Kofmanauthor=R.+Eisenstein&title=Mithramycin+in+the+treatment+of+disseminated+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED CANCER</span></div><div class="casAuthors">KOFMAN S; EISENSTEIN R</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy reports</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-96</span>
        ISSN:<span class="NLM_cas:issn">0069-0112</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5y_72QMlRq5SWdIdmEou5fW6udTcc2eZUP_dtaAyIdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2c%252Fks1GjtQ%253D%253D&md5=5b5e5a59401ba63a808e028d58016113</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKofman%26aufirst%3DS.%26aulast%3DEisenstein%26aufirst%3DR.%26atitle%3DMithramycin%2520in%2520the%2520treatment%2520of%2520disseminated%2520cancer%26jtitle%3DCancer%2520Chemother.%2520Rep.%26date%3D1963%26volume%3D32%26spage%3D77%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kofman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medrek, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. W.</span></span> <span> </span><span class="NLM_article-title">Mithramycin in the treatment of embryonal cancer</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">938</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1002/1097-0142(196407)17:7<938::AID-CNCR2820170714>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1002%2F1097-0142%28196407%2917%3A7%3C938%3A%3AAID-CNCR2820170714%3E3.0.CO%3B2-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1964&pages=938-948&author=S.+Kofmanauthor=T.+J.+Medrekauthor=R.+W.+Alexander&title=Mithramycin+in+the+treatment+of+embryonal+cancer&doi=10.1002%2F1097-0142%28196407%2917%3A7%3C938%3A%3AAID-CNCR2820170714%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%28196407%2917%3A7%3C938%3A%3AAID-CNCR2820170714%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%2528196407%252917%253A7%253C938%253A%253AAID-CNCR2820170714%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DKofman%26aufirst%3DS.%26aulast%3DMedrek%26aufirst%3DT.%2BJ.%26aulast%3DAlexander%26aufirst%3DR.%2BW.%26atitle%3DMithramycin%2520in%2520the%2520treatment%2520of%2520embryonal%2520cancer%26jtitle%3DCancer%26date%3D1964%26volume%3D17%26spage%3D938%26epage%3D948%26doi%3D10.1002%2F1097-0142%28196407%2917%3A7%3C938%3A%3AAID-CNCR2820170714%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delattre, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plougastel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmaze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joubert, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouleau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aurias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span> <span> </span><span class="NLM_article-title">Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">162</span>, <span class="refDoi"> DOI: 10.1038/359162a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1038%2F359162a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1992&pages=162&author=O.+Delattreauthor=J.+Zucmanauthor=B.+Plougastelauthor=C.+Desmazeauthor=T.+Melotauthor=M.+Peterauthor=H.+Kovarauthor=I.+Joubertauthor=P.+de+Jongauthor=G.+Rouleauauthor=A.+Auriasauthor=G.+Thomas&title=Gene+fusion+with+an+ETS+DNA-binding+domain+caused+by+chromosome+translocation+in+human+tumours&doi=10.1038%2F359162a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F359162a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F359162a0%26sid%3Dliteratum%253Aachs%26aulast%3DDelattre%26aufirst%3DO.%26aulast%3DZucman%26aufirst%3DJ.%26aulast%3DPlougastel%26aufirst%3DB.%26aulast%3DDesmaze%26aufirst%3DC.%26aulast%3DMelot%26aufirst%3DT.%26aulast%3DPeter%26aufirst%3DM.%26aulast%3DKovar%26aufirst%3DH.%26aulast%3DJoubert%26aufirst%3DI.%26aulast%3Dde%2BJong%26aufirst%3DP.%26aulast%3DRouleau%26aufirst%3DG.%26aulast%3DAurias%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DG.%26atitle%3DGene%2520fusion%2520with%2520an%2520ETS%2520DNA-binding%2520domain%2520caused%2520by%2520chromosome%2520translocation%2520in%2520human%2520tumours%26jtitle%3DNature%26date%3D1992%26volume%3D359%26spage%3D162%26doi%3D10.1038%2F359162a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, C. T.</span></span> <span> </span><span class="NLM_article-title">EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1038/ng1297-495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1038%2Fng1297-495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=9398859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADyaK2sXnvFWrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=495-497&author=W.+A.+Mayauthor=A.+Arvandauthor=A.+D.+Thompsonauthor=B.+S.+Braunauthor=M.+Wrightauthor=C.+T.+Denny&title=EWS%2FFLI1-induced+manic+fringe+renders+NIH+3T3+cells+tumorigenic&doi=10.1038%2Fng1297-495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic</span></div><div class="casAuthors">May, William A.; Arvand, Afsane; Thompson, Andrew D.; Braun, Benjamin S.; Wright, Marcienne; Denny, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">495-497</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">EWS/FLI1, a fusion gene found in Ewing's sarcoma, encodes a transcriptional regulator and promotes cellular transformation by modulating the transcription of specific target genes.  The authors have found that EWS/FLI1 and structurally related fusion proteins upregulate manic fringe (MFNG), a recently described member of the Fringe gene family instrumental in somatic development.  MFNG is also expressed in human tumor-derived cell lines expressing EWS/FLI1.  Overexpression of MFNG in NIH 3T3 cells renders them tumorigenic in mice with severe combined immunodeficiency disease (SCID).  These data demonstrate that part of the oncogenic effect of EWS/FLI1 is to transcriptionally deregulate a member of a family of morphogenic genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo21egGdVAYbrVg90H21EOLACvtfcHk0lh8gETBWoLIjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvFWrs7g%253D&md5=cf3fc24878a314b34c63f36511c246a3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng1297-495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1297-495%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DW.%2BA.%26aulast%3DArvand%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DA.%2BD.%26aulast%3DBraun%26aufirst%3DB.%2BS.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DDenny%26aufirst%3DC.%2BT.%26atitle%3DEWS%252FFLI1-induced%2520manic%2520fringe%2520renders%2520NIH%25203T3%2520cells%2520tumorigenic%26jtitle%3DNat.%2520Genet.%26date%3D1997%26volume%3D17%26spage%3D495%26epage%3D497%26doi%3D10.1038%2Fng1297-495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomlins, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanasekaran, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varambally, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tchinda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuefer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span> <span> </span><span class="NLM_article-title">Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1126/science.1117679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1126%2Fscience.1117679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=16254181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFChsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=644-648&author=S.+A.+Tomlinsauthor=D.+R.+Rhodesauthor=S.+Pernerauthor=S.+M.+Dhanasekaranauthor=R.+Mehraauthor=X.+W.+Sunauthor=S.+Varamballyauthor=X.+Caoauthor=J.+Tchindaauthor=R.+Kueferauthor=C.+Lee&title=Recurrent+fusion+of+TMPRSS2+and+ETS+transcription+factor+genes+in+prostate+cancer&doi=10.1126%2Fscience.1117679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer</span></div><div class="casAuthors">Tomlins, Scott A.; Rhodes, Daniel R.; Perner, Sven; Dhanasekaran, Saravana M.; Mehra, Rohit; Sun, Xiao-Wei; Varambally, Sooryanarayana; Cao, Xuhong; Tchinda, Joelle; Kuefer, Rainer; Lee, Charles; Montie, James E.; Shah, Rajal B.; Pienta, Kenneth J.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">5748</span>),
    <span class="NLM_cas:pages">644-648</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Recurrent chromosomal rearrangements have not been well characterized in common carcinomas.  We used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression.  Two ETS transcription factors, ERG and ETV1, were identified as outliers in prostate cancer.  We identified recurrent gene fusions of the 5' untranslated region of TMPRSS2 to ERG or ETV1 in prostate cancer tissues with outlier expression.  By using fluorescence in situ hybridization, we demonstrated that 23 of 29 prostate cancer samples harbor rearrangements in ERG or ETV1.  Cell line expts. suggest that the androgen-responsive promoter elements of TMPRSS2 mediate the overexpression of ETS family members in prostate cancer.  These results have implications in the development of carcinomas and the mol. diagnosis and treatment of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTX7VlR2WkVbVg90H21EOLACvtfcHk0lh8gETBWoLIjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFChsLjJ&md5=99162c7c1f22c60b16b254550fafa7ca</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1117679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1117679%26sid%3Dliteratum%253Aachs%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DRhodes%26aufirst%3DD.%2BR.%26aulast%3DPerner%26aufirst%3DS.%26aulast%3DDhanasekaran%26aufirst%3DS.%2BM.%26aulast%3DMehra%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DX.%2BW.%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DTchinda%26aufirst%3DJ.%26aulast%3DKuefer%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26atitle%3DRecurrent%2520fusion%2520of%2520TMPRSS2%2520and%2520ETS%2520transcription%2520factor%2520genes%2520in%2520prostate%2520cancer%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D644%26epage%3D648%26doi%3D10.1126%2Fscience.1117679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. J.</span></span> <span> </span><span class="NLM_article-title">Solution structure of the mithramycin dimer-DNA complex</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">6588</span>– <span class="NLM_lpage">6604</span>, <span class="refDoi"> DOI: 10.1021/bi00077a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00077a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADyaK3sXltlWjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=6588-6604&author=M.+Sastryauthor=D.+J.+Patel&title=Solution+structure+of+the+mithramycin+dimer-DNA+complex&doi=10.1021%2Fbi00077a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Solution structure of the mithramycin dimer-DNA complex</span></div><div class="casAuthors">Sastry, Mallika; Patel, Dinshaw J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6588-604</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The authors have characterized the NMR parameters for the complexes formed by the Mg2+-coordinated mithramycin dimer with self-complementary d(T-G-G-C-C-A) and d(T-C-G-C-G-A) duplexes.  The soln. structure of the latter complex has been detd. using a combined NMR-mol. dynamics study including relaxation matrix refinement.  The Mg2+-coordinated mithramycin dimer-d(T-C-G-C-G-A) complex exhibits a 2-fold center of symmetry with the divalent cation coordinated aglycons positioned opposite the central (G3-C4)·(G3-C4) segment such that the aglycon C8 hydroxyl oxygens form sym. sequence-specific hydrogen bonds to guanine amino protons in the complex.  The C-D-E trisaccharide segments of each monomer in the mithramycin dimer adopt extended conformations, are positioned inside the minor groove, and are directed toward the either end of the duplex.  The C-D saccharide component of one monomer and the aglycol of the other monomer in the mithramycin dimer share a widened minor groove with the hydrophobic edges of the C and D sugars interacting with individual strands of the duplex.  The E-sugar ring is positioned in the floor of the minor groove, and its hydroxyl-bearing face interacts with both strands of the duplex through hydrogen-bonding and hydroprobic intermol. interactions.  The A-B disaccharide and the hydrophilic side chain form intermol. contacts with the sugar-phosphate backbone in the complex.  The antiparallel alignment of divalent cation coordinated monomers in the mithramycin dimer results in the two outwardly directed C-D-E trisaccharide segments generating a right-handed continuous hexasaccharide domain that spans six base pairs in the minor groove of the duplex.  The soln. structure of the mithramycin dimer-DNA complex reported in this study and the soln. structure of the chromomycin dimer-DNA complex reported previously [Gao, X., Mirau, P., & Patel, D. J. (1992) J. Mol. Biol. 223, 259-279] show global similarities, as well as local differences that are of interest.  All four nucleotides in the tetranucleotide segment of the duplex centered about the sequence-specific (G-C)·(G-C) step adopt A-DNA sugar puckers and glycosidic torsion angles in the chromomycin dimer-DNA complex, while only the central cytidine adopts an A-DNA sugar pucker and glycosidic torsion angle in the mithramycin dimer-DNA complex.  Further, differences in both the hydrogen bonding and the hydrophobic nature of the substituents on the E-sugar face positioned in the floor of the minor groove result in reduced sequence selectivity for mithramycin dimer-DNA complexes relative to chromomycin dimer-DNA complexes.  These high-resoln. soln. structural studies provide plausible explanations for modulations in the sequence selectivity within the aureolic acid family of antitumor drug dimers for their DNA target sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPb4MWRqe2x7Vg90H21EOLACvtfcHk0lh8gETBWoLIjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlWjsbc%253D&md5=fff7ce3dd76317afad43c7a807eee634</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi00077a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00077a012%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26atitle%3DSolution%2520structure%2520of%2520the%2520mithramycin%2520dimer-DNA%2520complex%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D6588%26epage%3D6604%26doi%3D10.1021%2Fbi00077a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remsing, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nur-e-Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Lozano, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braña, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rix, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Méndez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span> <span> </span><span class="NLM_article-title">Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer streptomyces argillaceus through combinatorial biosynthesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">5745</span>– <span class="NLM_lpage">5753</span>, <span class="refDoi"> DOI: 10.1021/ja034162h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja034162h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=5745-5753&author=L.+L.+Remsingauthor=A.+M.+Gonz%C3%A1lezauthor=M.+Nur-e-Alamauthor=M.+J.+Fern%C3%A1ndez-Lozanoauthor=A.+F.+Bra%C3%B1aauthor=U.+Rixauthor=M.+A.+Oliveiraauthor=C.+M%C3%A9ndezauthor=J.+A.+Salasauthor=J.+Rohr&title=Mithramycin+SK%2C+a+novel+antitumor+drug+with+improved+therapeutic+index%2C+mithramycin+SA%2C+and+demycarosyl-mithramycin+SK%3A+three+new+products+generated+in+the+mithramycin+producer+streptomyces+argillaceus+through+combinatorial+biosynthesis&doi=10.1021%2Fja034162h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mithramycin SK, A Novel Antitumor Drug with Improved Therapeutic Index, Mithramycin SA, and Demycarosyl-mithramycin SK: Three New Products Generated in the Mithramycin Producer Streptomyces argillaceus through Combinatorial Biosynthesis</span></div><div class="casAuthors">Remsing, Lily L.; Gonzalez, Ana M.; Nur-e-Alam, Mohammad; Fernandez-Lozano, M. Jose; Brana, Alfredo F.; Rix, Uwe; Oliveira, Marcos A.; Mendez, Carmen; Salas, Jose A.; Rohr, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5745-5753</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To gain initial structure-activity relationships regarding the highly functionalized pentyl side chain attached at C-3 of mithramycin (MTM), we focused on a post-polyketide synthase (post-PKS) tailoring step of the MTM biosynthesis by Streptomyces argillaceus ATCC 12956, which was proposed to be catalyzed by ketoreductase (KR) MtmW.  In this last step of the MTM biosynthesis, a keto group of the pentyl side chain is reduced to a secondary alc., and we anticipated the generation of an MTM deriv. with an addnl. keto group in the 3-side chain.  Insertional inactivation of mtmW, a gene located ∼8 kb downstream of the mithramycin-PKS genes, yielded an S. argillaceus mutant, which accumulated three new mithramycin analogs, namely mithramycin SA, demycarosyl-mithramycin SK, and mithramycin SK (MTM-SK).  The structures of these three compds. confirmed indirectly the proposed role of MtmW in MTM biosynthesis.  However, the new mithramycin derivs. bear unexpectedly shorter 3-side chains (Et or butyl) than MTM, presumably caused by nonenzymic rearrangement or cleavage reactions of the initially formed pentyl side chain with a reactive β-dicarbonyl functional group.  The major product, MTM-SK, was tested in vitro against a variety of human cancer cell lines, as well as in an in vitro toxicity assay, and showed an improved therapeutic index, in comparison to the parent drug, MTM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNPA1wWdO_uLVg90H21EOLACvtfcHk0li1xBivtAdSlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFGnsr0%253D&md5=030ab7acf1d1e6315ae6273120193bc0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fja034162h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja034162h%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%26aufirst%3DL.%2BL.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DA.%2BM.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez-Lozano%26aufirst%3DM.%2BJ.%26aulast%3DBra%25C3%25B1a%26aufirst%3DA.%2BF.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DOliveira%26aufirst%3DM.%2BA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DMithramycin%2520SK%252C%2520a%2520novel%2520antitumor%2520drug%2520with%2520improved%2520therapeutic%2520index%252C%2520mithramycin%2520SA%252C%2520and%2520demycarosyl-mithramycin%2520SK%253A%2520three%2520new%2520products%2520generated%2520in%2520the%2520mithramycin%2520producer%2520streptomyces%2520argillaceus%2520through%2520combinatorial%2520biosynthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D5745%26epage%3D5753%26doi%3D10.1021%2Fja034162h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span> <span> </span><span class="NLM_article-title">Semi-synthetic mithramycin SA derivatives with improved anti-cancer activity</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1111%2Fcbdd.12107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=23331575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFSnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=615-624&author=D.+Scottauthor=J.+M.+Chenauthor=Y.+Baeauthor=J.+Rohr&title=Semi-synthetic+mithramycin+SA+derivatives+with+improved+anti-cancer+activity&doi=10.1111%2Fcbdd.12107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Semi-synthetic mithramycin SA derivatives with improved anticancer activity</span></div><div class="casAuthors">Scott, Daniel; Chen, Jhong-Min; Bae, Younsoo; Rohr, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">615-624</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mithramycin (MTM) is a potent anti-cancer agent that has recently garnered renewed attention.  This manuscript describes the design and development of mithramycin derivs. through a combinational approach of biosynthetic analog generation followed by synthetic manipulation for further derivatization.  Mithramycin SA is a previously discovered analog produced by the M7W1 mutant strain alongside the improved mithramycin analogs mithramycin SK and mithramycin SDK.  Mithramycin SA shows decreased anti-cancer activity compared to mithramycin and has a shorter, two carbon aglycon side chain that is terminated in a carboxylic acid.  The aglycon side chain is responsible for an interaction with the DNA-phosphate backbone as mithramycin interacts with its target DNA.  It was therefore decided to further functionalize this side chain through reactions with the terminal carboxylic acid in an effort to enhance the interaction with the DNA phosphate backbone and improve the anti-cancer activity.  This side chain was modified with a variety of mols. increasing the anti-cancer activity to a comparable level to mithramycin SK.  This work shows the ability to transform the previously useless mithramycin SA into a valuable mol. and opens the door to further functionalization and semi-synthetic modification for the development of mols. with increased specificity and/or drug formulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTa3ey2wYReLVg90H21EOLACvtfcHk0li1xBivtAdSlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFSnsrY%253D&md5=244713ab138576371da084c6dc44bb88</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12107%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DBae%26aufirst%3DY.%26aulast%3DRohr%26aufirst%3DJ.%26atitle%3DSemi-synthetic%2520mithramycin%2520SA%2520derivatives%2520with%2520improved%2520anti-cancer%2520activity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D615%26epage%3D624%26doi%3D10.1111%2Fcbdd.12107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leggas, M.</span>; <span class="NLM_string-name">Eckenrode, J.</span>; <span class="NLM_string-name">Mitra, P.</span>; <span class="NLM_string-name">Jha, J.</span>; <span class="NLM_string-name">Salem, S.</span>; <span class="NLM_string-name">Mandal, A.</span>; <span class="NLM_string-name">Thorson, J.</span>; <span class="NLM_string-name">Rohr, J.</span></span> <i>Molecular Targets and Cancer Therapeutics</i>, Proceedings of the AACR-NCI-EORTC International Conference, Philadelphia, PA, Oct 26–30, 2017; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2017</span>; Abstract B043.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+Leggas&author=J.+Eckenrode&author=P.+Mitra&author=J.+Jha&author=S.+Salem&author=A.+Mandal&author=J.+Thorson&author=J.+Rohr&title=Molecular+Targets+and+Cancer+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLeggas%26aufirst%3DM.%26btitle%3DMolecular%2520Targets%2520and%2520Cancer%2520Therapeutics%26pub%3DAACR%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span> </span><span class="NLM_article-title">Mithramycin-SA analogues with reduced toxicity
for the treatment of ETS transcription factor-driven tumors</span>.  <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume">17</span> (<span class="NLM_issue">1 Suppl.</span>), <span class="refDoi"> DOI: 10.1158/1535-7163.TARG-17-B043</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1158%2F1535-7163.TARG-17-B043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mithramycin-SA+analogues+with+reduced+toxicity%0Afor+the+treatment+of+ETS+transcription+factor-driven+tumors.+Mol.+Cancer+Ther.+2018%2C+17+%281+Suppl.%29%2C+10.1158%2F1535-7163.TARG-17-B043."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.TARG-17-B043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.TARG-17-B043%26sid%3Dliteratum%253Aachs%26atitle%3DMithramycin-SA%2520analogues%2520with%2520reduced%2520toxicity%250Afor%2520the%2520treatment%2520of%2520ETS%2520transcription%2520factor-driven%2520tumors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26issue%3D1%2520Suppl%26doi%3D10.1158%2F1535-7163.TARG-17-B043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidenbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsodikov, O. V.</span></span> <span> </span><span class="NLM_article-title">Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">8990</span>– <span class="NLM_lpage">9004</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1093%2Fnar%2Fgkw761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=27587584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFaku7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=8990-9004&author=C.+Houauthor=S.+Weidenbachauthor=K.+E.+Canoauthor=Z.+Wangauthor=P.+Mitraauthor=D.+N.+Ivanovauthor=J.+Rohrauthor=O.+V.+Tsodikov&title=Structures+of+mithramycin+analogues+bound+to+DNA+and+implications+for+targeting+transcription+factor+FLI1&doi=10.1093%2Fnar%2Fgkw761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1</span></div><div class="casAuthors">Hou, Caixia; Weidenbach, Stevi; Cano, Kristin E.; Wang, Zhonghua; Mitra, Prithiba; Ivanov, Dmitri N.; Rohr, Jurgen; Tsodikov, Oleg V.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8990-9004</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Transcription factors have been considered undruggable, but this paradigm has been recently challenged.  DNA binding natural product mithramycin (MTM) is a potent antagonist of oncogenic transcription factor EWS-FLI1.  Structural details of MTM recognition of DNA, including the FLI1 binding sequence GGA(A/T), are needed to understand how MTM interferes with EWS-FLI1.  We report a crystal structure of an MTM analog MTM SA-Trp bound to a DNA oligomer contg. a site GGCC, and two structures of a novel analog MTM SA-Phe in complex with DNA.  MTM SA-Phe is bound to sites AGGG and GGGT on one DNA, and to AGGG and GGGA(T) (a FLI1 binding site) on the other, revealing how MTM recognizes different DNA sequences.  Unexpectedly, at sub-micromolar concns. MTMs stabilize FLI1-DNA complex on GGAA repeats, which are crit. for the oncogenic function of EWS-FLI1.  We also directly demonstrate by NMR formation of a ternary FLI1-DNA-MTM complex on a single GGAA FLI1/MTM binding site.  These biochem. and structural data and a new FLI1-DNA structure suggest that MTM binds the minor groove and perturbs FLI1 bound nearby in the major groove.  This ternary complex model may lead to development of novel MTM analogs that selectively target EWS-FLI1 or other oncogenic transcription factors, as anti-cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPVKMe-9H0mrVg90H21EOLACvtfcHk0lisS9PydQOYpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFaku7zP&md5=3fa616913d7ad05b0834fa41635f051b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw761%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DC.%26aulast%3DWeidenbach%26aufirst%3DS.%26aulast%3DCano%26aufirst%3DK.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DMitra%26aufirst%3DP.%26aulast%3DIvanov%26aufirst%3DD.%2BN.%26aulast%3DRohr%26aufirst%3DJ.%26aulast%3DTsodikov%26aufirst%3DO.%2BV.%26atitle%3DStructures%2520of%2520mithramycin%2520analogues%2520bound%2520to%2520DNA%2520and%2520implications%2520for%2520targeting%2520transcription%2520factor%2520FLI1%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2016%26volume%3D44%26spage%3D8990%26epage%3D9004%26doi%3D10.1093%2Fnar%2Fgkw761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alqahtani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porwal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bis, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karty, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanathan, R.</span></span> <span> </span><span class="NLM_article-title">Synergism between genome sequencing, tandem mass spectrometry and bio-inspired synthesis reveals insights into nocardioazine B biogenesis</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">7177</span>– <span class="NLM_lpage">7192</span>, <span class="refDoi"> DOI: 10.1039/C5OB00537J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1039%2FC5OB00537J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=7177-7192&author=N.+Alqahtaniauthor=S.+K.+Porwalauthor=E.+D.+Jamesauthor=D.+M.+Bisauthor=J.+A.+Kartyauthor=A.+L.+Laneauthor=R.+Viswanathan&title=Synergism+between+genome+sequencing%2C+tandem+mass+spectrometry+and+bio-inspired+synthesis+reveals+insights+into+nocardioazine+B+biogenesis&doi=10.1039%2FC5OB00537J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC5OB00537J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00537J%26sid%3Dliteratum%253Aachs%26aulast%3DAlqahtani%26aufirst%3DN.%26aulast%3DPorwal%26aufirst%3DS.%2BK.%26aulast%3DJames%26aufirst%3DE.%2BD.%26aulast%3DBis%26aufirst%3DD.%2BM.%26aulast%3DKarty%26aufirst%3DJ.%2BA.%26aulast%3DLane%26aufirst%3DA.%2BL.%26aulast%3DViswanathan%26aufirst%3DR.%26atitle%3DSynergism%2520between%2520genome%2520sequencing%252C%2520tandem%2520mass%2520spectrometry%2520and%2520bio-inspired%2520synthesis%2520reveals%2520insights%2520into%2520nocardioazine%2520B%2520biogenesis%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D7177%26epage%3D7192%26doi%3D10.1039%2FC5OB00537J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, A.
S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, M. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzepa, H. S.</span></span> <span> </span><span class="NLM_article-title">Studies in sigmatropic rearrangements of <i>N</i>-prenylindole derivatives–a formal enantiomerically pure synthesis of tryprostatin B</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3966</span>– <span class="NLM_lpage">3972</span>, <span class="refDoi"> DOI: 10.1039/b606457d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1039%2Fb606457d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=3966-3972&author=A.%0AS.+P.+Cardosoauthor=M.+M.+B.+Marquesauthor=N.+Srinivasanauthor=S.+Prabhakarauthor=A.+M.+Loboauthor=H.+S.+Rzepa&title=Studies+in+sigmatropic+rearrangements+of+N-prenylindole+derivatives%E2%80%93a+formal+enantiomerically+pure+synthesis+of+tryprostatin+B&doi=10.1039%2Fb606457d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fb606457d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb606457d%26sid%3Dliteratum%253Aachs%26aulast%3DCardoso%26aufirst%3DA.%2BS.%2BP.%26aulast%3DMarques%26aufirst%3DM.%2BM.%2BB.%26aulast%3DSrinivasan%26aufirst%3DN.%26aulast%3DPrabhakar%26aufirst%3DS.%26aulast%3DLobo%26aufirst%3DA.%2BM.%26aulast%3DRzepa%26aufirst%3DH.%2BS.%26atitle%3DStudies%2520in%2520sigmatropic%2520rearrangements%2520of%2520N-prenylindole%2520derivatives%25E2%2580%2593a%2520formal%2520enantiomerically%2520pure%2520synthesis%2520of%2520tryprostatin%2520B%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D3966%26epage%3D3972%26doi%3D10.1039%2Fb606457d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loach, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozkal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Movassaghi, M.</span></span> <span> </span><span class="NLM_article-title">Derivatization of C3-alkylindoles including tryptophans and tryptamines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">11254</span>– <span class="NLM_lpage">11263</span>, <span class="refDoi"> DOI: 10.1021/jo502062z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo502062z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=11254-11263&author=R.+P.+Loachauthor=O.+S.+Fentonauthor=K.+Amaikeauthor=D.+S.+Siegelauthor=E.+Ozkalauthor=M.+Movassaghi&title=Derivatization+of+C3-alkylindoles+including+tryptophans+and+tryptamines&doi=10.1021%2Fjo502062z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo502062z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo502062z%26sid%3Dliteratum%253Aachs%26aulast%3DLoach%26aufirst%3DR.%2BP.%26aulast%3DFenton%26aufirst%3DO.%2BS.%26aulast%3DAmaike%26aufirst%3DK.%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26aulast%3DOzkal%26aufirst%3DE.%26aulast%3DMovassaghi%26aufirst%3DM.%26atitle%3DDerivatization%2520of%2520C3-alkylindoles%2520including%2520tryptophans%2520and%2520tryptamines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D11254%26epage%3D11263%26doi%3D10.1021%2Fjo502062z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Sterically controlled iodination of arenes via iridium-catalyzed C–H borylation</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1021/ol303164h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol303164h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyiur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=140-143&author=B.+M.+Partridgeauthor=J.+F.+Hartwig&title=Sterically+controlled+iodination+of+arenes+via+iridium-catalyzed+C%E2%80%93H+borylation&doi=10.1021%2Fol303164h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sterically controlled iodination of arenes via iridium-catalyzed C-H borylation</span></div><div class="casAuthors">Partridge, Benjamin M.; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-143</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mild method to prep. aryl and heteroaryl iodides by sequential C-H borylation and iodination is reported.  The regioselectivity of this process is controlled by steric effects on the C-H borylation step and is complementary to existing methods to form aryl iodides.  The iodination of boronic esters has potential for the synthesis of radiolabeled aryl iodides, as demonstrated by the concise synthesis of a potential tracer for SPECT imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo3JtHd06qSLVg90H21EOLACvtfcHk0lisS9PydQOYpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyiur7J&md5=e946fdf8ad48a36227499d7aa6599c68</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fol303164h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol303164h%26sid%3Dliteratum%253Aachs%26aulast%3DPartridge%26aufirst%3DB.%2BM.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DSterically%2520controlled%2520iodination%2520of%2520arenes%2520via%2520iridium-catalyzed%2520C%25E2%2580%2593H%2520borylation%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D140%26epage%3D143%26doi%3D10.1021%2Fol303164h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simke, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Total synthesis of erruculogen and fumitremorgin a enabled by ligand-controlled CH borylation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">10160</span>– <span class="NLM_lpage">10163</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b07154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b07154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=10160-10163&author=Y.+Fengauthor=D.+Holteauthor=J.+Zollerauthor=S.+Umemiyaauthor=L.+R.+Simkeauthor=P.+S.+Baran&title=Total+synthesis+of+erruculogen+and+fumitremorgin+a+enabled+by+ligand-controlled+CH+borylation&doi=10.1021%2Fjacs.5b07154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b07154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b07154%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DHolte%26aufirst%3DD.%26aulast%3DZoller%26aufirst%3DJ.%26aulast%3DUmemiya%26aufirst%3DS.%26aulast%3DSimke%26aufirst%3DL.%2BR.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DTotal%2520synthesis%2520of%2520erruculogen%2520and%2520fumitremorgin%2520a%2520enabled%2520by%2520ligand-controlled%2520CH%2520borylation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D10160%26epage%3D10163%26doi%3D10.1021%2Fjacs.5b07154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed, modular synthesis of highly functionalized indoles and tryptophans by direct annulation of substituted <i>o</i>-haloanilines and aldehydes</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">7826</span>– <span class="NLM_lpage">7834</span>, <span class="refDoi"> DOI: 10.1021/jo061471s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo061471s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVyks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=7826-7834&author=Y.+Jiaauthor=J.+Zhu&title=Palladium-catalyzed%2C+modular+synthesis+of+highly+functionalized+indoles+and+tryptophans+by+direct+annulation+of+substituted+o-haloanilines+and+aldehydes&doi=10.1021%2Fjo061471s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed, Modular Synthesis of Highly Functionalized Indoles and Tryptophans by Direct Annulation of Substituted o-Haloanilines and Aldehydes</span></div><div class="casAuthors">Jia, Yanxing; Zhu, Jieping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7826-7834</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One-pot synthesis of indoles by a palladium-catalyzed annulation of o-haloanilines and aldehydes has been developed.  Coupling of o-iodoaniline with aldehyde is realized under mild ligandless conditions [Pd(OAc)2, DABCO, DMF, 85 °C], whereas X-Phos is found to be the ligand of choice for coupling reactions involving o-chloroanilines/o-bromoanilines and aldehydes.  A variety of o-haloanilines with different electronic properties are suitable substrates, and aldehydes including chiral ones participated in this reaction without racemization.  Coupling of (S)-2-N,N-di-tert-butoxycarbonyl-5-oxopentanoate, derived from L-glutamic acid, with o-haloanilines provides a rapid access to the ring-A-substituted tryptophans in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1GhE5W5DDrVg90H21EOLACvtfcHk0ljzFLGFocnJHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVyks70%253D&md5=c141d2c793edc66ee1ffbf9ed5f4b290</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjo061471s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061471s%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DPalladium-catalyzed%252C%2520modular%2520synthesis%2520of%2520highly%2520functionalized%2520indoles%2520and%2520tryptophans%2520by%2520direct%2520annulation%2520of%2520substituted%2520o-haloanilines%2520and%2520aldehydes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D7826%26epage%3D7834%26doi%3D10.1021%2Fjo061471s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokotos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padrón, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín, V. S.</span></span> <span> </span><span class="NLM_article-title">A general approach to the asymmetric synthesis of unsaturated lipidic α-amino acids. The first synthesis of α-aminoarachidonic acid</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3741</span>– <span class="NLM_lpage">3744</span>, <span class="refDoi"> DOI: 10.1021/jo9715128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9715128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=3741-3744&author=G.+Kokotosauthor=J.+M.+Padr%C3%B3nauthor=T.+Mart%C3%ADnauthor=W.+A.+Gibbonsauthor=V.+S.+Mart%C3%ADn&title=A+general+approach+to+the+asymmetric+synthesis+of+unsaturated+lipidic+%CE%B1-amino+acids.+The+first+synthesis+of+%CE%B1-aminoarachidonic+acid&doi=10.1021%2Fjo9715128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo9715128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9715128%26sid%3Dliteratum%253Aachs%26aulast%3DKokotos%26aufirst%3DG.%26aulast%3DPadr%25C3%25B3n%26aufirst%3DJ.%2BM.%26aulast%3DMart%25C3%25ADn%26aufirst%3DT.%26aulast%3DGibbons%26aufirst%3DW.%2BA.%26aulast%3DMart%25C3%25ADn%26aufirst%3DV.%2BS.%26atitle%3DA%2520general%2520approach%2520to%2520the%2520asymmetric%2520synthesis%2520of%2520unsaturated%2520lipidic%2520%25CE%25B1-amino%2520acids.%2520The%2520first%2520synthesis%2520of%2520%25CE%25B1-aminoarachidonic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D3741%26epage%3D3744%26doi%3D10.1021%2Fjo9715128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudy-Floc’h, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngerebara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, L.</span></span> <span> </span><span class="NLM_article-title">Novel β-carboline-tripeptide conjugates attenuate mesenteric ischemia/reperfusion injury in the rat</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2441</span>– <span class="NLM_lpage">2452</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.03.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1016%2Fj.ejmech.2011.03.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2441-2452&author=W.+Biauthor=Y.+Biauthor=P.+Xueauthor=Y.+Zhangauthor=X.+Gaoauthor=Z.+Wangauthor=M.+Liauthor=M.+Baudy-Floc%E2%80%99hauthor=N.+Ngerebaraauthor=X.+Liauthor=M.+Gibsonauthor=L.+Bi&title=Novel+%CE%B2-carboline-tripeptide+conjugates+attenuate+mesenteric+ischemia%2Freperfusion+injury+in+the+rat&doi=10.1016%2Fj.ejmech.2011.03.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.03.029%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DW.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DBaudy-Floc%25E2%2580%2599h%26aufirst%3DM.%26aulast%3DNgerebara%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGibson%26aufirst%3DM.%26aulast%3DBi%26aufirst%3DL.%26atitle%3DNovel%2520%25CE%25B2-carboline-tripeptide%2520conjugates%2520attenuate%2520mesenteric%2520ischemia%252Freperfusion%2520injury%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2441%26epage%3D2452%26doi%3D10.1016%2Fj.ejmech.2011.03.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coste, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toumi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razafimahaléo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couty, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evano, G.</span></span> <span> </span><span class="NLM_article-title">Copper-catalyzed cyclization of iodo-tryptophans: A straightforward synthesis of pyrroloindoles</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3841</span>– <span class="NLM_lpage">3844</span>, <span class="refDoi"> DOI: 10.1021/ol8015513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol8015513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=3841-3844&author=A.+Costeauthor=M.+Toumiauthor=K.+Wrightauthor=V.+Razafimahal%C3%A9oauthor=F.+Coutyauthor=J.+Marrotauthor=G.+Evano&title=Copper-catalyzed+cyclization+of+iodo-tryptophans%3A+A+straightforward+synthesis+of+pyrroloindoles&doi=10.1021%2Fol8015513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fol8015513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol8015513%26sid%3Dliteratum%253Aachs%26aulast%3DCoste%26aufirst%3DA.%26aulast%3DToumi%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DRazafimahal%25C3%25A9o%26aufirst%3DV.%26aulast%3DCouty%26aufirst%3DF.%26aulast%3DMarrot%26aufirst%3DJ.%26aulast%3DEvano%26aufirst%3DG.%26atitle%3DCopper-catalyzed%2520cyclization%2520of%2520iodo-tryptophans%253A%2520A%2520straightforward%2520synthesis%2520of%2520pyrroloindoles%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D3841%26epage%3D3844%26doi%3D10.1021%2Fol8015513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozett, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venter, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokada, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R.</span></span> <span> </span><span class="NLM_article-title">Catalytic enantioselective acyl transfer: the case for 4-PPY with a C-3 carboxamide peptide auxiliary based on synthesis and modelling studies</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">10914</span>– <span class="NLM_lpage">10925</span>, <span class="refDoi"> DOI: 10.1039/C6OB01991A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1039%2FC6OB01991A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=27814425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2itbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=10914-10925&author=R.+E.+Cozettauthor=G.+A.+Venterauthor=M.+R.+Gokadaauthor=R.+Hunter&title=Catalytic+enantioselective+acyl+transfer%3A+the+case+for+4-PPY+with+a+C-3+carboxamide+peptide+auxiliary+based+on+synthesis+and+modelling+studies&doi=10.1039%2FC6OB01991A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic enantioselective acyl transfer: the case for 4-PPY with a C-3 carboxamide peptide auxiliary based on synthesis and modelling studies</span></div><div class="casAuthors">Cozett, Rudy E.; Venter, Gerhard A.; Gokada, Maheswara Rao; Hunter, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">10914-10925</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of 4-pyrrolidinopyridine (4-PPY) C-3 carboxamides contg. peptide-based side chains have been synthesized and evaluated in the kinetic resoln. of a small library of chiral benzylic secondary alcs.  A key design element was the incorporation of a tryptophan residue in the peptide side chain for promoting π-stacking between peptide side chain and the pyridinium ring of the N-acyl intermediate, in which modeling was used as a structure-based guiding tool.  Together, a catalyst contg. a LeuTrp-N-Boc side chain (catalyst 8) was identified that achieved s-values up to and in slight excess of 10.  A transition-state model based on the modeling is proposed to explain the origin of enantioselectivity.  This study establishes the usefulness of modeling as a structure-based guiding tool for enantioselectivity optimization as well as the potential for developing scalable peptide-based DMAP-type catalysts for large-scale resoln. work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0gd3nkVAMrVg90H21EOLACvtfcHk0liP-94IXVbgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2itbfF&md5=eceaeb772caf945d87daaa4622c3c467</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC6OB01991A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB01991A%26sid%3Dliteratum%253Aachs%26aulast%3DCozett%26aufirst%3DR.%2BE.%26aulast%3DVenter%26aufirst%3DG.%2BA.%26aulast%3DGokada%26aufirst%3DM.%2BR.%26aulast%3DHunter%26aufirst%3DR.%26atitle%3DCatalytic%2520enantioselective%2520acyl%2520transfer%253A%2520the%2520case%2520for%25204-PPY%2520with%2520a%2520C-3%2520carboxamide%2520peptide%2520auxiliary%2520based%2520on%2520synthesis%2520and%2520modelling%2520studies%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D10914%26epage%3D10925%26doi%3D10.1039%2FC6OB01991A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvet, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunatilleke, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podust, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Rational development of 4-aminopyridyl-based inhibitors targeting trypanosoma cruzi CYP51 as anti-chagas agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7651</span>– <span class="NLM_lpage">7668</span>, <span class="refDoi"> DOI: 10.1021/jm401067s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401067s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7651-7668&author=J.+Y.+Choiauthor=C.+M.+Calvetauthor=S.+S.+Gunatillekeauthor=C.+Ruizauthor=M.+D.+Cameronauthor=J.+H.+McKerrowauthor=L.+M.+Podustauthor=W.+R.+Roush&title=Rational+development+of+4-aminopyridyl-based+inhibitors+targeting+trypanosoma+cruzi+CYP51+as+anti-chagas+agents&doi=10.1021%2Fjm401067s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm401067s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401067s%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DCalvet%26aufirst%3DC.%2BM.%26aulast%3DGunatilleke%26aufirst%3DS.%2BS.%26aulast%3DRuiz%26aufirst%3DC.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DRational%2520development%2520of%25204-aminopyridyl-based%2520inhibitors%2520targeting%2520trypanosoma%2520cruzi%2520CYP51%2520as%2520anti-chagas%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7651%26epage%3D7668%26doi%3D10.1021%2Fjm401067s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kidd, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitchen-Goosen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segars, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebregiorgis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woldemichael, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessnick, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madaj, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, L.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Sabín, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helman, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morís, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grohar, P. J.</span></span> <span> </span><span class="NLM_article-title">Identification of mithramycin analogues with improved targeting of the EWS-FLI1 transcription factor</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4105</span>– <span class="NLM_lpage">4118</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-15-2624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1158%2F1078-0432.CCR-15-2624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=26979396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKrsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=4105-4118&author=C.+L.+Osgoodauthor=N.+Maloneyauthor=C.+G.+Kiddauthor=S.+Kitchen-Goosenauthor=L.+Segarsauthor=M.+Gebregiorgisauthor=G.+M.+Woldemichaelauthor=M.+Heauthor=S.+Sankarauthor=S.+L.+Lessnickauthor=M.+Kangauthor=M.+Smithauthor=L.+Turnerauthor=Z.+B.+Madajauthor=M.+E.+Winnauthor=L.%0AE.+N%C3%BA%C3%B1ezauthor=Z.+Gonz%C3%A1lez-Sab%C3%ADnauthor=L.+J.+Helmanauthor=F.+Mor%C3%ADsauthor=P.+J.+Grohar&title=Identification+of+mithramycin+analogues+with+improved+targeting+of+the+EWS-FLI1+transcription+factor&doi=10.1158%2F1078-0432.CCR-15-2624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor</span></div><div class="casAuthors">Osgood, Christy L.; Maloney, Nichole; Kidd, Christopher G.; Kitchen-Goosen, Susan; Segars, Laura; Gebregiorgis, Meti; Woldemichael, Girma M.; He, Min; Sankar, Savita; Lessnick, Stephen L.; Kang, Min; Smith, Malcolm; Turner, Lisa; Madaj, Zachary B.; Winn, Mary E.; Nuunez, Luz-Elena; Gonzunalez-Sabunain, Javier; Helman, Lee J.; Morunaiis, Francisco; Grohar, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4105-4118</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The goal of this study was to identify second-generation mithramycin analogs that better target the EWS-FLI1 transcription factor for Ewing sarcoma.  We previously established mithramycin as an EWS-FLI1 inhibitor, but the compd.'s toxicity prevented its use at effective concns. in patients.  Exptl. Design: We screened a panel of mithralogs to establish their ability to inhibit EWS-FLI1 in Ewing sarcoma.  We compared the IC50 with the MTD established in mice to det. the relationship between efficacy and toxicity.  We confirmed the suppression of EWS-FLI1 at the promoter, mRNA, gene signature, and protein levels.  We established an improved therapeutic window by using time-lapse microscopy to model the effects on cellular proliferation in Ewing sarcoma cells relative to HepG2 control cells.  Finally, we established an improved therapeutic window using a xenograft model of Ewing sarcoma.  Results: EC-8105 was found to be the most potent analog and was able to suppress EWS-FLI1 activity at concns. nontoxic to other cell types.  EC-8042 was substantially less toxic than mithramycin in multiple species but maintained suppression of EWS-FLI1 at similar concns.  Both compds. markedly suppressed Ewing sarcoma xenograft growth and inhibited EWS-FLI1 in vivo.  Conclusions: These results provide a basis for the continued development of EC-8042 and EC-8105 as EWS-FLI1 inhibitors for the clinic.  Clin Cancer Res; 22(16); 4105-18. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS5IC764aGtLVg90H21EOLACvtfcHk0liP-94IXVbgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKrsbnO&md5=a6acb4a7a1cc70459829e9b4537bf25f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-2624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-2624%26sid%3Dliteratum%253Aachs%26aulast%3DOsgood%26aufirst%3DC.%2BL.%26aulast%3DMaloney%26aufirst%3DN.%26aulast%3DKidd%26aufirst%3DC.%2BG.%26aulast%3DKitchen-Goosen%26aufirst%3DS.%26aulast%3DSegars%26aufirst%3DL.%26aulast%3DGebregiorgis%26aufirst%3DM.%26aulast%3DWoldemichael%26aufirst%3DG.%2BM.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DSankar%26aufirst%3DS.%26aulast%3DLessnick%26aufirst%3DS.%2BL.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DTurner%26aufirst%3DL.%26aulast%3DMadaj%26aufirst%3DZ.%2BB.%26aulast%3DWinn%26aufirst%3DM.%2BE.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DL.%2BE.%26aulast%3DGonz%25C3%25A1lez-Sab%25C3%25ADn%26aufirst%3DZ.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26aulast%3DMor%25C3%25ADs%26aufirst%3DF.%26aulast%3DGrohar%26aufirst%3DP.%2BJ.%26atitle%3DIdentification%2520of%2520mithramycin%2520analogues%2520with%2520improved%2520targeting%2520of%2520the%2520EWS-FLI1%2520transcription%2520factor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D4105%26epage%3D4118%26doi%3D10.1158%2F1078-0432.CCR-15-2624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Aragoncillo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Lopez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pestana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J.</span></span> <span> </span><span class="NLM_article-title">DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing’s tumor cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">6034</span>– <span class="NLM_lpage">6043</span>, <span class="refDoi"> DOI: 10.1038/onc.2008.203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1038%2Fonc.2008.203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=6034-6043&author=E.+Garcia-Aragoncilloauthor=J.+Carrilloauthor=E.+Lalliauthor=N.+Agraauthor=G.+Gomez-Lopezauthor=A.+Pestanaauthor=J.+Alonso&title=DAX1%2C+a+direct+target+of+EWS%2FFLI1+oncoprotein%2C+is+a+principal+regulator+of+cell-cycle+progression+in+Ewing%E2%80%99s+tumor+cells&doi=10.1038%2Fonc.2008.203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fonc.2008.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2008.203%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Aragoncillo%26aufirst%3DE.%26aulast%3DCarrillo%26aufirst%3DJ.%26aulast%3DLalli%26aufirst%3DE.%26aulast%3DAgra%26aufirst%3DN.%26aulast%3DGomez-Lopez%26aufirst%3DG.%26aulast%3DPestana%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DJ.%26atitle%3DDAX1%252C%2520a%2520direct%2520target%2520of%2520EWS%252FFLI1%2520oncoprotein%252C%2520is%2520a%2520principal%2520regulator%2520of%2520cell-cycle%2520progression%2520in%2520Ewing%25E2%2580%2599s%2520tumor%2520cells%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D6034%26epage%3D6043%26doi%3D10.1038%2Fonc.2008.203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grohar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woldemichael, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currier, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helman, L. J.</span></span> <span> </span><span class="NLM_article-title">Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">978</span>, <span class="refDoi"> DOI: 10.1093/jnci/djr156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=10.1093%2Fjnci%2Fdjr156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=21653923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2011&pages=962-978&author=P.+J.+Groharauthor=G.+M.+Woldemichaelauthor=L.+B.+Griffinauthor=A.+Mendozaauthor=Q.-R.+Chenauthor=C.+Yeungauthor=D.+G.+Currierauthor=S.+Davisauthor=C.+Khannaauthor=J.+Khanauthor=J.+B.+McMahonauthor=L.+J.+Helman&title=Identification+of+an+inhibitor+of+the+EWS-FLI1+oncogenic+transcription+factor+by+high-throughput+screening&doi=10.1093%2Fjnci%2Fdjr156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening</span></div><div class="casAuthors">Grohar, Patrick J.; Woldemichael, Girma M.; Griffin, Laurie B.; Mendoza, Arnulfo; Chen, Qing-Rong; Yeung, Choh; Currier, Duane G.; Davis, Sean; Khanna, Chand; Khan, Javed; McMahon, James B.; Helman, Lee J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">962-978</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Chromosomal translocations generating oncogenic transcription factors are the hallmark of a variety of tumors, including many sarcomas.  Ewing sarcoma family of tumors (ESFTs) are characterized by the t(11;22)(q24;q12) translocation that generates the Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1 (EWS-FLI1) fusion transcription factor responsible for the highly malignant phenotype of this tumor.  Although continued expression of EWS-FLI1 is believed to be crit. for ESFT cell survival, a clin. effective small-mol. inhibitor remains elusive likely because EWS-FLI1 is a transcription factor and therefore widely felt to be "undruggable.  " Methods We developed a high-throughput screen to evaluate more than 50 000 compds. for inhibition of EWS-FLI1 activity in TC32 ESFT cells.  We used a TC32 cell-based luciferase reporter screen using the EWS-FLI1 downstream target NR0B1 promoter and a gene signature secondary screen to sort and prioritize the compds.  We characterized the lead compd., mithramycin, based on its ability to inhibit EWS-FLI1 activity in vitro using microarray expression profiling, quant. reverse transcription-polymerase chain reaction, and immunoblot anal., and in vivo using immunohistochem.  We studied the impact of this inhibition on cell viability in vitro and on tumor growth in ESFT xenograft models in vivo (n = 15-20 mice per group).  All statistical tests were two-sided.  Results Mithramycin inhibited expression of EWS-FLI1 downstream targets at the mRNA and protein levels and decreased the growth of ESFT cells at half maximal inhibitory concns. between 10 (95% confidence interval [CI] = 8 to 13 nM) and 15 nM (95% CI = 13 to 19 nM).  Mithramycin suppressed the growth of two different ESFT xenograft tumors and prolonged the survival of ESFT xenograft-bearing mice by causing a decrease in mean tumor vol.  For example, in the TC32 xenograft model, on day 15 of treatment, the mean tumor vol. for the mithramycin-treated mice was approx. 3% of the tumor vol. obsd. in the control mice (mithramycin vs control: 69 vs 2388 mm3, difference = 2319 mm3, 95% CI = 1766 to 2872 mm3, P < .001).  Conclusion Mithramycin inhibits EWS-FLI1 activity and demonstrates ESFT antitumor activity both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-zpZMmMy4bLVg90H21EOLACvtfcHk0lj9KHx0KJFIIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cltro%253D&md5=814cc95d2b54de9b275cc1df8a1b19ee</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjr156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjr156%26sid%3Dliteratum%253Aachs%26aulast%3DGrohar%26aufirst%3DP.%2BJ.%26aulast%3DWoldemichael%26aufirst%3DG.%2BM.%26aulast%3DGriffin%26aufirst%3DL.%2BB.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DQ.-R.%26aulast%3DYeung%26aufirst%3DC.%26aulast%3DCurrier%26aufirst%3DD.%2BG.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DKhanna%26aufirst%3DC.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26atitle%3DIdentification%2520of%2520an%2520inhibitor%2520of%2520the%2520EWS-FLI1%2520oncogenic%2520transcription%2520factor%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2011%26volume%3D103%26spage%3D962%26epage%3D978%26doi%3D10.1093%2Fjnci%2Fdjr156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01107">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81727"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01107">10.1021/acs.jmedchem.8b01107</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC profiles and HRMS data of all the MTMSA analogues, LCMS data of all the free amines, detailed cytotoxicity data of select MTMSA analogues, and primers used for qRT-PCR (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings with associated biochemical and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_001.pdf">jm8b01107_si_001.pdf (980.78 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01107/suppl_file/jm8b01107_si_002.csv">jm8b01107_si_002.csv (13.82 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01107&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01107%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01107" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679996b67c142440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
